study name,sub-group,timepoint,Data format,OR,Lower Limit  ,Upper Limit  ,"Event 
delirium group",Delirium group total (N),"Event 
no-delirium group",Non-delirium group total (N),"95% confidence 
interval",Log OR,SE,"Delirium 
mean","Delirium
(SD)","Delirium 
Sample size","No-delirium 
mean","No-delirium
(SD)","No-delirium 
Sample size",Effect direction,"Independent 
group t-value","Independent 
group p-value",difference in means,Lower limit,upper limit,Tail,Hedges's g,Std Err,Variance
Bickel 2008,Dementia ,38 month,Odds ratio,41.2,4.3,396.2,,,,,,,,,,,,,,,,,,,,,,,
Bickel 2008,Dementia ,8 month,Odds ratio,4.6,0.9,24.2,,,,,,,,,,,,,,,,,,,,,,,
Brown 2020,Dementia,12 month,Odds ratio,1.59,1.06,2.39,,,,,,,,,,,,,,,,,,,,,,,
Davis 2012,Dementia,29 month,Odds ratio,8.65,2.13,35.12,,,,,,,,,,,,,,,,,,,,,,,
Davis 2014,Dementia,24 month,Odds ratio,8.82,2.76,28.2,,,,,,,,,,,,,,,,,,,,,,,
Dros 2020,Dementia ,12 month,Odds ratio,4.952,2.853,8.596,,,,,,,,,,,,,,,,,,,,,,,
Dros 2020,Dementia,3 month,Odds ratio,7.267,2.182,24.207,,,,,,,,,,,,,,,,,,,,,,,
Krogseth 2011,Dementia,6 month,Odds ratio,10.5,1.6,70.3,,,,,,,,,,,,,,,,,,,,,,,
Lingehall 2017,Dementia,60 month,Odds ratio,7.57,2.15,26.65,,,,,,,,,,,,,,,,,,,,,,,
Lundström 2003,Dementia,60 month,Odds ratio,5.66,1.31,23.56,,,,,,,,,,,,,,,,,,,,,,,
Neerland 2017,Dementia,12 month,Odds ratio,6.7,2.3,20.1,,,,,,,,,,,,,,,,,,,,,,,
Ojagbemi 2020,Dementia,3 month,Odds ratio,3.7,1.2,11.2,,,,,,,,,,,,,,,,,,,,,,,
Olofsson 2018,Dementia (postoperative delirium),36 month,Odds ratio,15.582,2.649,91.64,,,,,,,,,,,,,,,,,,,,,,,
Olofsson 2018,Dementia (preoperative delirium),36 month,Odds ratio,1.867,0.437,7.982,,,,,,,,,,,,,,,,,,,,,,,
Rawle 2021,Dementia,24 month,Odds ratio,8.63,5.06,14.7,,,,,,,,,,,,,,,,,,,,,,,
Richardson 2021,Dementia,12 month,Odds ratio,8.8,1.9,41.4,,,,,,,,,,,,,,,,,,,,,,,
Rockwood 1999,Dementia,36 month,Odds ratio,5.97,1.83,19.54,,,,,,,,,,,,,,,,,,,,,,,
van Rijsbergen 2011,Dementia (CDR scale),24 month,Odds ratio,4.7,1.08,20.42,,,,,,,,,,,,,,,,,,,,,,,
van Rijsbergen 2011,Dementia (Rotterdam-CAMCOG),24 month,Odds ratio,7.2,1.88,27.89,,,,,,,,,,,,,,,,,,,,,,,
Bulic 2020,Dementia ,12 month,Cohort 2x2 (Events),0.90625,,,3,27,4,33,,,,,,,,,,,,,,,,,,,
Bulic 2020,Dementia ,6 month,Cohort 2x2 (Events),0.933333333,,,2,27,3,38,,,,,,,,,,,,,,,,,,,
Dostovic 2021,Dementia (dementia rating scale),12 month,Cohort 2x2 (Events),10.32323232,,,56,74,22,95,,,,,,,,,,,,,,,,,,,
Dostovic 2021,Dementia (MMSE),12 month,Cohort 2x2 (Events),11.81512605,,,57,74,21,95,,,,,,,,,,,,,,,,,,,
Garcez 2019,Dementia,24 month,Cohort 2x2 (Events),2.51754386,,,21,66,38,243,,,,,,,,,,,,,,,,,,,
Kat 2008,Dementia,30 month,Cohort 2x2 (Events),14.54545455,,,16,27,2,22,,,,,,,,,,,,,,,,,,,
Marrama 2022,Dementia ,108 month,Cohort 2x2 (Events),0.921832884,,,18,25,53,72,,,,,,,,,,,,,,,,,,,
Marrama 2022,Dementia ,12 month,Cohort 2x2 (Events),0.756198347,,,3,25,11,72,,,,,,,,,,,,,,,,,,,
Marrama 2022,Dementia ,120 month,Cohort 2x2 (Events),0.846774194,,,21,25,62,72,,,,,,,,,,,,,,,,,,,
Marrama 2022,Dementia ,24 month,Cohort 2x2 (Events),0.947368421,,,6,25,18,72,,,,,,,,,,,,,,,,,,,
Marrama 2022,Dementia ,36 month,Cohort 2x2 (Events),0.496240602,,,6,25,28,72,,,,,,,,,,,,,,,,,,,
Marrama 2022,Dementia ,48 month,Cohort 2x2 (Events),0.622390892,,,8,25,31,72,,,,,,,,,,,,,,,,,,,
Marrama 2022,Dementia,60 month,Cohort 2x2 (Events),0.666666667,,,10,25,36,72,,,,,,,,,,,,,,,,,,,
Marrama 2022,Dementia ,72 month,Cohort 2x2 (Events),0.781065089,,,12,25,39,72,,,,,,,,,,,,,,,,,,,
Marrama 2022,Dementia ,84 month,Cohort 2x2 (Events),0.576241135,,,13,25,47,72,,,,,,,,,,,,,,,,,,,
Marrama 2022,Dementia ,96 month,Cohort 2x2 (Events),0.636363636,,,14,25,48,72,,,,,,,,,,,,,,,,,,,
Nerdal 2022,Dementia,18 month,Cohort 2x2 (Events),5.071428571,,,7,9,49,120,,,,,,,,,,,,,,,,,,,
Nerdal 2022,Dementia,3 month,Cohort 2x2 (Events),12.55172414,,,8,10,29,120,,,,,,,,,,,,,,,,,,,
Nerdal 2022,Dementia,36 month,Cohort 2x2 (Events),10,,,4,6,14,84,,,,,,,,,,,,,,,,,,,
Olofsson 2018,Dementia,12 month,Cohort 2x2 (Events),73.51948052,,,25,63,0,55,,,,,,,,,,,,,,,,,,,
Olofsson 2018,Dementia ,4 month,Cohort 2x2 (Events),18.02564103,,,9,67,0,55,,,,,,,,,,,,,,,,,,,
Rahkonen 2001,Dementia,36 month,Cohort 2x2 (Events),5.369565217,,,13,20,46,179,,,,,,,,,,,,,,,,,,,
Rolandi 2020,Dementia,96 month,Cohort 2x2 (Events),13.24615385,,,7,12,104,1088,,,,,,,,,,,,,,,,,,,
Bellelli 2008,Readmission,12 month,Odds ratio,1.6,1.1,2.4,,,,,,,,,,,,,,,,,,,,,,,
George 1997,Readmission ,12 month,Odds ratio,2.05,1.19,3.54,,,,,,,,,,,,,,,,,,,,,,,
George 1997,Readmission ,6 month,Odds ratio,1.92,1.04,3.66,,,,,,,,,,,,,,,,,,,,,,,
Han 2022,Rehopsitalization,1 month,Odds ratio,1.02,0.59,1.76,,,,,,,,,,,,,,,,,,,,,,,
Hempenius 2016,Readmission,3 month,Odds ratio,0.5,0.14,1.74,,,,,,,,,,,,,,,,,,,,,,,
Moon 2018,Readmission,6 month,Odds ratio,1.31,0.13,13.62,,,,,,,,,,,,,,,,,,,,,,,
Large 2013,Readmission,1 month,Odds ratio,10.7,2.2,51.8,,,,,,,,,,,,,,,,,,,,,,,
Noriega 2015,Readmission,1 month,Odds ratio,3.07,1.04,9.08,,,,,,,,,,,,,,,,,,,,,,,
Noriega 2015,Readmission,12 month,Odds ratio,1.55,0.56,4.26,,,,,,,,,,,,,,,,,,,,,,,
Pendlebury 2015,Readmission,1 month,Odds ratio,0.32,0.09,1.1,,,,,,,,,,,,,,,,,,,,,,,
Penfold 2023,Readmission,6 month,Odds ratio,1.79,1.02,3.15,,,,,,,,,,,,,,,,,,,,,,,
Sanguanwit 2023,Revisit: Emergency department,1 month,Odds ratio,1.55,0.59,4.11,,,,,,,,,,,,,,,,,,,,,,,
Traissac 2011,Readmission,1 month,Odds ratio,1.91,1.11,3.29,,,,,,,,,,,,,,,,,,,,,,,
Uthamalingam 2011,Readmission ,1 month,Odds ratio,4.24,2.77,6.47,,,,,,,,,,,,,,,,,,,,,,,
Uthamalingam 2011,Readmission,3 month,Odds ratio,3.72,2.51,5.54,,,,,,,,,,,,,,,,,,,,,,,
Durlach 2023,Readmission,3 month,Cohort 2x2 (Events),1.430041152,,,15,42,54,193,,,,,,,,,,,,,,,,,,,
Eide 2016,Readmission ,1 month,Cohort 2x2 (Events),4.153846154,,,24,76,6,60,,,,,,,,,,,,,,,,,,,
Eide 2016,Readmission,6 month,Cohort 2x2 (Events),1.761904762,,,37,76,21,60,,,,,,,,,,,,,,,,,,,
Falsini 2018,Readmission,6 month,Cohort 2x2 (Events),2.300653595,,,48,111,153,615,,,,,,,,,,,,,,,,,,,
Gleason 2015,Readmission (Complications and delirium vs Complications only),1 month,Cohort 2x2 (Events),1.885714286,,,6,20,5,27,,,,,,,,,,,,,,,,,,,
Gleason 2015,Readmission (Delirium only vs No complications or delirium),1 month,Cohort 2x2 (Events),2.574320051,,,22,115,34,404,,,,,,,,,,,,,,,,,,,
Gual 2018,Readmission,1 month,Cohort 2x2 (Events),0.845354196,,,51,352,93,557,,,,,,,,,,,,,,,,,,,
Hoogma 2023,Rehospitalization,6 month,Cohort 2x2 (Events),1.513227513,,,12,93,14,157,,,,,,,,,,,,,,,,,,,
Kennedy 2014,Rehospitalization,1 month,Cohort 2x2 (Events),2.393160127,,,17,63,82,613,,,,,,,,,,,,,,,,,,,
Koster 2012,Readmission,6 month,Cohort 2x2 (Events),2.327213115,,,21,46,61,230,,,,,,,,,,,,,,,,,,,
Li 2019,Readmission,1 month,Cohort 2x2 (Events),11.14285714,,,4,32,1,79,,,,,,,,,,,,,,,,,,,
Marcantonio 2005,Rehospitalization,1 month,Cohort 2x2 (Events),1.977099237,,,57,188,57,316,,,,,,,,,,,,,,,,,,,
Muzzana 2022,Readmission,1 month,Cohort 2x2 (Events),3.267857143,,,1,15,4,187,,,,,,,,,,,,,,,,,,,
Neufeld 2015,Readmission,18 month,Cohort 2x2 (Events),1.069053708,,,19,36,23,45,,,,,,,,,,,,,,,,,,,
Paulino 2023,Readmission ,3 month,Cohort 2x2 (Events),1.4,,,5,20,10,52,,,,,,,,,,,,,,,,,,,
Paulino 2023,Readmission ,6 month,Cohort 2x2 (Events),5.466666667,,,6,15,5,46,,,,,,,,,,,,,,,,,,,
Racine 2018,Readmission,1 month,Cohort 2x2 (Events),1.797101449,,,4,27,3,34,,,,,,,,,,,,,,,,,,,
Singler 2014,Contact: Emergency department,3 month,Cohort 2x2 (Events),1.04679803,,,5,19,29,114,,,,,,,,,,,,,,,,,,,
Suraarunsumrit 2022,Readmission,3 month,Cohort 2x2 (Events),1.119791667,,,6,42,32,247,,,,,,,,,,,,,,,,,,,
Vasunilashorn 2022,Rehospitalization(DEl-Long),12 month,Cohort 2x2 (Events),1.443073593,,,113,168,84,143,,,,,,,,,,,,,,,,,,,
Vasunilashorn 2022,Rehospitalization (DEL-short),12 month,Cohort 2x2 (Events),1.545189504,,,106,155,91,156,,,,,,,,,,,,,,,,,,,
Vasunilashorn 2022,Rehospitalization (DEl-Long),3 month,Cohort 2x2 (Events),1.531914894,,,72,168,47,143,,,,,,,,,,,,,,,,,,,
Vasunilashorn 2022,Rehospitalization (DEL-short),3 month,Cohort 2x2 (Events),1.522727273,,,67,155,52,156,,,,,,,,,,,,,,,,,,,
Whittamore 2014,Readmission,6 month,Cohort 2x2 (Events),1.021049754,,,45,107,59,142,,,,,,,,,,,,,,,,,,,
Zakriya 2004,Readmission: Emergency department ,1.5 month,Cohort 2x2 (Events),0.630769231,,,0,19,2,63,,,,,,,,,,,,,,,,,,,
Zakriya 2004,Readmission: Emergency department,3 month,Cohort 2x2 (Events),0.539170507,,,0,15,3,61,,,,,,,,,,,,,,,,,,,
Zakriya 2004,Readmission: Hospital admission ,1.5 month,Cohort 2x2 (Events),0.630769231,,,0,19,2,63,,,,,,,,,,,,,,,,,,,
Zakriya 2004,Readmission: Hospital admission ,3 month,Cohort 2x2 (Events),0.539170507,,,0,15,3,61,,,,,,,,,,,,,,,,,,,
Bellelli 2008,Institutionalisation,12 month,Odds ratio,2.3,1.3,3.9,,,,,,,,,,,,,,,,,,,,,,,
Cole 2008,Institutionalisation ,12 month,Odds ratio,1.37,0.67,2.83,,,,,,,,,,,,,,,,,,,,,,,
Cole 2008,Institutionalisation,6 month,Odds ratio,0.79,0.4,1.56,,,,,,,,,,,,,,,,,,,,,,,
deJong 2019,Institutionalisation (wth dementia) ,12 month,Odds ratio,2.09,0.36,12.32,,,,,,,,,,,,,,,,,,,,,,,
deJong 2019,Institutionalisation (wthout dementia),12 month,Odds ratio,7.06,2.13,23.41,,,,,,,,,,,,,,,,,,,,,,,
George 1997,Institutionalisation ,12 month,Odds ratio,4.53,,14.59,,,,,,,,,,,,,,,,,,,,,,,
George 1997,Institutionalisation,6 month,Odds ratio,4.3,1.8,,,,,,,,,,,,,,,,,,,,,,,,
Givens 2009,Institutionalisation,12 month,Odds ratio,2.49,1.06,5.83,,,,,,,,,,,,,,,,,,,,,,,
Hawley 2023,Institutionalisation,4 month,Odds ratio,2.1739,1.8181,2.6315,,,,,,,,,,,,,,,,,,,,,,,
Inouye 1998,Institutionalisation,3 month,Odds ratio,3,1.5,6,,,,,,,,,,,,,,,,,,,,,,,
Krogseth 2014,Institutionalisation,6 month,Odds ratio,5.5,1.77,17.11,,,,,,,,,,,,,,,,,,,,,,,
Labaste 2023,Institutionalisation,3 month,Odds ratio,5.23,1.1,27.04,,,,,,,,,,,,,,,,,,,,,,,
McCusker 2001,Institutionalisation,12 month,Odds ratio,1.15,0.33,4.05,,,,,,,,,,,,,,,,,,,,,,,
Morandi 2014,Institutionalisation,12 month,Odds ratio,2.41,1.02,5.66,,,,,,,,,,,,,,,,,,,,,,,
O'Keeffe 1997,Institutionalisation,6 month,Odds ratio,2.8,1.3,6.1,,,,,,,,,,,,,,,,,,,,,,,
Pitkala 2005,Institutionalisation,24 month,Odds ratio,2.45,1.2,4.9,,,,,,,,,,,,,,,,,,,,,,,
Rawle 2021,Institutionalisation,24 month,Odds ratio,4.79,2.87,7.99,,,,,,,,,,,,,,,,,,,,,,,
Durlach 2023,Institutionalisation ,3 month,Cohort 2x2 (Events),,,,18,42,53,193,,,,,,,,,,,,,,,,,,,
Eeles 2010,Institutionalisation ,12 month,Cohort 2x2 (Events),,,,15,37,24,136,,,,,,,,,,,,,,,,,,,
Eeles 2010,Institutionalisation ,24 month,Cohort 2x2 (Events),,,,7,21,17,112,,,,,,,,,,,,,,,,,,,
Eeles 2010,Institutionalisation ,36 month,Cohort 2x2 (Events),,,,4,14,13,95,,,,,,,,,,,,,,,,,,,
Eeles 2010,Institutionalisation ,48 month,Cohort 2x2 (Events),,,,2,11,11,87,,,,,,,,,,,,,,,,,,,
Eeles 2010,Institutionalisation ,60 month,Cohort 2x2 (Events),,,,1,8,7,61,,,,,,,,,,,,,,,,,,,
Francis 1990,Institutionalisation,6 month,Cohort 2x2 (Events),,,,6,49,8,167,,,,,,,,,,,,,,,,,,,
Hölttä 2011,Institutionalisation,24 month,Cohort 2x2 (Events),,,,51,66,130,189,,,,,,,,,,,,,,,,,,,
Kat 2008,Institutionalisation,30 month,Cohort 2x2 (Events),,,,19,38,8,28,,,,,,,,,,,,,,,,,,,
Maclullich 2019,Institutionalisation,3 month,Cohort 2x2 (Events),,,,1,34,2,206,,,,,,,,,,,,,,,,,,,
Mariz 2013,Institutionalisation,1 month,Cohort 2x2 (Events),,,,13,28,31,50,,,,,,,,,,,,,,,,,,,
McAvay 2006,Institutionalisation,12 month,Cohort 2x2 (Events),,,,14,31,111,378,,,,,,,,,,,,,,,,,,,
Neufeld 2015,Institutionalisation,18 month,Cohort 2x2 (Events),,,,3,36,2,45,,,,,,,,,,,,,,,,,,,
Paulino 2023,Institutionalisation ,3 month,Cohort 2x2 (Events),,,,5,20,5,52,,,,,,,,,,,,,,,,,,,
Paulino 2023,Institutionalisation,6 month,Cohort 2x2 (Events),,,,1,15,2,46,,,,,,,,,,,,,,,,,,,
Racine 2018,Institutionalisation,1 month,Cohort 2x2 (Events),,,,3,27,3,34,,,,,,,,,,,,,,,,,,,
Sheng 2006,Institutionalisation,12 month,Cohort 2x2 (Events),,,,13,39,19,117,,,,,,,,,,,,,,,,,,,
Visser 2015,Institutionalisation,12 month,Cohort 2x2 (Events),,,,10,22,27,441,,,,,,,,,,,,,,,,,,,
Zakriya 2004,Institutionalisation ,3 month,Cohort 2x2 (Events),,,,4,15,5,61,,,,,,,,,,,,,,,,,,,
Zakriya 2004,Institutionalisation,1.5 month,Cohort 2x2 (Events),,,,6,19,2,63,,,,,,,,,,,,,,,,,,,
Miu 2013,Institutionalisation,12 month,Cohort 2x2 (Events),,,,56,86,29,228,,,,,,,,,,,,,,,,,,,
Miu 2013,Institutionalisation ,6 month,Cohort 2x2 (Events),,,,52,86,28,228,,,,,,,,,,,,,,,,,,,
Abelha 2013,Mortality,6 month,Odds ratio,2.562,1.36,4.828,,,,,,,,,,,,,,,,,,,,,,,
Alzoubi 2023,Mortality,4 month,Odds ratio,7.11,1.97,25.68,,,,,,,,,,,,,,,,,,,,,,,
Arneson 2023,Mortality ,0.23 month,Odds ratio,5.23,1.44,19.05,,,,,,,,,,,,,,,,,,,,,,,
Arneson 2023,Mortality ,1 month,Odds ratio,2.82,1.45,5.46,,,,,,,,,,,,,,,,,,,,,,,
Bickel 2008,Mortality,38 month,Odds ratio,1.7,0.6,5,,,,,,,,,,,,,,,,,,,,,,,
Bickel 2008,Mortality,8 month,Odds ratio,1.3,0.2,8.5,,,,,,,,,,,,,,,,,,,,,,,
deJong 2019,Mortality ,1 month,Odds ratio,1.68,0.8,3.53,,,,,,,,,,,,,,,,,,,,,,,
deJong 2019,Mortality,12 month,Odds ratio,1.93,1.13,3.28,,,,,,,,,,,,,,,,,,,,,,,
Edelstein 2004,Mortality,12 month,Odds ratio,2.4,1.1,4.9,,,,,,,,,,,,,,,,,,,,,,,
Falsini 2018,Mortality ,1 month,Odds ratio,5.57,2.51,12.4,,,,,,,,,,,,,,,,,,,,,,,
Falsini 2018,Mortality ,6 month,Odds ratio,2.39,1.16,4.9,,,,,,,,,,,,,,,,,,,,,,,
Fick 2013,Mortality,1 month,Odds ratio,2.33,0.82,6.61,,,,,,,,,,,,,,,,,,,,,,,
George 1997,Mortality,12 month,Odds ratio,2.3,1.25,4.35,,,,,,,,,,,,,,,,,,,,,,,
George 1997,Mortality ,6 month,Odds ratio,3.11,1.52,6.77,,,,,,,,,,,,,,,,,,,,,,,
Givens 2009,Mortality,12 month,Odds ratio,1.32,0.56,3.08,,,,,,,,,,,,,,,,,,,,,,,
Han 2022,Mortality,1 month,Odds ratio,2.68,1.05,6.5,,,,,,,,,,,,,,,,,,,,,,,
Inouye 1998,Mortality,3 month,Odds ratio,1.6,0.8,3.2,,,,,,,,,,,,,,,,,,,,,,,
Kakuma 2003,mortality ,12 month,Odds ratio,2.5,0.76,8.18,,,,,,,,,,,,,,,,,,,,,,,
Kakuma 2003,Mortality,18 month,Odds ratio,1.34,0.45,4.01,,,,,,,,,,,,,,,,,,,,,,,
Kakuma 2003,Mortality ,6 month,Odds ratio,6.17,1.43,26.56,,,,,,,,,,,,,,,,,,,,,,,
Kilicaslan 2022,Mortality,6 month,Odds ratio,1.82,1.02,3.23,,,,,,,,,,,,,,,,,,,,,,,
Knauf 2019,Mortality,60 month,Odds ratio,0.462,0.26,0.818,,,,,,,,,,,,,,,,,,,,,,,
Krzych 2014,Mortality ,1 month,Odds ratio,3.735,1.428,9.772,,,,,,,,,,,,,,,,,,,,,,,
Maclullich 2019,Mortality,3 month,Odds ratio,2,0.85,4.7,,,,,,,,,,,,,,,,,,,,,,,
Mazzola 2015,Mortality,6 month,Odds ratio,3.8,1.72,8.39,,,,,,,,,,,,,,,,,,,,,,,
Monacelli 2018,Mortality,3 month,Odds ratio,7.88,0.97,63.71,,,,,,,,,,,,,,,,,,,,,,,
Morandi 2014,Mortality,12 month,Odds ratio,1.54,0.77,3.07,,,,,,,,,,,,,,,,,,,,,,,
Moskowitz 2017,Mortality,60 month,Odds ratio,7.35,1.49,36.18,,,,,,,,,,,,,,,,,,,,,,,
Noriega 2015,Mortality ,12 month,Odds ratio,4.2,1.81,9.74,,,,,,,,,,,,,,,,,,,,,,,
Ojagbemi 2021,Mortality ,12 month,Odds ratio,3.4,1.5,7.6,,,,,,,,,,,,,,,,,,,,,,,
Ojagbemi 2021,Mortality,3 month,Odds ratio,3.1,1.2,7.6,,,,,,,,,,,,,,,,,,,,,,,
O'Keeffe 1997,Mortality,6 month,Odds ratio,1.4,0.7,2.8,,,,,,,,,,,,,,,,,,,,,,,
Pasinska 2019,Mortality ,12 month,Odds ratio,1.72,1.01,2.92,,,,,,,,,,,,,,,,,,,,,,,
Pasinska 2019,Mortality ,3 month,Odds ratio,2.83,1.54,5.21,,,,,,,,,,,,,,,,,,,,,,,
Penfold 2023,Mortality,6 month,Odds ratio,1.69,1.13,2.54,,,,,,,,,,,,,,,,,,,,,,,
Pitkala 2005,Mortality ,12 month,Odds ratio,1.86,1.1,3.1,,,,,,,,,,,,,,,,,,,,,,,
Pitkala 2005,Mortality ,24 month,Odds ratio,1.76,1.1,2.8,,,,,,,,,,,,,,,,,,,,,,,
Praditsuwan 2013,Mortality,3 month,Odds ratio,3.33,1.45,7.62,,,,,,,,,,,,,,,,,,,,,,,
Radcliffe 2023,Mortality either COVID-19 or suspected COVID-19,1 month,Odds ratio,5.5,2.6,11.7,,,,,,,,,,,,,,,,,,,,,,,
Radcliffe 2023,Mortality patients with COVID-19,1 month,Odds ratio,7.1,2.2,22.7,,,,,,,,,,,,,,,,,,,,,,,
Rego 2022,Mortality,12 month,Odds ratio,1.96,0.25,15.39,,,,,,,,,,,,,,,,,,,,,,,
Rizzi 2015,Mortality,1 month,Odds ratio,3.532,1.422,8.769,,,,,,,,,,,,,,,,,,,,,,,
Rollo 2022,Mortality,3 month,Odds ratio,3.45,0.66,17.95,,,,,,,,,,,,,,,,,,,,,,,
Sanguanwit 2023,Mortality,1 month,Odds ratio,2.15,0.37,12.25,,,,,,,,,,,,,,,,,,,,,,,
VanRompaey 2009,Mortality ,3 month,Odds ratio,4.31,1.26,14.68,,,,,,,,,,,,,,,,,,,,,,,
VanRompaey 2009,Mortality ,6 month,Odds ratio,3.8,1.11,13.05,,,,,,,,,,,,,,,,,,,,,,,
Veiga 2012,Mortality,6 month,Odds ratio,3,1.8,5,,,,,,,,,,,,,,,,,,,,,,,
Wang 2021,Mortality,24 month,Odds ratio,0.946,0.226,3.97,,,,,,,,,,,,,,,,,,,,,,,
Ziman 2020,Mortality,60 month,Odds ratio,1.18,0.85,1.65,,,,,,,,,,,,,,,,,,,,,,,
Adamis 2007,Mortality,6 month,Cohort 2x2 (Events),,,,6,47,15,117,,,,,,,,,,,,,,,,,,,
Alberto 2018,Mortality,12 month,Cohort 2x2 (Events),,,,24,35,76,204,,,,,,,,,,,,,,,,,,,
AlHuraizi 2023,Mortality,12 month,Cohort 2x2 (Events),,,,55,153,21,131,,,,,,,,,,,,,,,,,,,
AlHuraizi 2023,Mortality ,3 month,Cohort 2x2 (Events),,,,39,153,11,131,,,,,,,,,,,,,,,,,,,
Arneson 2023,Mortality ,0.16 month,Cohort 2x2 (Events),,,,8,107,12,860,,,,,,,,,,,,,,,,,,,
Arneson 2023,Mortality ,0.33 month,Cohort 2x2 (Events),,,,10,107,20,860,,,,,,,,,,,,,,,,,,,
Arneson 2023,Mortality ,0.5 month,Cohort 2x2 (Events),,,,15,107,30,860,,,,,,,,,,,,,,,,,,,
Arneson 2023,Mortality ,0.66 month,Cohort 2x2 (Events),,,,18,107,37,860,,,,,,,,,,,,,,,,,,,
Arneson 2023,Mortality ,0.83 month,Cohort 2x2 (Events),,,,19,107,48,860,,,,,,,,,,,,,,,,,,,
Avelino-Silva 2017,Mortality (Delirium vs no delirium no dementia),12 month,Cohort 2x2 (Events),,,,53,207,85,527,,,,,,,,,,,,,,,,,,,
Avelino-Silva 2017,"Mortality (DSD vs No delirium, dementia)",12 month,Cohort 2x2 (Events),,,,92,250,42,160,,,,,,,,,,,,,,,,,,,
Avelino-Silva 2018,Mortality,12 month,Cohort 2x2 (Events),,,,145,457,127,687,,,,,,,,,,,,,,,,,,,
Bagienski 2017,Mortality ,1 month,Cohort 2x2 (Events),,,,5,29,0,112,,,,,,,,,,,,,,,,,,,
Bagienski 2017,Mortality,12 month,Cohort 2x2 (Events),,,,11,29,4,112,,,,,,,,,,,,,,,,,,,
Bagienski 2017,Mortality  ,15.8 month,Cohort 2x2 (Events),,,,14,29,12,112,,,,,,,,,,,,,,,,,,,
Bakker 2012,Mortality,1 month,Cohort 2x2 (Events),,,,9,63,0,138,,,,,,,,,,,,,,,,,,,
Beishuizen 2020,Mortality,7 month,Cohort 2x2 (Events),,,,4,14,6,77,,,,,,,,,,,,,,,,,,,
Bellelli 2007,Mortality,12 month,Cohort 2x2 (Events),,,,17,94,9,94,,,,,,,,,,,,,,,,,,,
Bellelli 2008,Mortality,12 month,Cohort 2x2 (Events),,,,37,139,99,933,,,,,,,,,,,,,,,,,,,
Bellelli 2018,Mortality,6 month,Cohort 2x2 (Events),,,,53,220,29,351,,,,,,,,,,,,,,,,,,,
Bulic 2020,Mortality,12 month,Cohort 2x2 (Events),,,,5,37,12,66,,,,,,,,,,,,,,,,,,,
Cartei 2022,Mortality,12 month,Cohort 2x2 (Events),,,,52,193,21,194,,,,,,,,,,,,,,,,,,,
Chalmers 2021,Mortality,44 month,Cohort 2x2 (Events),,,,371,831,499,1640,,,,,,,,,,,,,,,,,,,
Chan 2016,Mortality ,12 month,Cohort 2x2 (Events),,,,32,49,21,104,,,,,,,,,,,,,,,,,,,
Chan 2016,Mortality,1 month,Cohort 2x2 (Events),,,,11,49,5,104,,,,,,,,,,,,,,,,,,,
Chan 2017,Mortality ,12 month,Cohort 2x2 (Events),,,,16,39,18,117,,,,,,,,,,,,,,,,,,,
Chan 2017,Mortality,1 month,Cohort 2x2 (Events),,,,4,39,5,117,,,,,,,,,,,,,,,,,,,
Chan 2017,Mortality ,6 month,Cohort 2x2 (Events),,,,11,39,14,117,,,,,,,,,,,,,,,,,,,
Cheong 2021,Mortality,1 month,Cohort 2x2 (Events),,,,5,50,12,396,,,,,,,,,,,,,,,,,,,
Cole 2008,Mortality ,12 month,Cohort 2x2 (Events),,,,31,115,7,95,,,,,,,,,,,,,,,,,,,
Cole 2008,Mortality ,6 month,Cohort 2x2 (Events),,,,16,115,4,95,,,,,,,,,,,,,,,,,,,
Curyto 2001,Mortality,36 month,Cohort 2x2 (Events),,,,9,12,21,41,,,,,,,,,,,,,,,,,,,
Czyzycki 2022,Mortality total ,12 month,Cohort 2x2 (Events),,,,92,158,87,490,,,,,,,,,,,,,,,,,,,
Czyzycki 2022,Mortality total ,3 month,Cohort 2x2 (Events),,,,73,163,54,488,,,,,,,,,,,,,,,,,,,
Dani 2017,Mortality,36 month,Cohort 2x2 (Events),,,,59,72,311,636,,,,,,,,,,,,,,,,,,,
Davis 2014,Mortality,24 month,Cohort 2x2 (Events),,,,72,122,706,2075,,,,,,,,,,,,,,,,,,,
DeCrane 2011,Mortality,1 month,Cohort 2x2 (Events),,,,24,70,45,250,,,,,,,,,,,,,,,,,,,
deHaan 2023,Mortality ,12 month,Cohort 2x2 (Events),,,,109,326,286,1725,,,,,,,,,,,,,,,,,,,
deHaan 2023,Mortality,1 month,Cohort 2x2 (Events),,,,53,326,99,1725,,,,,,,,,,,,,,,,,,,
Diwell 2018,Mortality ,36 month,Cohort 2x2 (Events),,,,35,56,156,301,,,,,,,,,,,,,,,,,,,
Diwell 2018,Mortality,6 month,Cohort 2x2 (Events),,,,21,56,145,301,,,,,,,,,,,,,,,,,,,
Duprey 2020,Mortality ,1.67 month,Cohort 2x2 (Events),,,,115,542,171,953,,,,,,,,,,,,,,,,,,,
Duprey 2020,Mortality ,2.33 month,Cohort 2x2 (Events),,,,118,242,177,953,,,,,,,,,,,,,,,,,,,
Duprey 2020,Mortality ,3 month,Cohort 2x2 (Events),,,,124,542,183,953,,,,,,,,,,,,,,,,,,,
Durlach 2023,Mortality,3 month,Cohort 2x2 (Events),,,,9,42,29,193,,,,,,,,,,,,,,,,,,,
Edlund 2006,Mortality,12 month,Cohort 2x2 (Events),,,,45,125,55,275,,,,,,,,,,,,,,,,,,,
van Eijsden 2015,Mortality ,12 month,Cohort 2x2 (Events),,,,20,29,24,63,,,,,,,,,,,,,,,,,,,
van Eijsden 2015,Mortality ,18 month,Cohort 2x2 (Events),,,,26,29,63,63,,,,,,,,,,,,,,,,,,,
van Eijsden 2015,Mortality ,6 month,Cohort 2x2 (Events),,,,11,29,5,63,,,,,,,,,,,,,,,,,,,
Elsayem 2017,Mortality,10 month,Cohort 2x2 (Events),,,,39,44,144,198,,,,,,,,,,,,,,,,,,,
Elsayem 2017,Mortality ,15 month,Cohort 2x2 (Events),,,,43,44,186,198,,,,,,,,,,,,,,,,,,,
Elsayem 2017,Mortality ,5 month,Cohort 2x2 (Events),,,,33,44,81,198,,,,,,,,,,,,,,,,,,,
Evensen 2021,Mortality,12 month,Cohort 2x2 (Events),,,,18,83,45,145,,,,,,,,,,,,,,,,,,,
FialhoSilva 2021,Mortality,3 month,Cohort 2x2 (Events),,,,18,71,5,151,,,,,,,,,,,,,,,,,,,
Francis 1990,Mortality,6 month,Cohort 2x2 (Events),,,,7,49,17,167,,,,,,,,,,,,,,,,,,,
Francis 1992,Mortality,24 month,Cohort 2x2 (Events),,,,18,45,37,160,,,,,,,,,,,,,,,,,,,
Furlaneto 2007,Mortality ,24 month,Cohort 2x2 (Events),,,,9,25,16,60,,,,,,,,,,,,,,,,,,,
Furlaneto 2007,Mortality ,48 month,Cohort 2x2 (Events),,,,15,25,24,60,,,,,,,,,,,,,,,,,,,
Gonzale 2005,Mortality,3 month,Cohort 2x2 (Events),,,,20,58,10,91,,,,,,,,,,,,,,,,,,,
Gonzalez 2009,Mortality,3 month,Cohort 2x2 (Events),,,,49,192,20,350,,,,,,,,,,,,,,,,,,,
Gottschalk 2015,Mortality,168 month,Cohort 2x2 (Events),,,,127,151,213,308,,,,,,,,,,,,,,,,,,,
Gou 2021,Mortality ,12 month,Cohort 2x2 (Events),,,,1,122,6,375,,,,,,,,,,,,,,,,,,,
Goudzwaard 2020,Mortality,16 month,Cohort 2x2 (Events),,,,24,75,70,468,,,,,,,,,,,,,,,,,,,
Han 2010,Mortality,1 month,Cohort 2x2 (Events),,,,11,108,11,520,,,,,,,,,,,,,,,,,,,
Han 2010,Mortality ,2 month,Cohort 2x2 (Events),,,,15,108,19,520,,,,,,,,,,,,,,,,,,,
Han 2010,Mortality ,3 month,Cohort 2x2 (Events),,,,22,108,28,520,,,,,,,,,,,,,,,,,,,
Han 2010,Mortality,4 month,Cohort 2x2 (Events),,,,27,108,34,520,,,,,,,,,,,,,,,,,,,
Han 2010,Mortality ,5 month,Cohort 2x2 (Events),,,,29,108,46,520,,,,,,,,,,,,,,,,,,,
Han 2010,Mortality,6 month,Cohort 2x2 (Events),,,,30,108,49,520,,,,,,,,,,,,,,,,,,,
Hapca 2018,Mortality ,1 month,Cohort 2x2 (Events),,,,153,1065,382,4344,,,,,,,,,,,,,,,,,,,
Hapca 2018,Mortality ,12 month,Cohort 2x2 (Events),,,,233,508,222,522,,,,,,,,,,,,,,,,,,,
Hapca 2018,Mortality ,24 month,Cohort 2x2 (Events),,,,299,508,289,522,,,,,,,,,,,,,,,,,,,
Hapca 2018,Mortality ,3 month,Cohort 2x2 (Events),,,,263,1065,667,4344,,,,,,,,,,,,,,,,,,,
Hapca 2018,Mortality ,6 month,Cohort 2x2 (Events),,,,172,508,150,522,,,,,,,,,,,,,,,,,,,
Hempenius 2016,Mortality,3 month,Cohort 2x2 (Events),,,,1,31,11,222,,,,,,,,,,,,,,,,,,,
Lee 2017,"Mortality delirium vs No delirium, no dementia",1 month,Cohort 2x2 (Events),,,,8,73,9,248,,,,,,,,,,,,,,,,,,,
Lee 2017,Mortality DSD vs dementia,1 month,Cohort 2x2 (Events),,,,8,77,3,68,,,,,,,,,,,,,,,,,,,
Lee 2017,"Mortality delirium vs No delirium, no dementia",12 month,Cohort 2x2 (Events),,,,17,73,43,248,,,,,,,,,,,,,,,,,,,
Lee 2017,Mortality DSD vs dementia,12 month,Cohort 2x2 (Events),,,,31,77,18,68,,,,,,,,,,,,,,,,,,,
Lee 2017,"Mortality delirium vs No delirium, no dementia",6 month,Cohort 2x2 (Events),,,,15,73,30,248,,,,,,,,,,,,,,,,,,,
Lee 2017,Mortality DSD vs dementia,6 month,Cohort 2x2 (Events),,,,21,77,11,68,,,,,,,,,,,,,,,,,,,
Hölttä 2011,Mortality,24 month,Cohort 2x2 (Events),,,,36,66,82,189,,,,,,,,,,,,,,,,,,,
Honda 2016,Mortality ,12 month,Cohort 2x2 (Events),,,,85,134,257,465,,,,,,,,,,,,,,,,,,,
Honda 2016,Mortality ,18 month,Cohort 2x2 (Events),,,,104,134,354,465,,,,,,,,,,,,,,,,,,,
Honda 2016,Mortality ,24 month,Cohort 2x2 (Events),,,,124,134,422,465,,,,,,,,,,,,,,,,,,,
Honda 2016,Mortality ,6 month,Cohort 2x2 (Events),,,,59,134,159,465,,,,,,,,,,,,,,,,,,,
Hoogma 2023,Mortality ,1 month,Cohort 2x2 (Events),,,,2,93,2,157,,,,,,,,,,,,,,,,,,,
Hoogma 2023,Mortality ,6 month,Cohort 2x2 (Events),,,,6,93,5,157,,,,,,,,,,,,,,,,,,,
Hshieh 2023,Mortality ADRD patients,1 month,Cohort 2x2 (Events),,,,6,39,4,37,,,,,,,,,,,,,,,,,,,
Hshieh 2023,Mortality Non-ADRD patients,1 month,Cohort 2x2 (Events),,,,3,56,8,179,,,,,,,,,,,,,,,,,,,
Hshieh 2023,Mortality ADRD patients,12 month,Cohort 2x2 (Events),,,,2,39,3,37,,,,,,,,,,,,,,,,,,,
Hshieh 2023,Mortality Non-ADRD patients,12 month,Cohort 2x2 (Events),,,,13,56,36,179,,,,,,,,,,,,,,,,,,,
Hshieh 2023,Mortality ADRD patients,3 month,Cohort 2x2 (Events),,,,18,39,11,37,,,,,,,,,,,,,,,,,,,
Hshieh 2023,Mortality Non-ADRD patients,3 month,Cohort 2x2 (Events),,,,5,56,18,179,,,,,,,,,,,,,,,,,,,
Hughes 2021,Mortality,12 month,Cohort 2x2 (Events),,,,305,740,113,300,,,,,,,,,,,,,,,,,,,
Inouye 2016,Mortality,19 month,Cohort 2x2 (Events),,,,12,134,25,426,,,,,,,,,,,,,,,,,,,
Isaia 2009,Mortality,6 month,Cohort 2x2 (Events),,,,6,14,12,130,,,,,,,,,,,,,,,,,,,
Iwata 2020,Mortality ,12 month,Cohort 2x2 (Events),,,,77,109,138,299,,,,,,,,,,,,,,,,,,,
Iwata 2020,Mortality ,3 month,Cohort 2x2 (Events),,,,32,109,60,299,,,,,,,,,,,,,,,,,,,
Iwata 2020,Mortality ,6 month,Cohort 2x2 (Events),,,,53,109,94,299,,,,,,,,,,,,,,,,,,,
Iwata 2020,Mortality ,9 month,Cohort 2x2 (Events),,,,67,109,122,299,,,,,,,,,,,,,,,,,,,
Han 2017,Mortality ,1 month,Cohort 2x2 (Events),,,,15,155,20,929,,,,,,,,,,,,,,,,,,,
Han 2017,Mortality ,2 month,Cohort 2x2 (Events),,,,24,155,42,929,,,,,,,,,,,,,,,,,,,
Han 2017,Mortality ,3 month,Cohort 2x2 (Events),,,,32,155,61,929,,,,,,,,,,,,,,,,,,,
Han 2017,Mortality ,4 month,Cohort 2x2 (Events),,,,38,155,76,929,,,,,,,,,,,,,,,,,,,
Han 2017,Mortality ,5 month,Cohort 2x2 (Events),,,,40,155,89,929,,,,,,,,,,,,,,,,,,,
Han 2017,Mortality ,6 month,Cohort 2x2 (Events),,,,43,155,97,929,,,,,,,,,,,,,,,,,,,
Juliebø 2010,"Mortality (dementia, delirium vs dementia, no delirium) ",12 month,Cohort 2x2 (Events),,,,36,101,14,50,,,,,,,,,,,,,,,,,,,
Juliebø 2010,"Mortality (no dementia, delirium vs no dementia, no delirium) ",12 month,Cohort 2x2 (Events),,,,4,42,14,138,,,,,,,,,,,,,,,,,,,
Kat 2008,Mortality,30 month,Cohort 2x2 (Events),,,,39,71,14,41,,,,,,,,,,,,,,,,,,,
Kat 2011,Mortality,24 month,Cohort 2x2 (Events),,,,22,67,54,522,,,,,,,,,,,,,,,,,,,
Kennedy 2014,Mortality,1 month,Cohort 2x2 (Events),,,,4,63,7,613,,,,,,,,,,,,,,,,,,,
Kilicaslan 2022,Mortality ,12 month,Cohort 2x2 (Events),,,,25,44,67,371,,,,,,,,,,,,,,,,,,,
Kilicaslan 2022,Mortality ,18 month,Cohort 2x2 (Events),,,,29,44,88,371,,,,,,,,,,,,,,,,,,,
Kilicaslan 2022,Mortality,24 month,Cohort 2x2 (Events),,,,30,44,101,371,,,,,,,,,,,,,,,,,,,
Kilicaslan 2022,Mortality ,30 month,Cohort 2x2 (Events),,,,31,44,114,371,,,,,,,,,,,,,,,,,,,
Kilicaslan 2022,Mortality ,36 month,Cohort 2x2 (Events),,,,31,44,120,371,,,,,,,,,,,,,,,,,,,
Kilicaslan 2022,Mortality ,42 month,Cohort 2x2 (Events),,,,32,44,129,371,,,,,,,,,,,,,,,,,,,
Kilicaslan 2022,Mortality ,48 month,Cohort 2x2 (Events),,,,34,44,136,371,,,,,,,,,,,,,,,,,,,
Kilicaslan 2022,Mortality ,54 month,Cohort 2x2 (Events),,,,35,44,145,371,,,,,,,,,,,,,,,,,,,
Kilicaslan 2022,Mortality ,60 month,Cohort 2x2 (Events),,,,35,44,148,371,,,,,,,,,,,,,,,,,,,
Korber 2021,Mortality ,14 month,Cohort 2x2 (Events),,,,9,16,51,161,,,,,,,,,,,,,,,,,,,
Korber 2021,Mortality ,20 month,Cohort 2x2 (Events),,,,11,16,103,161,,,,,,,,,,,,,,,,,,,
Korber 2021,Mortality ,26.67 month,Cohort 2x2 (Events),,,,13,16,142,161,,,,,,,,,,,,,,,,,,,
Korber 2021,Mortality ,6.67 month,Cohort 2x2 (Events),,,,5,16,27,161,,,,,,,,,,,,,,,,,,,
Koster 2012,Mortality,6 month,Cohort 2x2 (Events),,,,7,46,5,218,,,,,,,,,,,,,,,,,,,
Kotfis 2019,Mortality ,12 month,Cohort 2x2 (Events),,,,69,121,151,639,,,,,,,,,,,,,,,,,,,
Kotfis 2019,Mortality ,1 month,Cohort 2x2 (Events),,,,41,121,82,639,,,,,,,,,,,,,,,,,,,
Kotfis 2019,Mortality ,3 month,Cohort 2x2 (Events),,,,57,121,118,639,,,,,,,,,,,,,,,,,,,
Krzych 2014,Mortality ,46 month,Cohort 2x2 (Events),,,,55,237,376,5544,,,,,,,,,,,,,,,,,,,
Kunicki 2023,Mortality ,1 month,Cohort 2x2 (Events),,,,0,129,1,419,,,,,,,,,,,,,,,,,,,
Kunicki 2023,Mortality ,12 month,Cohort 2x2 (Events),,,,1,120,2,391,,,,,,,,,,,,,,,,,,,
Kunicki 2023,Mortality,18 month,Cohort 2x2 (Events),,,,1,117,5,382,,,,,,,,,,,,,,,,,,,
Kunicki 2023,Mortality ,2 month,Cohort 2x2 (Events),,,,0,126,1,419,,,,,,,,,,,,,,,,,,,
Kunicki 2023,Mortality ,24 month,Cohort 2x2 (Events),,,,3,106,6,368,,,,,,,,,,,,,,,,,,,
Kunicki 2023,Mortality ,30 month,Cohort 2x2 (Events),,,,4,83,7,242,,,,,,,,,,,,,,,,,,,
Kunicki 2023,Mortality ,36 month,Cohort 2x2 (Events),,,,0,110,3,346,,,,,,,,,,,,,,,,,,,
Kunicki 2023,Mortality ,48 month,Cohort 2x2 (Events),,,,9,90,15,295,,,,,,,,,,,,,,,,,,,
Kunicki 2023,Mortality ,6 month,Cohort 2x2 (Events),,,,1,124,4,404,,,,,,,,,,,,,,,,,,,
Kunicki 2023,Mortality ,60 month,Cohort 2x2 (Events),,,,9,79,12,275,,,,,,,,,,,,,,,,,,,
Kunicki 2023,Mortality ,72 month,Cohort 2x2 (Events),,,,11,65,15,248,,,,,,,,,,,,,,,,,,,
Moon 2018,Mortality (delirium vs no delirium no dementia),1 month,Cohort 2x2 (Events),,,,2,14,1,36,,,,,,,,,,,,,,,,,,,
Moon 2018,Mortality (dsd vs dementia only),1 month,Cohort 2x2 (Events),,,,5,69,1,54,,,,,,,,,,,,,,,,,,,
Moon 2018,Mortality (delirium vs no delirium no dementia),3 month,Cohort 2x2 (Events),,,,3,14,1,36,,,,,,,,,,,,,,,,,,,
Moon 2018,Mortality (dsd vs dementia only),3 month,Cohort 2x2 (Events),,,,9,69,3,54,,,,,,,,,,,,,,,,,,,
Moon 2018,Mortality (delirium vs no delirium no dementia),6 month,Cohort 2x2 (Events),,,,4,14,2,36,,,,,,,,,,,,,,,,,,,
Moon 2018,Mortality (dsd vs dementia only),6 month,Cohort 2x2 (Events),,,,11,69,4,54,,,,,,,,,,,,,,,,,,,
Labaste 2020,Mortality,36 month,Cohort 2x2 (Events),,,,35,61,35,112,,,,,,,,,,,,,,,,,,,
Large 2013,Mortality ,12 month,Cohort 2x2 (Events),,,,5,14,12,35,,,,,,,,,,,,,,,,,,,
Large 2013,Mortality ,3 month,Cohort 2x2 (Events),,,,3,14,6,35,,,,,,,,,,,,,,,,,,,
Lee 2011,Mortality ,24 month,Cohort 2x2 (Events),,,,8,56,20,162,,,,,,,,,,,,,,,,,,,
Lee 2011,Mortality ,40 month,Cohort 2x2 (Events),,,,15,56,31,162,,,,,,,,,,,,,,,,,,,
Lee 2018,Mortality,1 month,Cohort 2x2 (Events),,,,2,83,5,517,,,,,,,,,,,,,,,,,,,
Leslie 2005,Mortality,12 month,Cohort 2x2 (Events),,,,48,115,174,804,,,,,,,,,,,,,,,,,,,
Leslie 2008,Mortality,12 month,Cohort 2x2 (Events),,,,47,109,161,732,,,,,,,,,,,,,,,,,,,
Lewis 1995,Mortality,3 month,Cohort 2x2 (Events),,,,4,20,28,362,,,,,,,,,,,,,,,,,,,
Li 2019,Mortality,12 month,Cohort 2x2 (Events),,,,1,32,5,79,,,,,,,,,,,,,,,,,,,
Li 2021,Mortality  POD vs No POD and frailty,3.33 month,Cohort 2x2 (Events),,,,1,15,2,198,,,,,,,,,,,,,,,,,,,
Li 2021,Mortality frailty and POD vs frailty only,10 month,Cohort 2x2 (Events),,,,4,23,6,62,,,,,,,,,,,,,,,,,,,
Li 2021,Mortality POD vs No POD and frailty,10 month,Cohort 2x2 (Events),,,,3,15,5,198,,,,,,,,,,,,,,,,,,,
Li 2021,Mortality frailty and POD vs frailty only,12 month,Cohort 2x2 (Events),,,,4,23,4,60,,,,,,,,,,,,,,,,,,,
Li 2021,Mortality POD vs No POD and frailty,12 month,Cohort 2x2 (Events),,,,2,14,2,188,,,,,,,,,,,,,,,,,,,
Li 2021,Mortality frailty and POD vs frailty only,3.33 month,Cohort 2x2 (Events),,,,4,23,3,62,,,,,,,,,,,,,,,,,,,
Li 2021,Mortality frailty and POD vs frailty only,6.67 month,Cohort 2x2 (Events),,,,4,23,6,62,,,,,,,,,,,,,,,,,,,
Li 2021,Mortality POD vs No POD and frailty,6.67 month,Cohort 2x2 (Events),,,,3,15,5,198,,,,,,,,,,,,,,,,,,,
Lima 2010,Mortality POD vs No POD and frailty,12 month,Cohort 2x2 (Events),,,,33,63,45,133,,,,,,,,,,,,,,,,,,,
Lundström 2003,Mortality frailty and POD vs frailty only,60 month,Cohort 2x2 (Events),,,,21,29,17,49,,,,,,,,,,,,,,,,,,,
Luz 2020,Mortality,1 month,Cohort 2x2 (Events),,,,7,89,8,80,,,,,,,,,,,,,,,,,,,
Mariz 2013,Mortality,1 month,Cohort 2x2 (Events),,,,15,28,19,50,,,,,,,,,,,,,,,,,,,
Marrama 2022,Mortality ,108 month,Cohort 2x2 (Events),,,,60,74,98,125,,,,,,,,,,,,,,,,,,,
Marrama 2022,Mortality ,12 month,Cohort 2x2 (Events),,,,32,74,36,125,,,,,,,,,,,,,,,,,,,
Marrama 2022,Mortality ,120 month,Cohort 2x2 (Events),,,,68,74,110,125,,,,,,,,,,,,,,,,,,,
Marrama 2022,Mortality ,24 month,Cohort 2x2 (Events),,,,37,74,43,125,,,,,,,,,,,,,,,,,,,
Marrama 2022,Mortality,36 month,Cohort 2x2 (Events),,,,39,74,48,125,,,,,,,,,,,,,,,,,,,
Marrama 2022,Mortality ,48 month,Cohort 2x2 (Events),,,,41,74,51,125,,,,,,,,,,,,,,,,,,,
Marrama 2022,Mortality ,60 month,Cohort 2x2 (Events),,,,47,74,58,125,,,,,,,,,,,,,,,,,,,
Marrama 2022,Mortality ,72 month,Cohort 2x2 (Events),,,,52,74,65,125,,,,,,,,,,,,,,,,,,,
Marrama 2022,Mortality ,84 month,Cohort 2x2 (Events),,,,54,74,83,125,,,,,,,,,,,,,,,,,,,
Marrama 2022,Mortality ,96 month,Cohort 2x2 (Events),,,,56,74,90,125,,,,,,,,,,,,,,,,,,,
Mauri 2021,Mortality ,12 month,Cohort 2x2 (Events),,,,42,66,224,595,,,,,,,,,,,,,,,,,,,
Mauri 2021,Mortality ,18 month,Cohort 2x2 (Events),,,,59,66,345,595,,,,,,,,,,,,,,,,,,,
Mauri 2021,Mortality,24 month,Cohort 2x2 (Events),,,,62,66,432,595,,,,,,,,,,,,,,,,,,,
Mauri 2021,Mortality ,6 month,Cohort 2x2 (Events),,,,35,66,108,595,,,,,,,,,,,,,,,,,,,
McAvay 2006,Mortality,12 month,Cohort 2x2 (Events),,,,8,31,75,378,,,,,,,,,,,,,,,,,,,
McCusker 2001,Mortality,12 month,Cohort 2x2 (Events),,,,93,220,14,95,,,,,,,,,,,,,,,,,,,
McCusker 2002,Mortality,12 month,Cohort 2x2 (Events),,,,101,243,17,118,,,,,,,,,,,,,,,,,,,
McCusker 2014,Mortality,6 month,Cohort 2x2 (Events),,,,7,31,21,243,,,,,,,,,,,,,,,,,,,
Minden 2005,Mortality,1 month,Cohort 2x2 (Events),,,,2,8,2,27,,,,,,,,,,,,,,,,,,,
Moreno-Gavino 2012,Mortality,12 month,Cohort 2x2 (Events),,,,108,198,430,1236,,,,,,,,,,,,,,,,,,,
Muresan 2016,Mortality,12 month,Cohort 2x2 (Events),,,,21,46,34,153,,,,,,,,,,,,,,,,,,,
Nishizawa 2023,Mortality ,1.3 month,Cohort 2x2 (Events),,,,53,334,21,743,,,,,,,,,,,,,,,,,,,
Nishizawa 2023,Mortality ,10 month,Cohort 2x2 (Events),,,,95,334,85,743,,,,,,,,,,,,,,,,,,,
Nishizawa 2023,Mortality ,2 month,Cohort 2x2 (Events),,,,64,334,35,743,,,,,,,,,,,,,,,,,,,
Nishizawa 2023,Mortality ,2.67 month,Cohort 2x2 (Events),,,,69,334,43,743,,,,,,,,,,,,,,,,,,,
Nishizawa 2023,Mortality ,3.33 month,Cohort 2x2 (Events),,,,70,334,48,743,,,,,,,,,,,,,,,,,,,
Nishizawa 2023,Mortality ,6.67 month,Cohort 2x2 (Events),,,,87,334,67,743,,,,,,,,,,,,,,,,,,,
Noriega 2015,Mortality ,1 month,Cohort 2x2 (Events),,,,10,35,10,168,,,,,,,,,,,,,,,,,,,
Olofsson 2018,Mortality ,12 month,Cohort 2x2 (Events),,,,4,75,1,60,,,,,,,,,,,,,,,,,,,
Olofsson 2018,Mortality ,36 month,Cohort 2x2 (Events),,,,18,75,7,60,,,,,,,,,,,,,,,,,,,
Olofsson 2018,Mortality ,4 month,Cohort 2x2 (Events),,,,4,75,1,60,,,,,,,,,,,,,,,,,,,
Pak 2020,Mortality ,1 month,Cohort 2x2 (Events),,,,16,36,15,96,,,,,,,,,,,,,,,,,,,
Pak 2020,Mortality ,2 month,Cohort 2x2 (Events),,,,19,36,31,96,,,,,,,,,,,,,,,,,,,
Pak 2020,Mortality,3 month,Cohort 2x2 (Events),,,,23,36,43,96,,,,,,,,,,,,,,,,,,,
Patel 2014,Mortality,10 month,Cohort 2x2 (Events),,,,48,87,3,10,,,,,,,,,,,,,,,,,,,
Patel 2014,Mortality ,3.33 month,Cohort 2x2 (Events),,,,38,87,2,10,,,,,,,,,,,,,,,,,,,
Patel 2014,Mortality ,6.67 month,Cohort 2x2 (Events),,,,44,87,3,10,,,,,,,,,,,,,,,,,,,
Paulino 2023,Mortality ,3 month,Cohort 2x2 (Events),,,,3,34,1,72,,,,,,,,,,,,,,,,,,,
Paulino 2023,Mortality ,6 month,Cohort 2x2 (Events),,,,0,34,4,72,,,,,,,,,,,,,,,,,,,
Pompei 1994,Mortality,3 month,Cohort 2x2 (Events),,,,6,57,11,359,,,,,,,,,,,,,,,,,,,
Qu 2018,Mortality ,3 month,Cohort 2x2 (Events),,,,2,38,0,223,,,,,,,,,,,,,,,,,,,
Qu 2018,Mortality ,6 month,Cohort 2x2 (Events),,,,2,33,1,208,,,,,,,,,,,,,,,,,,,
Raats 2015,Mortality,1 month,Cohort 2x2 (Events),,,,3,35,1,197,,,,,,,,,,,,,,,,,,,
Raats 2015,Mortality,12 month,Cohort 2x2 (Events),,,,19,35,112,197,,,,,,,,,,,,,,,,,,,
Raats 2015,Mortality ,3 month,Cohort 2x2 (Events),,,,8,35,19,197,,,,,,,,,,,,,,,,,,,
Raats 2015,Mortality ,6 month,Cohort 2x2 (Events),,,,14,35,45,197,,,,,,,,,,,,,,,,,,,
Raats 2015,Mortality ,9 month,Cohort 2x2 (Events),,,,14,35,87,197,,,,,,,,,,,,,,,,,,,
Radinovic 2014,Mortality,1 month,Cohort 2x2 (Events),,,,15,88,3,99,,,,,,,,,,,,,,,,,,,
Rahkonen 2001,Mortality,24 month,Cohort 2x2 (Events),,,,11,20,54,179,,,,,,,,,,,,,,,,,,,
Reynish 2017,Mortality (delirium alone vs no cognitive disorder),1 month,Cohort 2x2 (Events),,,,123,901,323,3584,,,,,,,,,,,,,,,,,,,
Reynish 2017,Mortality (DSD vs dementia alone),1 month,Cohort 2x2 (Events),,,,57,389,57,444,,,,,,,,,,,,,,,,,,,
Reynish 2017,Mortality (delirium alone vs no cognitive disorder),12 month,Cohort 2x2 (Events),,,,326,901,932,3584,,,,,,,,,,,,,,,,,,,
Reynish 2017,Mortality (DSD vs dementia alone),12 month,Cohort 2x2 (Events),,,,170,389,195,444,,,,,,,,,,,,,,,,,,,
Robinson 2009,mortality ,1 month,Cohort 2x2 (Events),,,,6,64,1,80,,,,,,,,,,,,,,,,,,,
Robinson 2009,Mortality ,6 month,Cohort 2x2 (Events),,,,13,64,2,78,,,,,,,,,,,,,,,,,,,
Robinson 2011,Mortality,1 month,Cohort 2x2 (Events),,,,8,73,1,98,,,,,,,,,,,,,,,,,,,
Robinson 2011,Mortality,6 month,Cohort 2x2 (Events),,,,18,73,2,98,,,,,,,,,,,,,,,,,,,
Rockwood 1999,Mortality,36 month,Cohort 2x2 (Events),,,,30,38,71,165,,,,,,,,,,,,,,,,,,,
Ruggiero 2017,Mortality,12 month,Cohort 2x2 (Events),,,,31,133,45,381,,,,,,,,,,,,,,,,,,,
Sasajima 2012,Mortality ,12 month,Cohort 2x2 (Events),,,,5,88,15,211,,,,,,,,,,,,,,,,,,,
Sasajima 2012,Mortality ,24 month,Cohort 2x2 (Events),,,,11,88,21,211,,,,,,,,,,,,,,,,,,,
Sasajima 2012,Mortality ,36 month,Cohort 2x2 (Events),,,,16,88,28,211,,,,,,,,,,,,,,,,,,,
Sato 2017,Mortality,2 month,Cohort 2x2 (Events),,,,8,35,5,128,,,,,,,,,,,,,,,,,,,
Sauer 2017,Mortality ,1 month,Cohort 2x2 (Events),,,,0,23,3,161,,,,,,,,,,,,,,,,,,,
Sauer 2017,Mortality ,12 month,Cohort 2x2 (Events),,,,1,23,3,161,,,,,,,,,,,,,,,,,,,
Serrano-Duenas 2005,Mortality,60 month,Cohort 2x2 (Events),,,,10,21,4,21,,,,,,,,,,,,,,,,,,,
Sheng 2006,Mortality ,1 month,Cohort 2x2 (Events),,,,4,39,5,117,,,,,,,,,,,,,,,,,,,
Sheng 2006,Mortality ,12 month,Cohort 2x2 (Events),,,,16,39,18,117,,,,,,,,,,,,,,,,,,,
Sheng 2006,Mortality ,6 month,Cohort 2x2 (Events),,,,11,39,14,117,,,,,,,,,,,,,,,,,,,
Shi 2019,Mortality,36 month,Cohort 2x2 (Events),,,,8,28,7,75,,,,,,,,,,,,,,,,,,,
Shintani 2009,Mortality ,1.67 month,Cohort 2x2 (Events),,,,66,182,12,42,,,,,,,,,,,,,,,,,,,
Shintani 2009,Mortality ,3.33 month,Cohort 2x2 (Events),,,,75,182,18,42,,,,,,,,,,,,,,,,,,,
Shintani 2009,Mortality ,5 month,Cohort 2x2 (Events),,,,82,182,20,42,,,,,,,,,,,,,,,,,,,
Sri-on 2016,Mortality,1 month,Cohort 2x2 (Events),,,,4,27,3,205,,,,,,,,,,,,,,,,,,,
Suraarunsumrit 2022,Mortality,3 month,Cohort 2x2 (Events),,,,7,42,6,247,,,,,,,,,,,,,,,,,,,
Tahir 2018,Mortality,1 month,Cohort 2x2 (Events),,,,7,70,19,311,,,,,,,,,,,,,,,,,,,
Tahir 2018,Mortality ,12 month,Cohort 2x2 (Events),,,,18,70,47,311,,,,,,,,,,,,,,,,,,,
Tan AH 2015,Mortality,6 month,Cohort 2x2 (Events),,,,11,28,22,222,,,,,,,,,,,,,,,,,,,
To-adithep 2023,Mortality,12 month,Cohort 2x2 (Events),,,,75,170,84,460,,,,,,,,,,,,,,,,,,,
Trevisan 2023,Mortality,9 month,Cohort 2x2 (Events),,,,20,132,23,964,,,,,,,,,,,,,,,,,,,
Tripathy 2014,Mortality ,1 month,Cohort 2x2 (Events),,,,22,56,11,53,,,,,,,,,,,,,,,,,,,
Tripathy 2014,Mortality ,12 month,Cohort 2x2 (Events),,,,33,56,18,53,,,,,,,,,,,,,,,,,,,
Tsai 2012,Mortality ,12 month,Cohort 2x2 (Events),,,,61,172,122,442,,,,,,,,,,,,,,,,,,,
Tsai 2012,Mortality ,24 month,Cohort 2x2 (Events),,,,74,172,168,442,,,,,,,,,,,,,,,,,,,
Tsai 2012,Mortality ,36 month,Cohort 2x2 (Events),,,,80,172,200,442,,,,,,,,,,,,,,,,,,,
Uthamalingam 2011,Mortality,3 month,Cohort 2x2 (Events),,,,36,134,62,687,,,,,,,,,,,,,,,,,,,
VanDerWulp 2019,Mortality ,1 month,Cohort 2x2 (Events),,,,9,116,19,587,,,,,,,,,,,,,,,,,,,
VanDerWulp 2019,Mortality ,12 month,Cohort 2x2 (Events),,,,29,116,80,587,,,,,,,,,,,,,,,,,,,
VanDerWulp 2019,Mortality ,24 month,Cohort 2x2 (Events),,,,50,116,229,587,,,,,,,,,,,,,,,,,,,
VanDerWulp 2019,Mortality ,36 month,Cohort 2x2 (Events),,,,67,116,368,578,,,,,,,,,,,,,,,,,,,
VanDerWulp 2019,Mortality ,48 month,Cohort 2x2 (Events),,,,78,116,454,587,,,,,,,,,,,,,,,,,,,
VanDerWulp 2019,Mortality ,60 month,Cohort 2x2 (Events),,,,94,116,511,587,,,,,,,,,,,,,,,,,,,
Vasunilashorn 2016,Mortality,1 month,Cohort 2x2 (Events),,,,57,620,7,299,,,,,,,,,,,,,,,,,,,
Vasunilashorn 2022,Mortality  (DEL-S long form 0-1 vs other score),1 month,Cohort 2x2 (Events),,,,11,184,9,168,,,,,,,,,,,,,,,,,,,
Vasunilashorn 2022,Mortality (DEL-S short form 0-1 vs other score),1 month,Cohort 2x2 (Events),,,,11,169,9,183,,,,,,,,,,,,,,,,,,,
Vasunilashorn 2022,Mortality (DEL-S long form 0-1 vs other score),12 month,Cohort 2x2 (Events),,,,58,184,34,168,,,,,,,,,,,,,,,,,,,
Vasunilashorn 2022,Mortality (DEL-S short form 0-1 vs other score),12 month,Cohort 2x2 (Events),,,,56,169,36,183,,,,,,,,,,,,,,,,,,,
Visser 2015,Mortality,12 month,Cohort 2x2 (Events),,,,5,22,33,441,,,,,,,,,,,,,,,,,,,
Vives-Borrás 2019,Mortality,6 month,Cohort 2x2 (Events),,,,9,37,53,490,,,,,,,,,,,,,,,,,,,
Whittamore 2014,Mortality,6 month,Cohort 2x2 (Events),,,,40,107,38,142,,,,,,,,,,,,,,,,,,,
Wolters 2014,Mortality,12 month,Cohort 2x2 (Events),,,,102,412,96,689,,,,,,,,,,,,,,,,,,,
Zakriya 2004,Mortality ,1.5 month,Cohort 2x2 (Events),,,,2,19,1,63,,,,,,,,,,,,,,,,,,,
Zakriya 2004,Mortality,3 month,Cohort 2x2 (Events),,,,2,15,2,61,,,,,,,,,,,,,,,,,,,
Zipprich 2020,Mortality ,10 month,Cohort 2x2 (Events),,,,28,64,134,527,,,,,,,,,,,,,,,,,,,
Zipprich 2020,Mortality ,12 month,Cohort 2x2 (Events),,,,28,64,129,527,,,,,,,,,,,,,,,,,,,
Zipprich 2020,Mortality ,13.33 month,Cohort 2x2 (Events),,,,30,64,152,527,,,,,,,,,,,,,,,,,,,
Zipprich 2020,Mortality ,16.67 month,Cohort 2x2 (Events),,,,34,64,164,527,,,,,,,,,,,,,,,,,,,
Zipprich 2020,Mortality ,20 month,Cohort 2x2 (Events),,,,43,64,276,527,,,,,,,,,,,,,,,,,,,
Zipprich 2020,Mortality ,23.33 month,Cohort 2x2 (Events),,,,45,64,285,527,,,,,,,,,,,,,,,,,,,
Zipprich 2020,Mortality ,26.67 month,Cohort 2x2 (Events),,,,45,64,296,527,,,,,,,,,,,,,,,,,,,
Zipprich 2020,Mortality ,3.33 month,Cohort 2x2 (Events),,,,21,64,86,527,,,,,,,,,,,,,,,,,,,
Zipprich 2020,Mortality ,30 month,Cohort 2x2 (Events),,,,45,64,309,527,,,,,,,,,,,,,,,,,,,
Zipprich 2020,Mortality ,33.33 month,Cohort 2x2 (Events),,,,48,64,324,527,,,,,,,,,,,,,,,,,,,
Zipprich 2020,Mortality ,36.67 month,Cohort 2x2 (Events),,,,50,64,340,527,,,,,,,,,,,,,,,,,,,
Zipprich 2020,Mortality,40 month,Cohort 2x2 (Events),,,,59,64,450,527,,,,,,,,,,,,,,,,,,,
Zipprich 2020,Mortality ,6.67 month,Cohort 2x2 (Events),,,,26,64,117,527,,,,,,,,,,,,,,,,,,,
Ditzel 2023,Mortality,3 month,Cohort 2x2 (Events),,,,0,38,5,208,,,,,,,,,,,,,,,,,,,
Miu 2013,Mortality,12 month,Cohort 2x2 (Events),,,,26,86,17,228,,,,,,,,,,,,,,,,,,,
van Rijsbergen 2011,Mortality,24 month,Cohort 2x2 (Events),,,,30,52,16,44,,,,,,,,,,,,,,,,,,,
Sánchez-Lozano 2023,Mortality,3 month,Cohort 2x2 (Events),,,,34,96,29,273,,,,,,,,,,,,,,,,,,,
Hempenius 2016,Quality of life ,3 month,Odds ratio,2.26,0.96,5.36,,,,,,,,,,,,,,,,,,,,,,,
Hempenius 2016,Quality of life,3 month,Cohort 2x2 (Events),,,,16,25,88,200,,,,,,,,,,,,,,,,,,,
Hoogma 2023,Quality of life,6 month,Cohort 2x2 (Events),,,,48,78,67,139,,,,,,,,,,,,,,,,,,,
Suraarunsumrit 2022,Quality of life,3 month,Cohort 2x2 (Events),,,,7,26,57,247,,,,,,,,,,,,,,,,,,,
VanderHeijden 2023,Quality of life,12 month,Cohort 2x2 (Events),,,,84,529,139,1871,,,,,,,,,,,,,,,,,,,
Brown 2020,Anxiety disorder,12 month,Odds ratio,1.18,0.91,1.54,,,,,,,,,,,,,,,,,,,,,,,
Brown 2020,Depressive disorder,12 month,Odds ratio,1.19,0.93,1.52,,,,,,,,,,,,,,,,,,,,,,,
Brown 2020,Trauma-and-stressor related disorder,12 month,Odds ratio,0.82,0.51,1.3,,,,,,,,,,,,,,,,,,,,,,,
DelaVarga-Martínez 2022,Emotional problems,36 month,Odds ratio,4.3,1.87,9.91,,,,,,,,,,,,,,,,,,,,,,,
DelaVarga-Martínez 2022,Nightmares/ Bad dreams,36 month,Odds ratio,8.99,1.98,40.9,,,,,,,,,,,,,,,,,,,,,,,
DelaVarga-Martínez 2022,Sleep disorders,36 month,Odds ratio,5.21,2.29,11.84,,,,,,,,,,,,,,,,,,,,,,,
Drews 2015,PTSD,3 month,Odds ratio,2.411,1.064,5.464,,,,,,,,,,,,,,,,,,,,,,,
Jackson 2014,Depression ,12 month,Odds ratio,2.31,1.25,4.27,,,,,,,,,,,,,,,,,,,,,,,
Jackson 2014,Depression ,3 month,Odds ratio,1.63,0.94,2.85,,,,,,,,,,,,,,,,,,,,,,,
Jackson 2014,PTSD,12 month,Odds ratio,1.92,1.03,3.55,,,,,,,,,,,,,,,,,,,,,,,
Jackson 2014,PTSD ,3 month,Odds ratio,1.39,0.78,2.47,,,,,,,,,,,,,,,,,,,,,,,
Miyamoto 2021,Anxiety symptoms ,12 month,Odds ratio,3.65,,12.97,,,,,,,,,,,,,,,,,,,,,,,
Miyamoto 2021,Anxiety symptoms ,3 month,Odds ratio,1.8,0.64,5.07,,,,,,,,,,,,,,,,,,,,,,,
Miyamoto 2021,Depression symptoms ,12 month,Odds ratio,3.3,0.62,17.75,,,,,,,,,,,,,,,,,,,,,,,
Miyamoto 2021,Depression symptoms ,3 month,Odds ratio,1.95,0.65,5.9,,,,,,,,,,,,,,,,,,,,,,,
Miyamoto 2021,PTSD symptoms ,12 month,Odds ratio,3.23,0.61,17.13,,,,,,,,,,,,,,,,,,,,,,,
Miyamoto 2021,PTSD symptoms ,3 month,Odds ratio,2.14,0.57,8.11,,,,,,,,,,,,,,,,,,,,,,,
Nguyen 2018,Alcohol consumption,6 month,Odds ratio,0.64,0.22,1.86,,,,,,,,,,,,,,,,,,,,,,,
Nguyen 2018,Depressed,6 month,Odds ratio,1.8,0.63,5.1,,,,,,,,,,,,,,,,,,,,,,,
Nguyen 2018,EuroQoL-5D anxiety/depression issue (>1),6 month,Odds ratio,4.41,1.52,12.92,,,,,,,,,,,,,,,,,,,,,,,
VanderHeijden 2023,"Anxiety, depression, or PTSD symptoms (Non-persistent delirium)",12 month,Odds ratio,1.2,0.9,1.6,,,,,,,,,,,,,,,,,,,,,,,
VanderHeijden 2023,"Anxiety, depression, or PTSD symptoms (persistent delirium)",12 month,Odds ratio,0.68,0.26,1.79,,,,,,,,,,,,,,,,,,,,,,,
Bulic 2020,PTSD (probable ) ,12 month,Cohort 2x2 (Events),,,,3,27,7,33,,,,,,,,,,,,,,,,,,,
Bulic 2020,PTSD (probable ) ,6 month,Cohort 2x2 (Events),,,,6,27,10,38,,,,,,,,,,,,,,,,,,,
Bulic 2020,PTSD (severe ) ,12 month,Cohort 2x2 (Events),,,,11,27,4,33,,,,,,,,,,,,,,,,,,,
Bulic 2020,PTSD (severe ),6 month,Cohort 2x2 (Events),,,,6,27,8,38,,,,,,,,,,,,,,,,,,,
Olofsson 2018,Depression ,12 month,Cohort 2x2 (Events),,,,38,62,17,50,,,,,,,,,,,,,,,,,,,
Olofsson 2018,Depression ,36 month,Cohort 2x2 (Events),,,,24,39,12,36,,,,,,,,,,,,,,,,,,,
Olofsson 2018,Depression ,4 month,Cohort 2x2 (Events),,,,42,67,14,55,,,,,,,,,,,,,,,,,,,
Slor 2013,Generalized anxiety disorder,3 month,Cohort 2x2 (Events),,,,1,20,1,27,,,,,,,,,,,,,,,,,,,
Slor 2013,Major depressive episode,3 month,Cohort 2x2 (Events),,,,5,20,4,27,,,,,,,,,,,,,,,,,,,
Slor 2013,Major depressive episode with melancholic features,3 month,Cohort 2x2 (Events),,,,2,21,3,27,,,,,,,,,,,,,,,,,,,
Svenningsen 2015,Anxiety ,2 month,Cohort 2x2 (Events),,,,12,159,7,118,,,,,,,,,,,,,,,,,,,
Svenningsen 2015,Anxiety ,6 month,Cohort 2x2 (Events),,,,5,159,4,118,,,,,,,,,,,,,,,,,,,
Svenningsen 2015,Depression ,2 month,Cohort 2x2 (Events),,,,16,159,14,118,,,,,,,,,,,,,,,,,,,
Svenningsen 2015,Depression ,6 month,Cohort 2x2 (Events),,,,11,159,12,118,,,,,,,,,,,,,,,,,,,
Svenningsen 2015,PTSD ,2 month,Cohort 2x2 (Events),,,,12,159,9,118,,,,,,,,,,,,,,,,,,,
Svenningsen 2015,PTSD,6 month,Cohort 2x2 (Events),,,,8,159,4,118,,,,,,,,,,,,,,,,,,,
Verloo 2016,Depression,0.067 month,Cohort 2x2 (Events),,,,7,20,37,94,,,,,,,,,,,,,,,,,,,
Whittamore 2014,Agitaion and aggression,6 month,Cohort 2x2 (Events),,,,12,57,7,64,,,,,,,,,,,,,,,,,,,
Whittamore 2014,Anxiety,6 month,Cohort 2x2 (Events),,,,13,57,8,64,,,,,,,,,,,,,,,,,,,
Whittamore 2014,Apathy,6 month,Cohort 2x2 (Events),,,,20,57,17,64,,,,,,,,,,,,,,,,,,,
Whittamore 2014,Appetite and eating problems,6 month,Cohort 2x2 (Events),,,,11,57,16,64,,,,,,,,,,,,,,,,,,,
Whittamore 2014,Delusion,6 month,Cohort 2x2 (Events),,,,11,57,4,64,,,,,,,,,,,,,,,,,,,
Whittamore 2014,Depression,6 month,Cohort 2x2 (Events),,,,10,57,7,64,,,,,,,,,,,,,,,,,,,
Whittamore 2014,Dinhibiltion,6 month,Cohort 2x2 (Events),,,,3,57,2,64,,,,,,,,,,,,,,,,,,,
Whittamore 2014,Elation,6 month,Cohort 2x2 (Events),,,,2,57,0,64,,,,,,,,,,,,,,,,,,,
Whittamore 2014,Hallucination,6 month,Cohort 2x2 (Events),,,,7,57,1,64,,,,,,,,,,,,,,,,,,,
Whittamore 2014,Irritablity,6 month,Cohort 2x2 (Events),,,,10,57,4,64,,,,,,,,,,,,,,,,,,,
Whittamore 2014,Psychomotor activity,6 month,Cohort 2x2 (Events),,,,10,57,3,64,,,,,,,,,,,,,,,,,,,
Whittamore 2014,Sleep problem,6 month,Cohort 2x2 (Events),,,,12,57,7,64,,,,,,,,,,,,,,,,,,,
Hempenius 2016,Cognitive decline,3 month,Odds ratio,1.36,0.34,5.36,,,,,,,,,,,,,,,,,,,,,,,
Bryson 2011,Cognitive decline,3 month,Odds ratio,2.1,0.28,15.92,,,,,,,,,,,,,,,,,,,,,,,
McCusker 2014,Cognitive decline,6 month,Cohort 2x2 (Events),,,,5,26,37,220,,,,,,,,,,,,,,,,,,,
Saczynski 2012,Objective_change (cognitive decline),12 month,Cohort 2x2 (Events),,,,41,103,29,122,,,,,,,,,,,,,,,,,,,
Saczynski 2012,Objective_change (cognitive decline) ,1 month,Cohort 2x2 (Events),,,,66,103,45,122,,,,,,,,,,,,,,,,,,,
Saczynski 2012,Objective_change (cognitive decline) ,6 month,Cohort 2x2 (Events),,,,32,103,24,122,,,,,,,,,,,,,,,,,,,
Vives-Borrás 2019,Objective_change (cognitive decline),6 month,Cohort 2x2 (Events),,,,8,37,114,490,,,,,,,,,,,,,,,,,,,
Daiello 2019,Objective_change (cognitive decline ),1 month,Cohort 2x2 (Events),,,,75,129,181,419,,,,,,,,,,,,,,,,,,,
Daiello 2019,Objective_change (cognitive decline ),2 month,Cohort 2x2 (Events),,,,31,126,92,410,,,,,,,,,,,,,,,,,,,
Daiello 2019,Objective_change (cognitive decline ,6 month,Cohort 2x2 (Events),,,,23,124,62,404,,,,,,,,,,,,,,,,,,,
Rudolph 2008,Objective_change (cognitive decline),3 month,Cohort 2x2 (Events),,,,9,61,85,883,,,,,,,,,,,,,,,,,,,
Bickel 2008,Objective_ performance (Cognitive impairment ),38 month,Odds ratio,6.2,1.5,25.8,,,,,,,,,,,,,,,,,,,,,,,
Bickel 2008,Objective performance(Cognitive impairment),8 month,Odds ratio,4.7,1.6,13.5,,,,,,,,,,,,,,,,,,,,,,,
Franck 2016,Objective performance(Cognitive impairment_PACU delirium),3 month,Odds ratio,1.27,0.53,3.04,,,,,,,,,,,,,,,,,,,,,,,
Franck 2016,Objective performance(Cognitive impairment_PACU delirium and post-operative delirium),3 month,Odds ratio,1.41,0.5,4.01,,,,,,,,,,,,,,,,,,,,,,,
Franck 2016,Objective performance(Cognitive impairment_post-operative delirium),3 month,Odds ratio,2.56,1.07,6.16,,,,,,,,,,,,,,,,,,,,,,,
Gonçalves 2023,Objective performance(Cognitive impairment),12 month,Odds ratio,2.04,1.2,3.45,,,,,,,,,,,,,,,,,,,,,,,
Nguyen 2018,Objective performance(Cognitive impairment CFT),6 month,Odds ratio,1.14,0.41,3.15,,,,,,,,,,,,,,,,,,,,,,,
Nguyen 2018,Objective performance(Cognitive impairment MIS),6 month,Odds ratio,1.02,0.33,3.16,,,,,,,,,,,,,,,,,,,,,,,
Chen 2017,Objective performance (Cognitive impairment),9.82 month,Odds ratio,4.787,2.038,11.244,,,,,,,,,,,,,,,,,,,,,,,
Bulic 2020,Objective performance Cognitive impairment ,12 month,Cohort 2x2 (Events),,,,14,27,20,33,,,,,,,,,,,,,,,,,,,
Bulic 2020,Objective performance Cognitive impairment ,6 month,Cohort 2x2 (Events),,,,14,27,18,38,,,,,,,,,,,,,,,,,,,
Dostovic 2021,Objective performance Cognitive impairment,12 month,Cohort 2x2 (Events),,,,55,75,24,96,,,,,,,,,,,,,,,,,,,
Mathies 2020,Objective performance Cognitive impairment,12 month,Cohort 2x2 (Events),,,,14,21,21,47,,,,,,,,,,,,,,,,,,,
Verloo 2016,Objective performance Cognitive impairment,0.067 month,Cohort 2x2 (Events),,,,17,20,75,94,,,,,,,,,,,,,,,,,,,
Van Rijsbergen 2011,Objective performance Cognitive impairment_Attention,24 month,Cohort 2x2 (Events),,,,10,14,7,20,,,,,,,,,,,,,,,,,,,
Van Rijsbergen 2011,Objective performance Cognitive impairment_Executive function,24 month,Cohort 2x2 (Events),,,,10,17,6,24,,,,,,,,,,,,,,,,,,,
Van Rijsbergen 2011,Objective performance Cognitive impairment_Language,24 month,Cohort 2x2 (Events),,,,9,17,5,23,,,,,,,,,,,,,,,,,,,
Van Rijsbergen 2011,Objective performance Cognitive impairment_Verbal memory,24 month,Cohort 2x2 (Events),,,,7,15,2,23,,,,,,,,,,,,,,,,,,,
Van Rijsbergen 2011,Objective performance Cognitive impairment_Visual construction,24 month,Cohort 2x2 (Events),,,,10,13,7,20,,,,,,,,,,,,,,,,,,,
Van Rijsbergen 2011,Objective performance Cognitive impairment_Visual memory,24 month,Cohort 2x2 (Events),,,,5,13,5,20,,,,,,,,,,,,,,,,,,,
Van Rijsbergen 2011,Objective performance Cognitive impairment_Visual perception,24 month,Cohort 2x2 (Events),,,,7,15,7,20,,,,,,,,,,,,,,,,,,,
DelaVarga-Martínez 2022,Subjective performance Cognitive impairment _Concentration problems,36 month,Odds ratio,11.2,3.58,35.09,,,,,,,,,,,,,,,,,,,,,,,
DelaVarga-Martínez 2022,Subjective performance Cognitive impairment _Confusion/ Desorientation,36 month,Odds ratio,10.93,3.61,33.12,,,,,,,,,,,,,,,,,,,,,,,
DelaVarga-Martínez 2022,Subjective performance Cognitive impairment _Memory problems,36 month,Odds ratio,6.11,2.54,14.68,,,,,,,,,,,,,,,,,,,,,,,
VanderHeijden 2023,Subjective performance Cognitive impairment_Non-persistent delirium,12 month,Odds ratio,1.24,0.8,1.93,,,,,,,,,,,,,,,,,,,,,,,
VanderHeijden 2023,Subjective performance Cognitive impairment_persistent delirium,12 month,Odds ratio,3.9,1.31,11.63,,,,,,,,,,,,,,,,,,,,,,,
Wolters 2014,Subjective performance Cognitive impairment_mild problems with cognitive functioning,12 month,Odds ratio,2.41,1.57,3.69,,,,,,,,,,,,,,,,,,,,,,,
Wolters 2014,Subjective performance Cognitive impairment_severe problems with cognitive functioning,3 month,Odds ratio,3.1,1.1,8.74,,,,,,,,,,,,,,,,,,,,,,,
Koster 2012,Subjective performance Cognitive impairment_concentration problems,6 month,"Log OR, SE",,,,,,,,,0.444685821,0.619383822,,,,,,,,,,,,,,,,
Koster 2012,Subjective performance Cognitive impairment_Confusion,6 month,"Log OR, SE",,,,,,,,,0.343589704,0.672863171,,,,,,,,,,,,,,,,
Koster 2012,Subjective performance Cognitive impairment_Memory problems,6 month,"Log OR, SE",,,,,,,,,0.652325186,0.715693918,,,,,,,,,,,,,,,,
Buurman 2011,Functional decline_change,12 month,Odds ratio,2.47,1.34,4.54,,,,,,,,,,,,,,,,,,,,,,,
Davis 2012,Functional decline (Functional worsening)_change,29 month,Odds ratio,2.76,1.38,5.52,,,,,,,,,,,,,,,,,,,,,,,
Furlaneto 2007,Functional impairment (Functional loss)_change,48 month,Odds ratio,2.11,0.43,10.28,,,,,,,,,,,,,,,,,,,,,,,
Givens 2009,Functional decline (ADL Decline)_change,6 month,Odds ratio,1.64,0.71,3.8,,,,,,,,,,,,,,,,,,,,,,,
Hempenius 2016,Functional decline (ADL functioning Decreased)_change,3 month,Odds ratio,2.65,1.02,6.88,,,,,,,,,,,,,,,,,,,,,,,
Hempenius 2016,Functional decline (No return to independent preoperative living situation)_change,3 month,Odds ratio,0.18,0.07,0.49,,,,,,,,,,,,,,,,,,,,,,,
Hempenius 2016,Functional decline (Use of supportive care Increased (Care assistance))_change,3 month,Odds ratio,2.45,1.02,5.87,,,,,,,,,,,,,,,,,,,,,,,
Hempenius 2016,Functional decline (Use of supportive care Increased (Domestic))_change,3 month,Odds ratio,0.72,0.27,1.9,,,,,,,,,,,,,,,,,,,,,,,
Hempenius 2016,Functional decline (Use of supportive care Increased (Informal care))_change,3 month,Odds ratio,1,0.41,2.49,,,,,,,,,,,,,,,,,,,,,,,
Inouye 1998,Functional decline (ADL)_change,3 month,Odds ratio,2.7,1.4,5.2,,,,,,,,,,,,,,,,,,,,,,,
Noriega 2015,Functional decline (need for help) _change,12 month,Odds ratio,2.66,0.76,9.33,,,,,,,,,,,,,,,,,,,,,,,
Noriega 2015,Functional decline_change,12 month,Odds ratio,2,0.61,6.5,,,,,,,,,,,,,,,,,,,,,,,
Quinlan 2011,Functional decline_change,3 month,Odds ratio,2.1,1.2,3.8,,,,,,,,,,,,,,,,,,,,,,,
Edelstein 2004,Functional decline (Ambulation decline)_change,12 month,Odds ratio,2.7,1.1,6.6,,,,,,,,,,,,,,,,,,,,,,,
Edelstein 2004,Functional decline (B-ADL decline)_change,12 month,Odds ratio,3.5,1.6,7.6,,,,,,,,,,,,,,,,,,,,,,,
Beishuizen 2020,Functional decline (ADL)_change,7 month,Cohort 2x2 (Events),,,,7,14,28,77,,,,,,,,,,,,,,,,,,,
Guenther 2020,Functional decline (ADL Decline)_change,6 month,Cohort 2x2 (Events),,,,29,39,46,86,,,,,,,,,,,,,,,,,,,
Liang 2014,Functional decline (ADL decline) _change,1 month,Cohort 2x2 (Events),,,,8,17,46,165,,,,,,,,,,,,,,,,,,,
Liang 2014,Functional decline (ADL decline)_change,12 month,Cohort 2x2 (Events),,,,7,17,26,165,,,,,,,,,,,,,,,,,,,
Liang 2014,Functional decline (ADL decline)_change,3 month,Cohort 2x2 (Events),,,,5,17,25,165,,,,,,,,,,,,,,,,,,,
Liang 2014,Functional decline (ADL decline) _change,6 month,Cohort 2x2 (Events),,,,6,17,27,165,,,,,,,,,,,,,,,,,,,
Liang 2014,Functional decline (IADL decline)_change,1 month,Cohort 2x2 (Events),,,,6,13,59,165,,,,,,,,,,,,,,,,,,,
Liang 2014,Functional decline (IADL decline)_change,12 month,Cohort 2x2 (Events),,,,8,13,39,165,,,,,,,,,,,,,,,,,,,
Liang 2014,Functional decline (IADL decline)_change,3 month,Cohort 2x2 (Events),,,,6,13,45,165,,,,,,,,,,,,,,,,,,,
Liang 2014,Functional decline (IADL decline)_change,6 month,Cohort 2x2 (Events),,,,7,13,41,165,,,,,,,,,,,,,,,,,,,
McCusker 2014,Functional decline_change,6 month,Cohort 2x2 (Events),,,,5,27,39,206,,,,,,,,,,,,,,,,,,,
Murray 1993,Functional decline (physical function worse: community)_change,3 month,Cohort 2x2 (Events),,,,18,35,41,143,,,,,,,,,,,,,,,,,,,
Murray 1993,Functional decline (physical function worse: nursing home)_change,3 month,Cohort 2x2 (Events),,,,20,38,10,39,,,,,,,,,,,,,,,,,,,
Neufeld 2015,Functional decline (change from independent to dependent)_change,18 month,Cohort 2x2 (Events),,,,6,36,6,45,,,,,,,,,,,,,,,,,,,
Noriega 2015,Functional decline (need for help)_change,1 month,Cohort 2x2 (Events),,,,10,17,40,126,,,,,,,,,,,,,,,,,,,
Noriega 2015,Functional decline_change,1 month,Cohort 2x2 (Events),,,,6,18,41,129,,,,,,,,,,,,,,,,,,,
Racine 2018,Functional decline (Decline in physical function)_change,1 month,Cohort 2x2 (Events),,,,11,27,13,34,,,,,,,,,,,,,,,,,,,
Racine 2018,Functional decline (New impairment in cognitive IADL)_change,1 month,Cohort 2x2 (Events),,,,7,27,2,34,,,,,,,,,,,,,,,,,,,
Rudolph 2010,Functional decline_change,1 month,Cohort 2x2 (Events),,,,21,33,21,64,,,,,,,,,,,,,,,,,,,
Rudolph 2010,Functional decline_change,12 month,Cohort 2x2 (Events),,,,8,33,8,59,,,,,,,,,,,,,,,,,,,
Shim 2015,Functional decline (ADL deterioration)_change,1 month,Cohort 2x2 (Events),,,,49,90,62,206,,,,,,,,,,,,,,,,,,,
Shim 2015,Functional decline (IADL deterioration)_change,1 month,Cohort 2x2 (Events),,,,51,88,79,205,,,,,,,,,,,,,,,,,,,
Suraarunsumrit 2022,Functional decline(ADL)_change,3 month,Cohort 2x2 (Events),,,,6,26,49,247,,,,,,,,,,,,,,,,,,,
Suraarunsumrit 2022,Functional decline(IADL)_change,3 month,Cohort 2x2 (Events),,,,9,26,44,247,,,,,,,,,,,,,,,,,,,
Vives-Borrás 2019,Functional decline (ADL)_change,6 month,Cohort 2x2 (Events),,,,13,37,135,490,,,,,,,,,,,,,,,,,,,
Edelstein 2004,Functional decline (IADL decline)_change,12 month,Cohort 2x2 (Events),,,,18,25,335,613,,,,,,,,,,,,,,,,,,,
Francis 1990,Functional decline (ADL)_change,6 month,Cohort 2x2 (Events),,,,12,50,42,176,,,,,,,,,,,,,,,,,,,
Abelha 2013,Functional impairment (dependent for ADL)_performance ,6 month,Odds ratio,2.18,1.075,4.455,,,,,,,,,,,,,,,,,,,,,,,
Abelha 2013,Functional impairment (dependent for IADL)_performance ,6 month,Odds ratio,0.786,0.394,1.57,,,,,,,,,,,,,,,,,,,,,,,
Alzoubi 2022,Functional impairment (dependence ADL)_performance ,4 month,Odds ratio,1.4,0.27,7.15,,,,,,,,,,,,,,,,,,,,,,,
Bickel 2008,Functional impairment (need for long-term care)_performance ,38 month,Odds ratio,5.6,1.6,19.7,,,,,,,,,,,,,,,,,,,,,,,
Bickel 2008,Functional impairment (need for long-term care )_performance ,8 month,Odds ratio,1.7,0.5,5.4,,,,,,,,,,,,,,,,,,,,,,,
Czyzycki 2022,Functional impairment ( (poor functional outcome hyperactive)_performance ,12 month,Odds ratio,4.12,1.48,11.44,,,,,,,,,,,,,,,,,,,,,,,
Czyzycki 2022,Functional impairment ( (poor functional outcome hyperactive)_performance ,3 month,Odds ratio,3.25,1.23,8.55,,,,,,,,,,,,,,,,,,,,,,,
Czyzycki 2022,Functional impairment ( (poor functional outcome hypoactive)_performance ,12 month,Odds ratio,3.57,2.17,5.88,,,,,,,,,,,,,,,,,,,,,,,
Czyzycki 2022,Functional impairment ( (poor functional outcome mixed)_performance ,12 month,Odds ratio,1.83,1.35,2.48,,,,,,,,,,,,,,,,,,,,,,,
Czyzycki 2022,Functional impairment ( (poor functional outcome mixed)_performance ,3 month,Odds ratio,1.71,1.28,2.28,,,,,,,,,,,,,,,,,,,,,,,
Czyzycki 2022,Functional impairment (poor functional outcome hypoactive)_performance ,3 month,Odds ratio,3.07,1.94,4.85,,,,,,,,,,,,,,,,,,,,,,,
DelaVarga-Martínez 2022,Functional impairment (Less mobility)_performance ,36 month,Odds ratio,2.436,1.06,5.61,,,,,,,,,,,,,,,,,,,,,,,
Francis 1992,Functional impairment ( (loss of Independent Community Living)_performance ,24 month,Odds ratio,2.56,1.1,5.951,,,,,,,,,,,,,,,,,,,,,,,
Hawley 2023,Functional impairment (Not Return to outdoor mobility_performance ,4 month,Odds ratio,1.5873,1.33333,1.8867,,,,,,,,,,,,,,,,,,,,,,,
Jackson 2014,Functional impairment (Disabilities in ADL)_performance ,12 month,Odds ratio,0.63,0.27,1.46,,,,,,,,,,,,,,,,,,,,,,,
Jackson 2014,Functional impairment (Disabilities in ADL)_performance ,3 month,Odds ratio,1.5,0.63,3.57,,,,,,,,,,,,,,,,,,,,,,,
Jackson 2014,Functional impairment (Disabilities in ADL_performance ,12 month,Odds ratio,1.84,0.96,3.54,,,,,,,,,,,,,,,,,,,,,,,
Jackson 2014,Functional impairment (Disabilities in IADL)_performance ,3 month,Odds ratio,1.57,0.89,2.77,,,,,,,,,,,,,,,,,,,,,,,
Miyamoto 2021,Functional impairment (ADL disability)_performance ,12 month,Odds ratio,5.2,0.45,60.25,,,,,,,,,,,,,,,,,,,,,,,
Miyamoto 2021,Functional impairment (ADL disability)_performance ,3 month,Odds ratio,1.57,0.37,6.7,,,,,,,,,,,,,,,,,,,,,,,
Morandi 2014,Functional impairment (Walking Dependence)_performance ,12 month,Odds ratio,4.31,2.08,8.94,,,,,,,,,,,,,,,,,,,,,,,
Ogawa 2017,Frailty_performance ,10.3 month,Odds ratio,2.98,1.46,6.2,,,,,,,,,,,,,,,,,,,,,,,
Qu 2018,Functional impairment (disability)_performance ,3 month,Odds ratio,2.055,0.71,5.952,,,,,,,,,,,,,,,,,,,,,,,
Qu 2018,Functional impairment (disability)_performance ,6 month,Odds ratio,1.202,0.417,3.468,,,,,,,,,,,,,,,,,,,,,,,
Qu 2018,Functional impairment (poor IADL)_performance ,3 month,Odds ratio,2.9,1.071,7.851,,,,,,,,,,,,,,,,,,,,,,,
Qu 2018,Functional impairment (poor IADL)_performance ,6 month,Odds ratio,1.655,0.605,4.523,,,,,,,,,,,,,,,,,,,,,,,
Rawle 2021,Functional impairment,24 month,Odds ratio,30.5,15.7,59.2,,,,,,,,,,,,,,,,,,,,,,,
Rollo 2022,Functional impairment (poor functional outcome (disability and functional dependence))_performance ,3 month,Odds ratio,4.83,1.88,12.35,,,,,,,,,,,,,,,,,,,,,,,
Verloo 2016,Frailty_performance ,0.067 month,Odds ratio,1.19,1,1.43,,,,,,,,,,,,,,,,,,,,,,,
DelaVarga-Martínez 2022,Functional impairment ((dependency on ADL))_performance ,36 month,Cohort 2x2 (Events),,,,10,55,12,160,,,,,,,,,,,,,,,,,,,
Durlach 2023,Functional impairment ( (poor functional outcome? BADL)_performance ,3 month,Cohort 2x2 (Events),,,,21,42,62,193,,,,,,,,,,,,,,,,,,,
Durlach 2023,Functional impairment ( (poor functional outcome? IADL)_performance ,3 month,Cohort 2x2 (Events),,,,31,42,104,193,,,,,,,,,,,,,,,,,,,
Eeles 2012,Frailty_performance ,60 month,Cohort 2x2 (Events),,,,72,102,39,171,,,,,,,,,,,,,,,,,,,
FialhoSilva 2021,Functional impairment (disability)_performance ,1 month,Cohort 2x2 (Events),,,,58,70,74,140,,,,,,,,,,,,,,,,,,,
FialhoSilva 2021,Functional Impairment (disability)_performance ,3 month,Cohort 2x2 (Events),,,,52,65,52,131,,,,,,,,,,,,,,,,,,,
Gandossi 2023,Functional impairment ( (poor functional status (fraility: delirium vs non-delirium)_performance ,4 month,Cohort 2x2 (Events),,,,62,100,88,106,,,,,,,,,,,,,,,,,,,
Gandossi 2023,Functional impairment ( (poor functional status (No fraility: delirium vs non-delirium)_performance ,4 month,Cohort 2x2 (Events),,,,45,46,196,210,,,,,,,,,,,,,,,,,,,
Lee 2011,Functional impairment_performance ,12 month,Cohort 2x2 (Events),,,,20,48,35,136,,,,,,,,,,,,,,,,,,,
Lee 2011,Functional impairment (housebound patient)_performance ,40 month,Cohort 2x2 (Events),,,,12,38,18,110,,,,,,,,,,,,,,,,,,,
Neufeld 2015,Fall_performance ,18 month,Cohort 2x2 (Events),,,,9,36,14,45,,,,,,,,,,,,,,,,,,,
Paulino 2023,Functional impairment ( (ADL dependency)_performance ,3 month,Cohort 2x2 (Events),,,,12,18,19,51,,,,,,,,,,,,,,,,,,,
Paulino 2023,Functional impairment ( (ADL dependency)_performance ,6 month,Cohort 2x2 (Events),,,,6,13,5,45,,,,,,,,,,,,,,,,,,,
Singler 2014,Fall_performance ,3 month,Cohort 2x2 (Events),,,,7,19,54,114,,,,,,,,,,,,,,,,,,,
Suraarunsumrit 2022,Frailty_performance ,3 month,Cohort 2x2 (Events),,,,3,26,22,247,,,,,,,,,,,,,,,,,,,
To-adithep 2023,Functional impairment (dependent on B-ADL)_performance ,12 month,Cohort 2x2 (Events),,,,104,141,158,366,,,,,,,,,,,,,,,,,,,
To-adithep 2023,Functional impairment (dependent on I-ADL)_performance ,12 month,Cohort 2x2 (Events),,,,113,141,174,366,,,,,,,,,,,,,,,,,,,
VanderHeijden 2023,Fatigue_performance ,12 month,Cohort 2x2 (Events),,,,332,529,915,1871,,,,,,,,,,,,,,,,,,,
Verloo 2016,Functional impairment (IADL)_performance ,0.067 month,Cohort 2x2 (Events),,,,5,20,49,94,,,,,,,,,,,,,,,,,,,
Zakriya 2004,Functional impairment (Ambulation)_performance ,1.5 month,Cohort 2x2 (Events),,,,8,19,42,63,,,,,,,,,,,,,,,,,,,
Zakriya 2004,Functional impairment (Ambulation)_performance ,3 month,Cohort 2x2 (Events),,,,6,15,29,61,,,,,,,,,,,,,,,,,,,
Zakriya 2004,Functional impairment (Banking and finances)_performance ,1.5 month,Cohort 2x2 (Events),,,,10,19,41,63,,,,,,,,,,,,,,,,,,,
Zakriya 2004,Functional impairment (Banking and finances)_performance ,3 month,Cohort 2x2 (Events),,,,8,15,32,61,,,,,,,,,,,,,,,,,,,
Zakriya 2004,Functional impairment (Bathing)_performance ,1.5 month,Cohort 2x2 (Events),,,,9,19,29,63,,,,,,,,,,,,,,,,,,,
Zakriya 2004,Functional impairment (Bathing)_performance ,3 month,Cohort 2x2 (Events),,,,5,15,15,61,,,,,,,,,,,,,,,,,,,
Zakriya 2004,Functional impairment (Bed-to-wheelchair transfer)_performance ,1.5 month,Cohort 2x2 (Events),,,,6,19,16,63,,,,,,,,,,,,,,,,,,,
Zakriya 2004,Functional impairment (Bed-to-wheelchair transfer)_performance ,3 month,Cohort 2x2 (Events),,,,3,15,6,61,,,,,,,,,,,,,,,,,,,
Zakriya 2004,Functional impairment (Dressing)_performance ,1.5 month,Cohort 2x2 (Events),,,,7,19,18,63,,,,,,,,,,,,,,,,,,,
Zakriya 2004,Functional impairment (Dressing)_performance ,3 month,Cohort 2x2 (Events),,,,5,15,12,61,,,,,,,,,,,,,,,,,,,
Zakriya 2004,Functional impairment (Feeding)_performance ,1.5 month,Cohort 2x2 (Events),,,,3,19,3,63,,,,,,,,,,,,,,,,,,,
Zakriya 2004,Functional impairment (Feeding)_performance ,3 month,Cohort 2x2 (Events),,,,1,15,3,61,,,,,,,,,,,,,,,,,,,
Zakriya 2004,Functional impairment (Food shopping)_performance ,1.5 month,Cohort 2x2 (Events),,,,12,19,50,63,,,,,,,,,,,,,,,,,,,
Zakriya 2004,Functional impairment (Food shopping)_performance ,3 month,Cohort 2x2 (Events),,,,11,15,41,61,,,,,,,,,,,,,,,,,,,
Zakriya 2004,Functional impairment (Housework)_performance ,1.5 month,Cohort 2x2 (Events),,,,12,19,50,63,,,,,,,,,,,,,,,,,,,
Zakriya 2004,Functional impairment (Housework)_performance ,3 month,Cohort 2x2 (Events),,,,10,15,38,61,,,,,,,,,,,,,,,,,,,
Zakriya 2004,Functional impairment (Laundry)_performance ,1.5 month,Cohort 2x2 (Events),,,,11,19,48,63,,,,,,,,,,,,,,,,,,,
Zakriya 2004,Functional impairment (Laundry)_performance ,3 month,Cohort 2x2 (Events),,,,9,15,35,61,,,,,,,,,,,,,,,,,,,
Zakriya 2004,Functional impairment (Preparing meals)_performance ,1.5 month,Cohort 2x2 (Events),,,,9,19,44,63,,,,,,,,,,,,,,,,,,,
Zakriya 2004,Functional impairment (Preparing meals)_performance ,3 month,Cohort 2x2 (Events),,,,8,15,31,61,,,,,,,,,,,,,,,,,,,
Zakriya 2004,Functional impairment (Public transportation)_performance ,1.5 month,Cohort 2x2 (Events),,,,10,19,49,63,,,,,,,,,,,,,,,,,,,
Zakriya 2004,Functional impairment (Public transportation)_performance ,3 month,Cohort 2x2 (Events),,,,10,15,42,61,,,,,,,,,,,,,,,,,,,
Zakriya 2004,Functional impairment (Toilet)_performance ,1.5 month,Cohort 2x2 (Events),,,,5,19,14,63,,,,,,,,,,,,,,,,,,,
Zakriya 2004,Functional impairment (Toilet)_performance ,3 month,Cohort 2x2 (Events),,,,2,15,8,61,,,,,,,,,,,,,,,,,,,
Brown 2018,Objective Cognitive change (change from baseline to 1 month),1 month,"Independent groups (means, SD's)",,,,,,,,,,,-0.23,0.87,76,0.035,0.46,66,Negative,,,,,,,-0.371374521,0.168795728,2.85E-02
Brown 2018,Objective Cognitive change (change from 1 month to 1 year),12 month,"Independent groups (means, SD's)",,,,,,,,,,,-0.15,0.8,76,-0.28,0.48,66,Positive,,,,,,,0.192789252,0.167741586,2.81E-02
Cavallari 2017,Objective Cognitive change,12 month,"Independent groups (means, SD's)",,,,,,,,,,,1.21,3.74,25,0.75,3.39,88,Negative,,,,,,,-0.131717619,0.225271147,5.07E-02
Giroux 2021,Objective Cognitive change,2 month,"Raw difference (indep groups), CI",,,,,,,,,,,,,69,310,,,Negative,,,-2.19,-4.12,-0.26,,-0.296401343,0.133281609,1.78E-02
Inouye 2016,Objective Cognitive change (GCP change from baseline to 1 month,1 month,"Independent groups (means, SD's)",,,,,,,,,,,-1.75,3.33201255,129,-0.71,7.414968132,419,Negative,,,,,,,-0.15534835,0.100661538,0.010132745
Inouye 2016,Objective Cognitive change (GCP change from baseline to 12 month),12 month,"Independent groups (means, SD's)",,,,,,,,,,,-0.05,2.850392901,120,0.26,2.77437397,391,Negative,,,,,,,-0.110854656,0.104263202,1.09E-02
Inouye 2016,Objective Cognitive change (GCP change from baseline to 18 month),18 month,"Independent groups (means, SD's)",,,,,,,,,,,-0.36,2.924911494,117,0.14,2.891835655,382,Negative,,,,,,,-0.172177863,0.105644811,1.12E-02
Inouye 2016,Objective Cognitive change (GCP change from baseline to 2 month),2 month,"Independent groups (means, SD's)",,,,,,,,,,,0.47,3.092594371,126,0.47,3.099253581,410,Positive,,,,,,,0,0.101717228,1.03E-02
Inouye 2016,Objective Cognitive change (GCP change from baseline to 24 month),24 month,"Independent groups (means, SD's)",,,,,,,,,,,-0.67,3.072930425,106,0.02,3.131971607,368,Negative,,,,,,,-0.220877709,0.110291479,1.22E-02
Inouye 2016,Objective Cognitive change (GCP change from baseline to 30 month),30 month,"Independent groups (means, SD's)",,,,,,,,,,,-0.99,3.091039964,83,-0.1,2.89697319,242,Negative,,,,,,,-0.301254111,0.127455614,1.62E-02
Inouye 2016,Objective Cognitive change (GCP change from baseline to 36 month),36 month,"Independent groups (means, SD's)",,,,,,,,,,,-1.3,3.595892886,86,-0.23,3.259770898,226,Negative,,,,,,,-0.318127676,0.1270324,1.61E-02
Inouye 2016,Objective Cognitive change (GCP change from baseline to 6 month),6 month,"Independent groups (means, SD's)",,,,,,,,,,,0.26,2.982730909,124,0.39,2.92266791,404,Negative,,,,,,,-4.42E-02,0.102525922,1.05E-02
Jankowski 2011,Objective Cognitive change (Changes in AVLTDelayed Recall) 3 month,3 month,"Independent groups (means, SD's)",,,,,,,,,,,5.8,11.7,37,4,11.8,33,Positive,,,,,,,0.151532206,0.237132446,5.62E-02
Jankowski 2011,Objective Cognitive change (Changes in AVLTLearning Efficiency) 3 month,3 month,"Independent groups (means, SD's)",,,,,,,,,,,3.6,9.3,37,7.3,11.6,33,Negative,,,,,,,-0.350293927,0.23862995,5.69E-02
Jankowski 2011,Objective Cognitive change (Changes in AVLTPercent Retention) 3 month,3 month,"Independent groups (means, SD's)",,,,,,,,,,,9.7,19.9,37,1.8,17.5,33,Positive,,,,,,,0.415367099,0.239374474,5.73E-02
Jankowski 2011,Objective Cognitive change (Changes in COWAT) 3 month,3 month,"Independent groups (means, SD's)",,,,,,,,,,,0.5,1.8,37,-0.03,2.4,33,Positive,,,,,,,0.249138841,0.237720721,5.65E-02
Jankowski 2011,Objective Cognitive change (Changes in SCWT) 3 month,3 month,"Independent groups (means, SD's)",,,,,,,,,,,1.2,6.9,37,2.6,7.9,33,Negative,,,,,,,-0.187412191,0.237315536,5.63E-02
Katz 2001,Objective Cognitive change (Buschke SRT verbal memory) 2 month,2 month,"Independent groups (Sample size, t)",,,,,,,,,,,,,12,35,,,Positive,0.52,,,,,,0.171035895,0.329387921,0.108496402
Katz 2001,Objective Cognitive change (EEG Alpha activity (right hemisphere) 2 month,2 month,"Independent groups (Sample size, t)",,,,,,,,,,,,,12,35,,,Negative,-0.38,,,,,,-0.124987769,0.32916772,0.108351388
Katz 2001,Objective Cognitive change (EEG Delta activity (right hemisphere) 2 month,2 month,"Independent groups (Sample size, t)",,,,,,,,,,,,,12,35,,,Negative,-1.96,,,,,,-0.644673758,0.335568948,0.112606519
Katz 2001,Objective Cognitive change (EEG Theta activity (right hemisphere) 2 month,2 month,"Independent groups (Sample size, t)",,,,,,,,,,,,,12,35,,,Negative,-1.76,,,,,,-0.578890721,0.334290659,0.111750245
Katz 2001,Objective Cognitive change (MMSE) 2 month,2 month,"Independent groups (Sample size, t)",,,,,,,,,,,,,12,35,,,Negative,-0.79,,,,,,-0.259842994,0.330005269,0.108903478
Katz 2001,Objective Cognitive change(Stroop % correct) 2 month,2 month,"Independent groups (Sample size, t)",,,,,,,,,,,,,12,35,,,Negative,-0.44,,,,,,-0.14472268,0.329253721,0.108408013
Katz 2001,Objective Cognitive change(Stroop Interference) 2 month,2 month,"Independent groups (Sample size, t)",,,,,,,,,,,,,12,35,,,Negative,-0.23,,,,,,-7.57E-02,0.329007721,0.10824608
Katz 2001,Objective Cognitive change (Verbal vigilance) 2 month,2 month,"Independent groups (Sample size, t)",,,,,,,,,,,,,12,35,,,Negative,-1.62,,,,,,-0.532842596,0.33347509,0.111205636
Kunicki 2023,Objective Cognitive change(GCP change from baseline to 12 month),12 month,"Independent groups (means, SD's)",,,,,,,,,,,0.21,3.176790834,120,0.59,2.570583591,391,Positive,,,,,,,0.139273707,0.104296552,1.09E-02
Kunicki 2023,Objective Cognitive change(GCP change from baseline to 18 month),18 month,"Independent groups (means, SD's)",,,,,,,,,,,0.08,3.13682961,117,0.62,2.73627484,382,Positive,,,,,,,0.190199855,0.105675778,1.12E-02
Kunicki 2023,Objective Cognitive change(GCP change from baseline to 1month),1 month,"Independent groups (means, SD's)",,,,,,,,,,,-1.75,3.407345007,129,-0.54,3.070423424,419,Negative,,,,,,,-0.383277691,0.101216404,1.02E-02
Kunicki 2023,Objective Cognitive change(GCP change from baseline to 2 month),2 month,"Independent groups (means, SD's)",,,,,,,,,,,0.36,3.928740256,126,0.47,2.834783942,410,Positive,,,,,,,3.51E-02,0.101722892,1.03E-02
Kunicki 2023,Objective Cognitive change(GCP change from baseline to 24 month),24 month,"Independent groups (means, SD's)",,,,,,,,,,,-0.28,3.294601645,106,0.44,3.069332175,368,Negative,,,,,,,-0.230339471,0.110311893,1.22E-02
Kunicki 2023,Objective Cognitive change(GCP change from baseline to 30 month),30 month,"Independent groups (means, SD's)",,,,,,,,,,,-0.9,3.097547417,83,0.01,2.644579362,242,Negative,,,,,,,-0.32815838,0.127557774,1.63E-02
Kunicki 2023,Objective Cognitive change(GCP change from baseline to 36 month),36 month,"Independent groups (means, SD's)",,,,,,,,,,,-1.6,3.985473623,110,-0.5,3.16218279,346,Negative,,,,,,,-0.325079164,0.109806109,0.012057382
Kunicki 2023,Objective Cognitive change(GCP change from baseline to 48 month),48 month,"Independent groups (means, SD's)",,,,,,,,,,,-2.99,4.553679831,90,-1.51,3.606868448,295,Negative,,,,,,,-0.383889614,0.120977515,1.46E-02
Kunicki 2023,Objective Cognitive change(GCP change from baseline to 6 month),6 month,"Independent groups (means, SD's)",,,,,,,,,,,0.3,3.563369192,124,0.51,2.612967661,404,Positive,,,,,,,7.32E-02,0.102541663,1.05E-02
Kunicki 2023,Objective Cognitive change(GCP change from baseline to 60 month),60 month,"Independent groups (means, SD's)",,,,,,,,,,,-4.39,5.33291665,79,-2.52,4.145780988,275,Negative,,,,,,,-0.420621598,0.128355248,1.65E-02
Kunicki 2023,Objective Cognitive change(GCP change from baseline to 72 month),72 month,"Independent groups (means, SD's)",,,,,,,,,,,-5.79,5.804825579,65,-3.53,4.881884882,248,Negative,,,,,,,-0.443326329,0.140132864,1.96E-02
Neufeld 2015,Objective Cognitive change(difference Digit Span: backward from baseline to 18 month),18 month,"Independent groups (means, SD's)",,,,,,,,,,,-0.7108,16.9857,36,-2.4803,6.8922,45,Positive,,,,,,,0.141104287,0.221754499,4.92E-02
Neufeld 2015,Objective Cognitive change(difference Digit Span: forward from baseline to 18 month),18 month,"Independent groups (means, SD's)",,,,,,,,,,,0.3554,13.1253,36,-1.4175,15.316,45,Positive,,,,,,,0.122058639,0.221684729,0.049144119
Neufeld 2015,Objective Cognitive change(difference verbal fluency: Category-cued (animals) fluency from baseline to 18 month),18 month,"Independent groups (means, SD's)",,,,,,,,,,,-0.7771,3.8604,36,1.5197,11.487,45,Negative,,,,,,,-0.254194739,0.222375835,4.95E-02
Neufeld 2015,Objective Cognitive changes(difference verbal fluency: Letter-cued (p) fluency from baseline to 18 month),18 month,"Independent groups (means, SD's)",,,,,,,,,,,0.3554,5.4045,36,4,6.1264,45,Negative,,,,,,,-0.620508241,0.226779376,0.051428886
Neufeld 2015,Objective Cognitive change(difference verbal fluency: Letter-cued (s) fluency from baseline to 18 month),18 month,"Independent groups (means, SD's)",,,,,,,,,,,-1.0662,8.4928,36,-0.0827,5.3606,45,Negative,,,,,,,-0.140662411,0.221752767,4.92E-02
Neufeld 2015,Objective Cognitive change(MMSE change from baseline to 18 month),18 month,"Independent groups (means, SD's)",,,,,,,,,,,0.3554,2.3162,36,-1.3543,2.2974,45,Positive,,,,,,,0.734432871,0.228870558,5.24E-02
Neufeld 2015,Objective Cognitive change(verbal fluency: Letter-cued (s+p) fluency from baseline to 18 month),18 month,"Independent groups (means, SD's)",,,,,,,,,,,0.7892,6.9487,36,-2,5.3606,45,Positive,,,,,,,0.451759159,0.224303247,5.03E-02
Witlox 2013,Objective Cognitive change(change from baseline to 3 month (Expanded degit span forward)),3 month,"Independent groups (means, SD's)",,,,,,,,,,,-1,3.1,22,-0.4,2.2,26,Negative,,,,,,,-0.222780971,0.285839609,8.17E-02
Witlox 2013,Objective Cognitive change(change from baseline to 3 month (Expanded digit span backward)),3 month,"Independent groups (means, SD's)",,,,,,,,,,,-0.7,2.1,22,-0.4,2.1,26,Negative,,,,,,,-0.140515222,0.285294516,8.14E-02
Witlox 2013,Objective Cognitive change(change from baseline to 3 month (MMSE)),3 month,"Independent groups (means, SD's)",,,,,,,,,,,0.1,4.2,22,1.6,1.8,26,Negative,,,,,,,-0.470968186,0.288959894,8.35E-02
Sauer 2017,Objective Cognitive change (change from the baseline: Grooved pegboard (s)) 1 month,1 month,"Independent groups (means, SD's)",,,,,,,,,,,0.2407,1.474,22,0.2038,1.0926,154,Positive,,,,,,,0.032077042,0.226943761,5.15E-02
Sauer 2017,Objective Cognitive change (change from the baseline: Grooved pegboard (s)) 12 month,12 month,"Independent groups (means, SD's)",,,,,,,,,,,-0.6104,0.6702,20,0.1854,0.6824,126,Negative,,,,,,,-1.162815433,0.248925984,6.20E-02
Sauer 2017,Objective Cognitive change (change from the baseline: RAVL (DR)) 1 month,1 month,"Independent groups (means, SD's)",,,,,,,,,,,-0.1263,0.7529,22,0.0165,0.8531,154,Negative,,,,,,,-0.168936336,0.227115886,5.16E-02
Sauer 2017,Objective Cognitive change (change from the baseline: RAVL (DR)) 12 month,12 month,"Independent groups (means, SD's)",,,,,,,,,,,0.6373,0.9095,20,0.6264,0.8549,126,Positive,,,,,,,1.26E-02,0.239445342,5.73E-02
Sauer 2017,Objective Cognitive change (change from the baseline: RAVL (IR) 1 month,1 month,"Independent groups (means, SD's)",,,,,,,,,,,-0.62,1.7989,22,0.1292,0.8382,154,Negative,,,,,,,-0.742873991,0.230365658,0.053068337
Sauer 2017,Objective Cognitive change (change from the baseline: RAVL (IR) 12 month,12 month,"Independent groups (means, SD's)",,,,,,,,,,,0.5186,1.1569,20,0.7625,1.2149,126,Negative,,,,,,,-0.200949242,0.239732809,5.75E-02
Sauer 2017,Objective Cognitive change(change from the baseline: Trailmaking test A (s)) 1 month,1 month,"Independent groups (means, SD's)",,,,,,,,,,,-0.03,1.4582,22,0.0062,0.5688,154,Negative,,,,,,,-4.90E-02,0.226952348,5.15E-02
Sauer 2017,Objective Cognitive change (change from the baseline: Trailmaking test A (s)) 12 month,12 month,"Independent groups (means, SD's)",,,,,,,,,,,0.0787,1.125,20,-0.0027,0.525,126,Negative,,,,,,,-0.12704451,0.239559607,5.74E-02
Sauer 2017,Objective Cognitive change (change from the baseline: Trailmaking test B (s)) 1 month,1 month,"Independent groups (means, SD's)",,,,,,,,,,,-0.7992,1.7593,22,-0.0776,0.5463,154,Negative,,,,,,,-0.900943579,0.231962306,5.38E-02
Sauer 2017,Objective Cognitive change (change from the baseline: Trailmaking test B (s)) 12 month,12 month,"Independent groups (means, SD's)",,,,,,,,,,,-0.1499,1.2367,20,0.2227,0.6224,126,Negative,,,,,,,-0.505303543,0.241263246,5.82E-02
Sauer 2017,Objective Cognitive change (change from the baseline: WAIS digit span (span)) 1 month,1 month,"Independent groups (means, SD's)",,,,,,,,,,,-0.4645,0.7608,22,-0.1235,1.4294,154,Negative,,,,,,,-0.248523494,0.227323587,5.17E-02
Sauer 2017,Objective Cognitive change (change from the baseline: WAIS digit span (span)) 12 month,12 month,"Independent groups (means, SD's)",,,,,,,,,,,-0.0863,1.3404,20,0,1.4399,126,Negative,,,,,,,-6.02E-02,0.239470086,5.73E-02
Sauer 2017,Objective Cognitive change (change from the baseline: WAIS digit span (total)) 1 month,1 month,"Independent groups (means, SD's)",,,,,,,,,,,-0.4272,1.4106,22,-0.43,1.3321,154,Positive,,,,,,,2.08E-03,0.226937348,5.15E-02
Sauer 2017,Objective Cognitive change(change from the baseline: WAIS digit span (total)) 12 month,12 month,"Independent groups (means, SD's)",,,,,,,,,,,0.3202,1.4122,20,0.4435,1.3274,126,Negative,,,,,,,-9.16E-02,0.23950422,5.74E-02
Sauer 2017,Objective Cognitive change(change from the baseline: Corsi blocks (total score)) 1 month,1 month,"Independent groups (means, SD's)",,,,,,,,,,,-0.3926,0.9748,22,-0.0857,0.696,154,Negative,,,,,,,-0.41559076,0.228015826,5.20E-02
Sauer 2017,Objective Cognitive change(change from the baseline: Corsi blocks (total score)) 12 month,12 month,"Independent groups (means, SD's)",,,,,,,,,,,0.2936,0.9175,20,0.5556,0.7799,126,Negative,,,,,,,-0.326030502,0.240203158,5.77E-02
Racine 2020,Objective Cognitive change (GCP  from the baseline 1 month,1 month,"Hedges's g, CI",,,,,,,,,,,,,30,,,110,Negative,,,,-0.5207,0.3225,,-0.0991,,
Racine 2020,Objective Cognitive change (GCP from 1 month to 2 month,2 month,"Hedges's g, CI",,,,,,,,,,,,,30,,,110,Positive,,,,-0.2418,0.469,,0.1136,,
Racine 2020,Objective Cognitive change (GCP from 2 month to 36 month,36 month,"Hedges's g, CI",,,,,,,,,,,,,30,,,110,Negative,,,,-0.5772,0.408,,-0.0846,,
Krogseth 2016,Objective Cognitive change from the baseline,12 month,"Independent groups (means, SD's)",,,,,,,,,,,2.4702,2.0908,201,0.9648,1.4326,86,Negative,,,,,,,-0.78270018,0.13260078,0.017582967
Duppils 2004,Objective Cognitive change,6 month,"Independent groups (difference, t)",,,,,,,,,,,,,32,83,,,Negative,2,,5.39,,,,-0.413396079,0.208487666,4.35E-02
Witlox 2013,Objective Cognitive performance (Clock drawing),3 month,"Independent groups (means, SD's)",,,,,,,,,,,2,1.585,22,3.1425,1.5687,26,Negative,,,,,,,-0.712978956,0.294079048,8.65E-02
Witlox 2013,Objective Cognitive performance (COWAT total),3 month,"Independent groups (means, SD's)",,,,,,,,,,,19.2,8.1,22,23.5,11,26,Negative,,,,,,,-0.432318494,0.288329944,8.31E-02
Witlox 2013,Objective Cognitive performance (DART),3 month,"Independent groups (means, SD's)",,,,,,,,,,,71.2,15.8,22,62.6,16.9,26,Positive,,,,,,,0.515574325,0.289751988,0.083956215
Witlox 2013,Objective Cognitive performance (EMCT total error),3 month,"Independent groups (means, SD's)",,,,,,,,,,,7.8637,10.4608,22,4.0725,4.706,26,Negative,,,,,,,-0.473618286,0.28900501,8.35E-02
Witlox 2013,Objective Cognitive performance (EMCT total time (seconds)),3 month,"Independent groups (means, SD's)",,,,,,,,,,,272,123,22,224,80,26,Negative,,,,,,,-0.463297393,0.288830692,8.34E-02
Witlox 2013,Objective Cognitive performance (EMCT total),3 month,"Independent groups (means, SD's)",,,,,,,,,,,17.7,5.8,22,20.3,2.8,26,Negative,,,,,,,-0.577383689,0.290963766,8.47E-02
Witlox 2013,Objective Cognitive performance (Expanded digit span backward),3 month,"Independent groups (means, SD's)",,,,,,,,,,,5.5,2.5,22,6.6,1.9,26,Negative,,,,,,,-0.493067243,0.289343637,8.37E-02
Witlox 2013,Objective Cognitive performance (Expanded digit span forwardd),3 month,"Independent groups (means, SD's)",,,,,,,,,,,10.5,2.7,22,10.5,2.8,26,Positive,,,,,,,0,0.284933833,8.12E-02
Witlox 2013,Objective Cognitive performance (Fifteen Words Test total recall),3 month,"Independent groups (means, SD's)",,,,,,,,,,,20.3,5.9,22,29.7,8.2,26,Negative,,,,,,,-1.276846331,0.31332086,0.098169961
Witlox 2013,Objective Cognitive performance (MMSE),3 month,"Independent groups (means, SD's)",,,,,,,,,,,23.1,4.5,22,26.8,2.7,26,Negative,,,,,,,-1.001449177,0.302711362,9.16E-02
Witlox 2013,Objective Cognitive performance Fifteen Words Test delayed recall),3 month,"Independent groups (means, SD's)",,,,,,,,,,,1.1,1.7,22,5.1,2.9,26,Negative,,,,,,,-1.621152085,0.329490039,0.108563686
Witlox 2013,Objective Cognitive performance RT mean (millisecond),3 month,"Independent groups (means, SD's)",,,,,,,,,,,617.6436,418.4336,22,360.88,136.474,26,Negative,,,,,,,-0.841598979,0.297599223,8.86E-02
Witlox 2013,Objective Cognitive performance RT SD (millisecond),3 month,"Independent groups (means, SD's)",,,,,,,,,,,358.5886,393.074,22,144.9475,113.7283,26,Negative,,,,,,,-0.754523008,0.295156821,0.087117549
Witlox 2013,Objective Cognitive performance RT total error,3 month,"Independent groups (means, SD's)",,,,,,,,,,,1,4.45,22,1,2.59,26,Positive,,,,,,,0,0.284933833,8.12E-02
Witlox 2013,Objective Cognitvive performance (Fifteen Words Test recognition),3 month,"Independent groups (means, SD's)",,,,,,,,,,,22.1,3.8,22,26.5,3.2,26,Negative,,,,,,,-1.24123466,0.311826662,9.72E-02
Whittamore 2014,Objective Cognitive performance,6 month,"Independent groups (means, SD's)",,,,,,,,,,,11.2964,13.5267,47,23,8.89,74,Negative,,,,,,,-1.065150041,0.197586042,3.90E-02
Vives-Borrás 2019,Objective Cognitive performance,6 month,"Independent groups (means, SD's)",,,,,,,,,,,5.3553,5.3986,37,1,1.487,490,Negative,,,,,,,-2.158927716,0.182775775,3.34E-02
Verloo 2016,Objective Cognitive performance,0.067 month,"Independent groups (means, SD's)",,,,,,,,,,,19.2,5.4,20,24.57,4.3,94,Negative,,,,,,,-1.183861122,0.256854319,6.60E-02
Vasunilashorn 2018,Objective Cognitive performance (GCP (CAM-S 0-2 vs 3-7),1 month,"Independent groups (means, SD's)",,,,,,,,,,,55,7.9,242,60,6.9,243,Negative,,,,,,,-0.67318499,9.32E-02,8.69E-03
Vasunilashorn 2018,Objective Cognitive performance (GCP (CAM-S 0-2 vs 3-7),12 month,"Independent groups (means, SD's)",,,,,,,,,,,56.8,7.6,224,61.2,7,227,Negative,,,,,,,-0.601389755,9.61E-02,9.24E-03
Vasunilashorn 2018,Objective Cognitive performance (GCP (CAM-S 0-2 vs 3-7) ,18 month,"Independent groups (means, SD's)",,,,,,,,,,,56.5,7.9,222,61.5,6.9,219,Negative,,,,,,,-0.672677089,0.097738234,9.55E-03
Vasunilashorn 2018,Objective Cognitive performance (GCP (CAM-S 0-2 vs 3-7),2 month,"Independent groups (means, SD's)",,,,,,,,,,,56.2,8.1,237,60.9,7.1,238,Negative,,,,,,,-0.616193397,9.38E-02,8.79E-03
Vasunilashorn 2018,Objective Cognitive performance (GCP (CAM-S 0-2 vs 3-7) ,36 month,"Independent groups (means, SD's)",,,,,,,,,,,55.8,8.2,141,60.6,7.4,123,Negative,,,,,,,-0.610673935,0.125862878,1.58E-02
Vasunilashorn 2018,Objective Cognitive performance (GCP (CAM-S 0-2 vs 3-7) ,6 month,"Independent groups (means, SD's)",,,,,,,,,,,56.4,7.9,230,61,6.5,237,Negative,,,,,,,-0.635786974,9.47E-02,8.97E-03
Vasunilashorn 2018,Objective Cognitive performance (GCP (CAM-S 0-2 vs 8-19) ,6 month,"Independent groups (means, SD's)",,,,,,,,,,,54.2,6.1,61,61,6.5,237,Negative,,,,,,,-1.056350516,0.149601855,2.24E-02
Vasunilashorn 2018,Objective Cognitive performance (GCP CAM-S 0-2 vs 3-7),30 month,"Independent groups (means, SD's)",,,,,,,,,,,56.1,7.9,152,60.7,7.5,132,Negative,,,,,,,-0.594518035,0.121250656,1.47E-02
Vasunilashorn 2018,Objective Cognitive performance (GCP) (CAM-S 0-2 vs 8-19),1 month,"Independent groups (means, SD's)",,,,,,,,,,,51.4,5.8,63,60,6.9,243,Negative,,,,,,,-1.282258554,0.150253908,2.26E-02
Vasunilashorn 2018,Objective Cognitive performance (GCP) (CAM-S 0-2 vs 8-19) ,12 month,"Independent groups (means, SD's)",,,,,,,,,,,53.9,5.4,60,61.2,7,227,Negative,,,,,,,-1.086648929,0.151717665,0.02301825
Vasunilashorn 2018,Objective Cognitive performance (GCP) (CAM-S 0-2 vs 8-19) ,18 month,"Independent groups (means, SD's)",,,,,,,,,,,52.7,7.2,58,61.5,6.9,219,Negative,,,,,,,-1.260329017,0.156703203,2.46E-02
Vasunilashorn 2018,Objective Cognitive performance (GCP) (CAM-S 0-2 vs 8-19),2 month,"Independent groups (means, SD's)",,,,,,,,,,,53.8,5.3,61,60.9,7.1,238,Negative,,,,,,,-1.045318625,0.14939342,2.23E-02
Vasunilashorn 2018,Objective Cognitive performance (GCP) (CAM-S 0-2 vs 8-19),24 month,"Independent groups (means, SD's)",,,,,,,,,,,52.4,7.2,50,61.2,6.8,213,Negative,,,,,,,-1.275971248,0.166277574,2.76E-02
Vasunilashorn 2018,Objective Cognitive performance (GCP) (CAM-S 0-2 vs 8-19) ,30 month,"Independent groups (means, SD's)",,,,,,,,,,,52.4,7.3,41,60.7,7.5,132,Negative,,,,,,,-1.108650236,0.187718224,3.52E-02
Vasunilashorn 2018,Objective Cognitive performance (GCP) (CAM-S 0-2 vs 8-19) ,36 month,"Independent groups (means, SD's)",,,,,,,,,,,51.8,7.7,48,60.6,7.4,123,Negative,,,,,,,-1.170515875,0.180866515,3.27E-02
Vasunilashorn 2018,Objective Cognitive performance GCP (CAM-S 0-2 vs 3-7) ,24 month,"Independent groups (means, SD's)",,,,,,,,,,,56.4,8.1,211,61.2,6.8,213,Negative,,,,,,,-0.640978618,9.94E-02,9.89E-03
Sheng 2006,Objective Cognitive performance ,1 month,"Independent groups (means, SD's)",,,,,,,,,,,18.5,6.6,16,24.3,5.4,82,Negative,,,,,,,-1.026783422,0.280906652,7.89E-02
Sheng 2006,Objective Cognitive performance ,12 month,"Independent groups (means, SD's)",,,,,,,,,,,17.5,7.5,10,24.7,4.9,73,Negative,,,,,,,-1.35795886,0.350292932,0.122705138
Serrano-Duenas 2005,Objective Cognitive performance ,12 month,"Independent groups (means, SD's)",,,,,,,,,,,31,2.3,21,34.1,2.1,21,Negative,,,,,,,-1.381078291,0.338208488,0.114384981
Serrano-Duenas 2005, Cognitive performance ,18 month,"Independent groups (means, SD's)",,,,,,,,,,,29.8,2.8,19,33.8,1.9,21,Negative,,,,,,,-1.654705728,0.361292633,0.130532367
Serrano-Duenas 2005,Objective Cognitive performance ,24 month,"Independent groups (means, SD's)",,,,,,,,,,,27.4,3.3,18,33.3,1.8,21,Negative,,,,,,,-2.223764723,0.402995612,0.162405463
Serrano-Duenas 2005,Objective Cognitive performance ,30 month,"Independent groups (means, SD's)",,,,,,,,,,,26.3,3.2,17,32.6,2,21,Negative,,,,,,,-2.369907106,0.419433055,0.175924088
Serrano-Duenas 2005,Objective Cognitive performance ,36 month,"Independent groups (means, SD's)",,,,,,,,,,,25.4,2.9,15,32.6,2,21,Negative,,,,,,,-2.919206738,0.477096086,0.227620675
Serrano-Duenas 2005,Objective Cognitive performance ,42 month,"Independent groups (means, SD's)",,,,,,,,,,,24.4,3,14,32.3,1.9,20,Negative,,,,,,,-3.202895422,0.516352994,0.266620415
Serrano-Duenas 2005,Objective Cognitive performance ,48 month,"Independent groups (means, SD's)",,,,,,,,,,,22.9,3.2,13,32,1.9,20,Negative,,,,,,,-3.572300671,0.560500427,0.314160728
Serrano-Duenas 2005,Objective Cognitive performance ,54 month,"Independent groups (means, SD's)",,,,,,,,,,,21.6,3.4,11,31.8,2.1,18,Negative,,,,,,,-3.731679601,0.615191415,0.378460477
Serrano-Duenas 2005,Objective Cognitive performance ,6 month,"Independent groups (means, SD's)",,,,,,,,,,,31.8,2.2,21,34.4,1.9,21,Negative,,,,,,,-1.241044818,0.331683179,0.110013731
Serrano-Duenas 2005,Objective Cognitive performance,60 month,"Independent groups (means, SD's)",,,,,,,,,,,21.1,3.3,11,31.6,2.1,17,Negative,,,,,,,-3.880207195,0.640308237,0.409994639
Sauer 2017,Objective Cognitive performance  (Trailmaking test A (s)),1 month,"Independent groups (means, SD's)",,,,,,,,,,,49.7943,24.5671,22,34.7177,14.2648,154,Negative,,,,,,,-0.94607373,0.232472189,5.40E-02
Sauer 2017,Objective Cognitive performance  (Trailmaking test A (s)),12 month,"Independent groups (means, SD's)",,,,,,,,,,,47.7988,23.1375,20,36.7577,14.2488,126,Negative,,,,,,,-0.699039202,0.242913583,5.90E-02
Sauer 2017,Objective Cognitive performance (Corsi blocks),1 month,"Independent groups (means, SD's)",,,,,,,,,,,29.6411,10.3023,22,43.1614,14.2188,154,Negative,,,,,,,-0.975135211,0.232813092,5.42E-02
Sauer 2017,Objective Cognitive performance (Grooved pegboard (s)),1 month,"Independent groups (means, SD's)",,,,,,,,,,,105,62.23,22,81,20,154,Negative,,,,,,,-0.834955072,0.231259783,5.35E-02
Sauer 2017,Objective Cognitive performance (Grooved pegboard (s)),12 month,"Independent groups (means, SD's)",,,,,,,,,,,112.6705,47.8708,20,78.0546,20.2484,126,Negative,,,,,,,-1.342155855,0.251997317,6.35E-02
Sauer 2017,Objective Cognitive performance (RAVL (DR)),1 month,"Independent groups (means, SD's)",,,,,,,,,,,5.3589,2.3775,22,8,4.4902,154,Negative,,,,,,,-0.612872654,0.229276317,5.26E-02
Sauer 2017,Objective Cognitive performance (RAVL (DR)),12 month,"Independent groups (means, SD's)",,,,,,,,,,,7.3598,3.9892,20,9,4.4996,126,Negative,,,,,,,-0.367849896,0.240409926,5.78E-02
Sauer 2017,Objective Cognitive performance (RAVL (IR)),1 month,"Independent groups (means, SD's)",,,,,,,,,,,34.7177,12.6798,22,42.2975,11.9738,154,Negative,,,,,,,-0.625732224,0.229374975,5.26E-02
Sauer 2017,Objective Cognitive performance (RAVL (IR)),12 month,"Independent groups (means, SD's)",,,,,,,,,,,36.9208,11.9677,20,44.9454,14.2488,126,Negative,,,,,,,-0.571453619,0.241768244,5.85E-02
Sauer 2017,Objective Cognitive performance (Trailmaking test B (s)),1 month,"Independent groups (means, SD's)",,,,,,,,,,,107.3261,81.6262,22,61.5127,34.4245,154,Negative,,,,,,,-1.061644913,0.233885672,5.47E-02
Sauer 2017,Objective Cognitive performance (Trailmaking test B (s)),12 month,"Independent groups (means, SD's)",,,,,,,,,,,98.5913,77.3911,20,53.4608,27.7477,126,Negative,,,,,,,-1.175515729,0.249130186,6.21E-02
Sauer 2017,Objective Cognitive performance (WAIS digit span (span)),1 month,"Independent groups (means, SD's)",,,,,,,,,,,5.3589,0.7925,22,5.7025,1.4967,154,Negative,,,,,,,-0.239204377,0.227295184,5.17E-02
Sauer 2017,Objective Cognitive performance (WAIS digit span (span)),12 month,"Independent groups (means, SD's)",,,,,,,,,,,5.3598,0.7978,20,6,1.4999,126,Negative,,,,,,,-0.446236241,0.24086401,5.80E-02
Sauer 2017,Objective Cognitive performance (WAIS digit span (total)),1 month,"Independent groups (means, SD's)",,,,,,,,,,,12.6411,2.3775,22,14,2.9934,154,Negative,,,,,,,-0.462424909,0.228271852,5.21E-02
Sauer 2017,Objective Cognitive performance (WAIS digit span (total)),12 month,"Independent groups (means, SD's)",,,,,,,,,,,13.6403,2.3935,20,15.3515,3.7497,126,Negative,,,,,,,-0.472835692,0.241037742,5.81E-02
Sauer 2017,Objective Cognitive performance Corsi blocks (total),12 month,"Independent groups (means, SD's)",,,,,,,,,,,38.9208,5.5849,20,51.1876,14.1876,126,Negative,,,,,,,-0.912476076,0.245326197,6.02E-02
Saczynski 2012,Objective Cognitive performance ,12 month,"Raw difference (indep groups), CI",,,,,,,,,,,,,103,,,122,Negative,,,-0.9,-1.8,0,,-0.262808535,0.133934954,1.79E-02
Saczynski 2012,Objective Cognitive performance,1 month,"Raw difference (indep groups), CI",,,,,,,,,,,,,103,,,122,Negative,,,-2.2,,-1.3,,-0.642420864,0.136756016,1.87E-02
Saczynski 2012,Objective Cognitive performance ,6 month,"Raw difference (indep groups), CI",,,,,,,,,,,,,103,,,122,Negative,,,-0.9,-1.8,0,,-0.262808535,0.133934954,1.79E-02
Richardson 2021_2,Objective Cognitive performance ,24 month,"Independent groups (means, SD's)",,,,,,,,,,,25.2,3.9,48,27.4,2.5,87,Negative,,,,,,,-0.712888444,0.18397172,3.38E-02
Richardson 2021_2,Objective Cognitive performance ,36 month,"Independent groups (means, SD's)",,,,,,,,,,,21.8,5.8,48,26.7,3.2,87,Negative,,,,,,,-1.132509816,0.191607999,3.67E-02
Pandharipande 2013,Objective Cognitive performance (Part B (Trails B) ,12 month,"Raw difference (indep groups), CI",,,,,,,,,,,,,352,,,115,Negative,,,-6,-10.2,-1.9,,-0.304663114,0.107697424,1.16E-02
Pandharipande 2013,Objective Cognitive performance (Part B (Trails B),3 month,"Raw difference (indep groups), CI",,,,,,,,,,,,,352,,,115,Negative,,,-5.1,-9.2,-1.1,,-0.265357811,0.107585999,1.16E-02
Pandharipande 2013,Objective Cognitive performance (RBANS),12 month,"Raw difference (indep groups), CI",,,,,,,,,,,,,352,,,115,Negative,,,-5.6,-9.5,-1.8,,-0.306509557,0.107703033,1.16E-02
Pandharipande 2013,Objective Cognitive performance (RBANS) ,3 month,"Raw difference (indep groups), CI",,,,,,,,,,,,,352,,,115,Negative,,,-6.3,-10.3,-2.3,,-0.33189238,0.107783547,1.16E-02
Olofsson 2018,Objective Cognitive performance ,12 month,"Independent groups (means, SD's)",,,,,,,,,,,19.9,6.3,64,25.9,4.8,55,Negative,,,,,,,-1.053757855,0.195037007,3.80E-02
Olofsson 2018,Objective Cognitive performance ,36 month,"Independent groups (means, SD's)",,,,,,,,,,,18.7,7.1,64,26,4.2,55,Negative,,,,,,,-1.221030556,0.199093485,3.96E-02
Olofsson 2018,Objective Cognitive performance ,4 month,"Independent groups (means, SD's)",,,,,,,,,,,20.4,5.2,64,26.2,3.5,55,Negative,,,,,,,-1.281753806,0.200690746,4.03E-02
Ojagbemi 2020,Objective Cognitive performance (executive function),3 month,"Raw difference (indep groups), CI",,,,,,,,,,,,,11,,,100,Negative,,,-2.2,-4.1,-0.3,,-0.72397779,0.319191242,0.101883049
Ojagbemi 2020,Objective Cognitive performance (global cognitive functioning),3 month,"Raw difference (indep groups), CI",,,,,,,,,,,,,11,,,100,Negative,,,-5.6,-9,-2.1,,-1.014904306,0.322741102,0.104161819
Ojagbemi 2020,Objective Cognitive performance (Memory),3 month,"Raw difference (indep groups), CI",,,,,,,,,,,,,11,,,100,Negative,,,-1.9,,-0.9,,-1.187981737,0.32539092,0.105879251
Neufeld 2015,Objective Cognitive performance  (Letter-cued (p) fluency),18 month,"Independent groups (means, SD's)",,,,,,,,,,,43.7111,13.9136,36,48.2911,13.7946,45,Negative,,,,,,,-0.327596901,0.222967759,4.97E-02
Neufeld 2015,Objective Cognitive performance  (Letter-cued (s) fluency),18 month,"Independent groups (means, SD's)",,,,,,,,,,,41.4879,10.0487,36,45.5823,13.7946,45,Negative,,,,,,,-0.330329306,0.222992643,4.97E-02
Neufeld 2015,Objective Cognitive performance (Category-cued (animals) fluency),18 month,"Independent groups (means, SD's)",,,,,,,,,,,47.3556,14.6866,36,47.2911,10.7291,45,Positive,,,,,,,5.06E-03,0.221477565,4.91E-02
Neufeld 2015,Objective Cognitive performance (Digit Span: backward),18 month,"Independent groups (means, SD's)",,,,,,,,,,,44.2889,17.0055,36,47.6455,6.9027,45,Negative,,,,,,,-0.267335514,0.222470934,4.95E-02
Neufeld 2015,Objective Cognitive performance (Digit Span: forward),18 month,"Independent groups (means, SD's)",,,,,,,,,,,47.4223,10.8217,36,46,9.1964,45,Positive,,,,,,,0.141593573,0.221756425,4.92E-02
Neufeld 2015,Objective Cognitive performance (MMSE score),18 month,"Independent groups (means, SD's)",,,,,,,,,,,24.6446,2.3162,36,25.3543,2.2974,45,Negative,,,,,,,-0.304864601,0.222768653,4.96E-02
Nerdal 2022,Objective Cognitive performance ,18 month,"Raw difference (indep groups), CI",,,,,,,,,,,,,9,,,100,Negative,,,4.2,1.4,7.1,,-1.009536562,0.352264614,0.124090358
Nerdal 2022,Objective Cognitive performance ,3 month,"Raw difference (indep groups), CI",,,,,,,,,,,,,10,,,115,Negative,,,2.9,0.1,5.7,,-0.67177902,0.330418828,0.109176602
Nerdal 2022,Objective Cognitive performance ,36 month,"Raw difference (indep groups), CI",,,,,,,,,,,,,5,,,83,Negative,,,3.6,0.5,6.7,,-1.053767738,0.463318851,0.214664358
Muller 2023,Objective Cognitive performance,3 month,"Independent groups (means, SD's)",,,,,,,,,,,-0.44,0.86,11,0.08,0.65,46,Negative,,,,,,,-0.740154626,0.338213873,0.114388624
McCusker 2001,Objective Cognitive performance (delirium & dementia vs dementia only) ,6 month,"Independent groups (Sample size, p)",,,,,,,,,,,,,220,,,95,Negative,,0.0001,,,,,-0.48270387,0.12397345,1.54E-02
McCusker 2001,Objective Cognitive performance (delirium only vs neither) ,6 month,"Independent groups (Sample size, p)",,,,,,,,,,,,,220,,,95,Negative,,0.08,,,,,-0.215109705,0.122772221,1.51E-02
McCusker 2001,Objective Cognitive performance with dementia,12 month,"Raw difference (indep groups), CI",,,,,,,,,,,,,220,,,95,Negative,,,-4.99,-7.17,-2.81,,-0.551587098,0.124428711,1.55E-02
McCusker 2001,Objective Cognitive performance without dementia,12 month,"Raw difference (indep groups), CI",,,,,,,,,,,,,220,,,95,Negative,,,-3.36,-6.15,-0.58,,-0.290726169,0.123019233,1.51E-02
Lingehall 2017,Objective Cognitive performance,12 month,"Independent groups (means, SD's)",,,,,,,,,,,26.1,3.1,64,27.1,2.6,50,Negative,,,,,,,-0.343471853,0.188854022,3.57E-02
Lingehall 2017,Objective Cognitive performance ,36 month,"Independent groups (means, SD's)",,,,,,,,,,,25.2,4.8,64,27.2,2.8,50,Negative,,,,,,,-0.490699896,0.190274794,3.62E-02
Lingehall 2017,Objective Cognitive performance ,60 month,"Independent groups (means, SD's)",,,,,,,,,,,23.1,6.2,64,26.6,2.9,50,Negative,,,,,,,-0.691141766,0.192985728,3.72E-02
Kunicki 2023,Objective Cognitive performance ,12 month,"Raw difference (indep groups), SE",,,,,,,,,,0.32,,,120,,,391,Negative,,,-3.8,,,,-1.237440588,0.111162439,1.24E-02
Kunicki 2023,Objective Cognitive performance ,18 month,"Raw difference (indep groups), SE",,,,,,,,,,0.33,,,117,,,382,Negative,,,-0.54,,,,-0.172643122,0.105645572,1.12E-02
Kunicki 2023,Objective Cognitive performance ,2 month,"Raw difference (indep groups), SE",,,,,,,,,,0.39,,,126,,,410,Negative,,,-0.11,,,,-2.87E-02,0.101721002,1.03E-02
Kunicki 2023,Objective Cognitive performance ,24 month,"Raw difference (indep groups), SE",,,,,,,,,,0.36,,,106,,,368,Negative,,,-0.72,,,,-0.220115853,0.110289872,1.22E-02
Kunicki 2023,Objective Cognitive performance ,30 month,"Raw difference (indep groups), SE",,,,,,,,,,0.39,,,83,,,242,Negative,,,-0.91,,,,-0.296115648,0.127437087,1.62E-02
Kunicki 2023,Objective Cognitive performance,36 month,"Raw difference (indep groups), SE",,,,,,,,,,0.42,,,110,,,346,Negative,,,-1.1,,,,-0.286202213,0.109687391,1.20E-02
Kunicki 2023,Objective Cognitive performance ,48 month,"Raw difference (indep groups), SE",,,,,,,,,,0.52,,,90,,,295,Negative,,,-1.49,,,,-0.344373076,0.120822948,1.46E-02
Kunicki 2023,Objective Cognitive performance ,6 month,"Raw difference (indep groups), SE",,,,,,,,,,0.35,,,124,,,404,Negative,,,-0.22,,,,-6.44E-02,0.102536075,1.05E-02
Kunicki 2023,Objective Cognitive performance ,60 month,"Raw difference (indep groups), SE",,,,,,,,,,0.65,,,79,,,275,Negative,,,-1.87,,,,-0.36645698,0.128120471,1.64E-02
Kunicki 2023,Objective Cognitive performance ,72 month,"Raw difference (indep groups), SE",,,,,,,,,,0.78,,,65,,,248,Negative,,,-2.26,,,,-0.402767151,0.13993713,1.96E-02
Kunicki 2023,Objective Cognitive performance month,1 month,"Raw difference (indep groups), SE",,,,,,,,,,0.34,,,129,,,419,Negative,,,-1.21,,,,-0.3578472,0.10113142,1.02E-02
Krogseth 2023,Objective Cognitive performance (MoCA with dementia),24 month,"Independent groups (means, SD's)",,,,,,,,,,,9.6,6.4,39,12.2,6.2,63,Negative,,,,,,,-0.411112569,0.204256248,4.17E-02
Krogseth 2023,Objective Cognitive performance (MoCA without dementia),24 month,"Independent groups (means, SD's)",,,,,,,,,,,19.1,5.5,18,22.2,5.2,68,Negative,,,,,,,-0.58384329,0.266440384,7.10E-02
Kat 2008,Objective Cognitive performance (Digit span backwards),30 month,"Independent groups (means, SD's)",,,,,,,,,,,7.4,4,25,8.7,3.6,21,Negative,,,,,,,-0.334185091,0.293009598,0.085854625
Kat 2008,Objective Cognitive performance (Digit span forward),30 month,"Independent groups (means, SD's)",,,,,,,,,,,15.3,4.1,25,16.1,2.6,21,Negative,,,,,,,-0.224728122,0.291872674,8.52E-02
Kat 2008,Objective Cognitive performance (MMSE),30 month,"Independent groups (means, SD's)",,,,,,,,,,,22.6,6.5,27,26.2,3.9,22,Negative,,,,,,,-0.64491624,0.290017371,8.41E-02
Janssen 2021,Objective Cognitive performance ,12 month,"Independent groups (means, SD's)",,,,,,,,,,,26.4261,4.988,10,27.6487,2.2452,153,Negative,,,,,,,-0.49070183,0.326010378,0.106282767
Janssen 2021,Objective Cognitive performance ,6 month,"Independent groups (means, SD's)",,,,,,,,,,,27.1123,3.306,8,27.6487,2.2459,148,Negative,,,,,,,-0.23160754,0.361450397,0.13064639
Jankowski 2011,Objective Cognitive performance: AVLT delayed recall ,3 month,"Independent groups (means, SD's)",,,,,,,,,,,91.1,18.2,37,97.8,15.9,33,Negative,,,,,,,-0.386208421,0.2390255,5.71E-02
Jankowski 2011,Objective Cognitive performance: AVLT learning efficency ,3 month,"Independent groups (means, SD's)",,,,,,,,,,,90.6,18.5,37,99.6,17.7,33,Negative,,,,,,,-0.490975534,0.240394714,5.78E-02
Jankowski 2011,Objective Cognitive performance: AVLT percent retention ,3 month,"Independent groups (means, SD's)",,,,,,,,,,,95.1,19.3,37,97.7,14.5,33,Negative,,,,,,,-0.149413219,0.237122842,5.62E-02
Jankowski 2011,Objective Cognitive performance: COWA,3 month,"Independent groups (means, SD's)",,,,,,,,,,,8.7,2.6,37,9.8,2.6,33,Negative,,,,,,,-0.418393415,0.239412117,5.73E-02
Jankowski 2011,Objective Cognitive performance: SCWT,3 month,"Independent groups (means, SD's)",,,,,,,,,,,44.9,9.1,37,52.2,8.9,33,Positive,,,,,,,0.801558853,0.246286508,6.07E-02
Inouye 2016,Objective Cognitive performance  ,24 month,"Independent groups (means, SD's)",,,,,,,,,,,57.1,3.939654391,106,57.8,5.3830762,368,Negative,,,,,,,-0.13710529,0.110147974,1.21E-02
Inouye 2016,Objective Cognitive performance ,1 month,"Independent groups (means, SD's)",,,,,,,,,,,55.9,4.346103326,129,56.9,5.743989398,419,Negative,,,,,,,-0.183282544,0.1007044,1.01E-02
Inouye 2016,Objective Cognitive performance,12 month,"Independent groups (means, SD's)",,,,,,,,,,,57.6,3.912303982,120,57.9,5.54874794,391,Negative,,,,,,,-5.75E-02,0.104221029,1.09E-02
Inouye 2016,Objective Cognitive performance ,18 month,"Independent groups (means, SD's)",,,,,,,,,,,57.3,3.863090652,117,57.8,5.484515896,382,Negative,,,,,,,-0.096904458,0.105548713,1.11E-02
Inouye 2016,Objective Cognitive performance ,2 month,"Independent groups (means, SD's)",,,,,,,,,,,58,3.722567298,126,58,5.165422636,410,Negative,,,,,,,0,0.101717228,1.03E-02
Inouye 2016,Objective Cognitive performance ,30 month,"Independent groups (means, SD's)",,,,,,,,,,,56.8,3.950953338,83,57.7,4.76214771,242,Negative,,,,,,,-0.196484582,0.127140498,1.62E-02
Inouye 2016,Objective Cognitive performance ,36 month,"Independent groups (means, SD's)",,,,,,,,,,,56.5,4.494866108,86,57.6,4.985531962,226,Negative,,,,,,,-0.22597864,0.126715745,1.61E-02
Inouye 2016,Objective Cognitive performance,6 month,"Independent groups (means, SD's)",,,,,,,,,,,57.9,3.692904935,124,58,5.640236318,404,Negative,,,,,,,-1.90E-02,0.102518569,1.05E-02
Humbert 2021,Objective Cognitive performance (Clock Drawing Test),3 month,"Independent groups (means, SD's)",,,,,,,,,,,8.4837,1.4373,15,9.2336,2.1507,62,Negative,,,,,,,-0.364518869,0.28636585,8.20E-02
Humbert 2021,Objective Cognitive performance (MMSE),3 month,"Independent groups (means, SD's)",,,,,,,,,,,24.9349,4.5993,15,27.6168,1.9356,62,Negative,,,,,,,-1.003789521,0.2961172,8.77E-02
Giroux 2021,Objective Cognitive performance,2 month,"Independent groups (means, SD's)",,,,,,,,,,,27,7.64,69,32.3,5.58,310,Negative,,,,,,,-0.880981766,0.136645534,1.87E-02
Francis 1992,Objective Cognitive performance,24 month,"Independent groups (means, SD's)",,,,,,,,,,,23.7,5.1,11,26.4,4.2,81,Negative,,,,,,,-0.621317179,0.321922802,0.10363429
Eide 2016,Objective Cognitive performance (SAVR),6 month,"Independent groups (difference, p)",,,,,,,,,,,,,48,,,25,Negative,,0.5,-0.6,,,2,-0.165442493,0.244413361,5.97E-02
Eide 2016,Objective Cognitive performance (TAVI),6 month,"Independent groups (difference, p)",,,,,,,,,,,,,28,,,35,Negative,,0.2,-1.4,,,2,-0.324435204,0.252078546,6.35E-02
Cole 2008,Objective Cognitive performance  ,6 month,"Raw difference (indep groups), CI",,,,,,,,,,,,,83,,,87,Negative,,,-0.6,-2.5,1.3,,-9.52E-02,0.152836757,2.34E-02
Cole 2008,Objective Cognitive performance ,12 month,"Raw difference (indep groups), CI",,,,,,,,,,,,,83,,,87,Negative,,,-1.1,-3.1,0.9,,-0.165855665,0.15301408,2.34E-02
Cole 2008,Objective Cognitive performance ,2 month,"Independent groups (means, SD's)",,,,,,,,,,,22.3,4.9,83,23.3,5.2,87,Negative,,,,,,,-0.196908478,0.153122306,2.34E-02
Chan 2017,Objective Cognitive performance ,6 month,"Independent groups (means, SD's)",,,,,,,,,,,18.5,6.6,39,24.3,5.4,117,Negative,,,,,,,-1.009119214,0.192663326,3.71E-02
Chan 2017,Objective Cognitive performance ,12 month,"Independent groups (means, SD's)",,,,,,,,,,,17.5,7.5,39,24.7,4.9,117,Negative,,,,,,,-1.267270259,0.197490907,3.90E-02
Cavallari 2017,Objective Cognitive performance,12 month,"Independent groups (means, SD's)",,,,,,,,,,,56,6,25,60,7,88,Negative,,,,,,,-0.584573027,0.228434634,5.22E-02
Bulic 2020,Objective Cognitive performance (IQCODE) ,12 month,"Independent groups (means, SD's)",,,,,,,,,,,51.3572,5.4788,27,50.3559,3.8748,33,Negative,,,,,,,-0.211963435,0.256859371,6.60E-02
Bulic 2020,Objective Cognitive performance (TICS) ,12 month,"Independent groups (means, SD's)",,,,,,,,,,,31.3572,3.9234,27,30.7118,4.45,33,Positive,,,,,,,0.15087824,0.25649958,6.58E-02
Bulic 2020,Objective Cognitive performance (TICS) ,6 month,"Independent groups (means, SD's)",,,,,,,,,,,31.6428,2.3481,27,32.3551,3.8521,38,Negative,,,,,,,-0.212293994,0.249387548,6.22E-02
Ditzel 2023,Objective Cognitive performance,3 month,"Independent groups (means, SD's)",,,,,,,,,,,97.8411,27.7351,38,87.5625,30.6126,203,Negative,,,,,,,-0.339449523,0.176875606,3.13E-02
Sánchez-Lozano 2023,Objective Cognitive performance,3 month,"Independent groups (means, SD's)",,,,,,,,,,,21.6455,8.4366,43,27.9346,3.8521,38,Negative,,,,,,,-0.930766296,0.232335037,5.40E-02
Chen 2017,Objective Cognitive performance,9.82 month,"Independent groups (means, SD's)",,,,,,,,,,,30.4,6.9,44,36.8,5.2,92,Negative,,,,,,,-1.097247328,0.19402938,3.76E-02
Brown 2018,Objective Cognitive performance ,1 month,"Independent groups (means, SD's)",,,,,,,,,,,-0.45,1.21,76,0.23,1.01,66,Negative,,,,,,,-0.603030077,0.171133891,2.93E-02
Brown 2018,Objective Cognitive performance ,12 month,"Independent groups (means, SD's)",,,,,,,,,,,-0.42,0.9,76,-0.04,0.94,66,Negative,,,,,,,-0.411368711,0.169121931,2.86E-02
Wolters 2017,Subjective Cognitive performance (multile day delirium vs no delirium) (CFQ),12 month,"Independent groups (means, SD's)",,,,,,,,,,,25.351,14.1956,186,23,16.4436,177,Negative,,,,,,,-0.153012583,0.104940516,1.10E-02
Wolters 2017,Subjective Cognitive performance 1 day delirium vs no delirium (CFQ),12 month,"Independent groups (means, SD's)",,,,,,,,,,,20.351,15.6899,186,23,16.4436,177,Positive,,,,,,,0.164582865,0.10496463,1.10E-02
VandenBoogaard 2012,Subjective Cognitive performance (CFQ),18 month,"Independent groups (means, SD's)",,,,,,,,,,,28.7023,14.9531,171,26,13.3696,744,Negative,,,,,,,-0.19739815,8.49E-02,7.20E-03
Svenningsen 2014,Subjective Cognitive performance (Factual memories) ICU-Memory Tool,6 month,"Independent groups (means, SD's)",,,,,,,,,,,4.98,3.89,129,6.9,2.63,117,Negative,,,,,,,-0.571268706,0.129854181,1.69E-02
Svenningsen 2014,Subjective Cognitive performance (Factual memory ) ICU-Memory Tool,2 month,"Independent groups (means, SD's)",,,,,,,,,,,4.77,3.79,158,7.1,2.54,137,Negative,,,,,,,-0.710762495,0.120062013,1.44E-02
Svenningsen 2014,Subjective Cognitive performance (Memories of delusions) ICU-Memory Tool,2 month,"Independent groups (means, SD's)",,,,,,,,,,,1.247,1.37,158,0.82,1.15,137,Negative,,,,,,,-0.334668075,0.117253909,1.37E-02
Svenningsen 2014,Subjective Cognitive performance (Memories of delusions) ICU-Memory Tool,6 month,"Independent groups (means, SD's)",,,,,,,,,,,1.3,1.4,129,0.71,1.06,117,Negative,,,,,,,-0.470567688,0.129030495,1.66E-02
Svenningsen 2014,Subjective Cognitive performance (Memories of feelings) ICU-Memory Tool,2 month,"Independent groups (means, SD's)",,,,,,,,,,,1.92,1.84,158,2.15,1.59,137,Negative,,,,,,,-0.132725401,0.116569729,1.36E-02
Svenningsen 2014,Subjective Cognitive performance (Memories of feelings) ICU-Memory Tool,6 month,"Independent groups (means, SD's)",,,,,,,,,,,2.07,1.96,129,2.03,1.7,117,Negative,,,,,,,-0.021660728,0.127278251,1.62E-02
Kainz 2022,Subjective Cognitive performance (CFQ),3 month,"Independent groups (means, SD's)",,,,,,,,,,,16.5892,12.104,72,14,11.9768,150,Negative,,,,,,,-0.214708234,0.143245635,2.05E-02
Hoogma 2023,Subjective Cognitive performance (CFQ),6 month,"Independent groups (means, SD's)",,,,,,,,,,,29,16,93,28,15,157,Negative,,,,,,,-6.48E-02,0.130487592,1.70E-02
Bruck 2018,Subjective Cognitive performance (CFQ),3 month,"Raw difference (indep groups), CI",,,,,,,,,,,,,43,,,82,Negative,,,0.61,-3.32,4.54,,-5.75E-02,0.187169103,3.50E-02
Koster 2012,Subjective Cognitive impairment (CFQ),6 month,"Raw difference (indep groups), CI",,,,,,,,,,,,,40,,,223,Negative,,,5.7,1.3,10.2,,-0.431843047,0.172248301,2.97E-02
Fick 2013,Functional change (Change in Katz impaired ADLs from admission to follow-up),1 month,"Independent groups (means, SD's)",,,,,,,,,,,0.19,1.724645,44,0.4,1.656955,95,Positive,,,,,,,0.124425927,0.181509016,3.29E-02
Fick 2013,Functional change (Change in Lawton IADLs from admission to follow-up),1 month,"Independent groups (means, SD's)",,,,,,,,,,,0.51,3.382957,44,0.15,1.949359,95,Positive,,,,,,,0.143794228,0.181560485,3.30E-02
Giroux 2021,Functional change,2 month,"Raw difference (indep groups), CI",,,,,,,,,,,,,69,,,310,Negative,,,-1.36,-2.33,-0.39,,-0.366235581,0.133510433,1.78E-02
Jankowski 2011,Functional change (ADL Change between preoperative and follow-up),3 month,"Independent groups (means, SD's)",,,,,,,,,,,0.1,0.7,37,0.2,0.5,33,Negative,,,,,,,-0.161050082,0.23717725,5.63E-02
Jankowski 2011,Functional change (IADL Change between preoperative and follow-up),3 month,"Independent groups (means, SD's)",,,,,,,,,,,-0.2,1.5,37,-0.3,2.1,33,Positive,,,,,,,5.47E-02,0.236831519,5.61E-02
Katz 2001,Functional change,2 month,"Independent groups (Sample size, t)",,,,,,,,,,,,,12,,,35,Negative,-3.38,,,,,,-1.111733317,0.348329746,0.121333612
Neufeld 2015,Functional change (Change in ADLs baseline to 18-month follow-up),18 month,"Independent groups (means, SD's)",,,,,,,,,,,0,1.00E-15,36,0,1.00E-15,45,Auto,,,,,,,0,0.221477209,4.91E-02
Neufeld 2015,Functional change (Change in IADLs baseline to 18-month follow-up),18 month,"Independent groups (means, SD's)",,,,,,,,,,,0,1.00E-15,36,0,1.00E-15,45,Auto,,,,,,,0,0.221477209,4.91E-02
Shi 2019,Functional change (1 month SAVR change from the baseline),1 month,"Independent groups (means, SD's)",,,,,,,,,,,-4.4,4.016216866,34,-3.2,4.074850871,35,Negative,,,,,,,-0.293251134,0.239396494,5.73E-02
Shi 2019,Functional change (12 month SAVR change from the baseline),12 month,"Independent groups (means, SD's)",,,,,,,,,,,0.6,3.421221775,34,0.1,3.319072646,32,Positive,,,,,,,0.146529845,0.243732403,5.94E-02
Shi 2019,Functional change (3 month SAVR change from the baseline),3 month,"Independent groups (means, SD's)",,,,,,,,,,,-1.1,3.030457634,32,-0.9,3.030457634,32,Negative,,,,,,,-0.065195054,0.247030783,6.10E-02
Shi 2019,Functional change (6 month SAVR change from the baseline),6 month,"Independent groups (means, SD's)",,,,,,,,,,,0,3.018408053,35,0.01,2.794502844,30,Negative,,,,,,,-3.39E-03,0.24583307,6.04E-02
Shi 2019,Functional change (9 month SAVR change from the baseline),9 month,"Independent groups (means, SD's)",,,,,,,,,,,0.3,2.974975457,34,0.01,2.886150127,32,Positive,,,,,,,9.77E-02,0.243547101,5.93E-02
Shi 2019,Functional change (TAVR change from the baseline 12 month),12 month,"Independent groups (means, SD's)",,,,,,,,,,,-2.3,4.107063632,20,-0.5,4.252100321,63,Negative,,,,,,,-0.422726159,0.256381633,6.57E-02
Shi 2019,Functional change (TAVR change from the baseline 1month),1 month,"Independent groups (means, SD's)",,,,,,,,,,,-3.6,3.644657418,28,-0.7,3.581618117,77,Negative,,,,,,,-0.800064554,0.225922634,5.10E-02
Shi 2019,Functional change (TAVR change from the baseline 3 month),3 month,"Independent groups (means, SD's)",,,,,,,,,,,-2.7,4.03730715,23,0.1,4.112763931,72,Negative,,,,,,,-0.678225081,0.242619303,5.89E-02
Shi 2019,Functional change (TAVR change from the baseline 6 month),6 month,"Independent groups (means, SD's)",,,,,,,,,,,-2,3.740878118,21,-0.5,3.730425798,66,Negative,,,,,,,-0.398277619,0.250152221,6.26E-02
Shi 2019,Functional change (TAVR change from the baseline 9 month),9 month,"Independent groups (means, SD's)",,,,,,,,,,,-2.8,3.891874057,19,-0.3,3.847138386,63,Negative,,,,,,,-0.642035018,0.264075056,6.97E-02
Shi 2019_2,Functional change (ADL) follow up - baseline,36 month,"Independent groups (means, SD's)",,,,,,,,,,,16,11.12,20,9,11.12,68,Negative,,,,,,,-0.623990603,0.256498047,6.58E-02
Cirbus 2019,Functional decline (ADL drug etiology) ,6 month,"Independent groups (Sample size, p)",,,,,,,,,,,,,68,,,91,Negative,,0.3635,,,,,-0.145389505,0.159737502,2.55E-02
Cirbus 2019,Functional decline (ADL infection etiology)  ,6 month,"Independent groups (Sample size, p)",,,,,,,,,,,,,68,,,91,Negative,,0.4314,,,,,-0.125841751,0.159685305,2.55E-02
Cirbus 2019,Functional decline (ADL other etiology) ,6 month,"Independent groups (Sample size, p)",,,,,,,,,,,,,68,,,91,Negative,,0.4354,,,,,-0.124749827,0.159682611,2.55E-02
Isaia 2009,Functional change(loss of more ADL functions),6 month,"Independent groups (means, SD's)",,,,,,,,,,,2.8,2.2,14,0.7,0.6,130,Negative,,,,,,,-2.380292133,0.312983578,9.80E-02
Ojagbemi 2020,Functional change(ADL decline),3 month,"Raw difference (indep groups), CI",,,,,,,,,,,,,29,,,121,Negative,,-2.8,-5.5,-0.2,,,-0.429506568,0.207193775,4.29E-02
Sánchez-Lozano 2023,Functional performance  (IADL),3 month,"Independent groups (means, SD's)",,,,,,,,,,,4.3545,5.3687,43,4.4262,3.698,38,Negative,,,,,,,-1.52E-02,0.220529616,4.86E-02
Miu 2013,Functional performance  (ADL),12 month,"Independent groups (Sample size, p)",,,,,,,,,,,,,86,,,228,Negative,,0.0001,,,,2,-0.497578486,0.12779341,0.016331156
Miu 2013,Functional performance  (ADL),6 month,"Independent groups (Sample size, p)",,,,,,,,,,,,,86,,,228,Negative,,0.0001,,,,2,-0.497578486,0.12779341,0.016331156
Miu 2013,Functional performance  (mRs),12 month,"Independent groups (Sample size, p)",,,,,,,,,,,,,86,,,228,Negative,,0.0001,,,,2,-0.497578486,0.12779341,0.016331156
Miu 2013,Functional performance  (mRsL),6 month,"Independent groups (Sample size, p)",,,,,,,,,,,,,86,,,228,Negative,,0.0001,,,,2,-0.497578486,0.12779341,0.016331156
Zipprich 2020,Functional performance  (disabled (require special care)),6 month,"Independent groups (means, SD's)",,,,,,,,,,,35,35,64,64,34,527,Negative,,,,,,,-0.849148311,0.134491435,1.81E-02
Zakriya 2004,Functional performance  (Best grip strength) ,1.5 month,"Independent groups (means, SD's)",,,,,,,,,,,20,10,19,24,9,63,Negative,,,,,,,-0.429087168,0.261428428,0.068344823
Zakriya 2004,Functional performance  (Best grip strength) ,3 month,"Independent groups (means, SD's)",,,,,,,,,,,28,8,15,24,9,61,Positive,,,,,,,0.448927587,0.28758518,8.27E-02
Witlox 2013,Functional performance  (ADL),3 month,"Independent groups (means, SD's)",,,,,,,,,,,16.4617,5.9437,22,18.9285,1.7255,26,Negative,,,,,,,-0.575978124,0.290934746,0.084643026
Witlox 2013,Functional performance  (IADL),3 month,"Independent groups (means, SD's)",,,,,,,,,,,19.9,6.4,22,16.2,6.4,26,Negative,,,,,,,-0.568647541,0.290784495,0.084555623
Whittamore 2014,Functional performance  (ADL),6 month,"Independent groups (means, SD's)",,,,,,,,,,,6.9394,6.8514,55,13.2955,7.54,86,Negative,,,,,,,-0.868344186,0.179338129,3.22E-02
Weng 2019,Functional performance  (ADL) ,1 month,"Independent groups (means, SD's)",,,,,,,,,,,50.9,30.3,85,72,27.8,64,Negative,,,,,,,-0.717564444,0.169818451,2.88E-02
Weng 2019,Functional performance  (ADL) ,3 month,"Independent groups (means, SD's)",,,,,,,,,,,51.6,29.3,85,74.8,27,64,Negative,,,,,,,-0.81452891,0.171279962,0.029336825
Weng 2019,Functional performance  (ADL) ,6 month,"Independent groups (means, SD's)",,,,,,,,,,,52.4,29.1,85,77.6,25.4,64,Negative,,,,,,,-0.909195958,0.172871076,2.99E-02
Wang 2021,Functional performance  (ADL),24 month,"Independent groups (means, SD's)",,,,,,,,,,,98.6,1.4,17,96,2,35,Negative,,,,,,,-1.399701769,0.321897377,0.103617922
Vives-Borrás 2019,Functional performance  (ADL),6 month,"Independent groups (means, SD's)",,,,,,,,,,,77.5655,34.7051,37,91.496,14.8702,490,Negative,,,,,,,-0.818906969,0.172107708,0.029621063
Vives-Borrás 2019,Functional performance  (IADL),6 month,"Independent groups (means, SD's)",,,,,,,,,,,2.1447,3.0849,37,5,2.974,490,Negative,,,,,,,-0.956227773,0.17277829,2.99E-02
Verloo 2016,Functional performance  (IADL ),0.067 month,"Independent groups (means, SD's)",,,,,,,,,,,23.7,6,20,20.59,5.6,94,Negative,,,,,,,-0.544834557,0.247242882,6.11E-02
VandenBoogaard 2012,Functional performance (Fatigue),18 month,"Independent groups (means, SD's)",,,,,,,,,,,32.7023,16.4484,171,28,16.3406,744,Negative,,,,,,,-0.287177728,8.50E-02,7.23E-03
Svenningsen 2014,Functional performance  (Healthcare dependency (Barthel Index),2 month,"Independent groups (means, SD's)",,,,,,,,,,,92.21,16.63,148,93.53,13.37,131,Negative,,,,,,,-0.08667845,0.119690928,1.43E-02
Svenningsen 2014,Functional performance  (Healthcare dependency (Barthel Index) ,6 month,"Independent groups (means, SD's)",,,,,,,,,,,95.11,12.28,126,95.69,12.27,114,Negative,,,,,,,-4.71E-02,0.128871292,1.66E-02
Suraarunsumrit 2022,Functional performance  (ADL),3 month,"Independent groups (means, SD's)",,,,,,,,,,,87.63,19.95,26,93.69,12.68,247,Negative,,,,,,,-0.447135198,0.206497231,4.26E-02
Suraarunsumrit 2022,Functional performance  (IADL),3 month,"Independent groups (means, SD's)",,,,,,,,,,,5.1,2.42,26,6.33,1.89,247,Negative,,,,,,,-0.630655326,0.207372541,4.30E-02
Shi 2019_2,Functional decline (ADL),36 month,"Independent groups (means, SD's)",,,,,,,,,,,40,17.04,20,27,12.59,68,Negative,,,,,,,-0.940734659,0.261929869,6.86E-02
Shi 2019,Functional performance  (functional status SAVR) ,12 month,"Raw difference (indep groups), CI",,,,,,,,,,,,,34,,,32,Negative,,,-1.1,-2.7,0.6,,-0.324162921,0.245028361,6.00E-02
Shi 2019,Functional performance  (functional status SAVR) ,9 month,"Raw difference (indep groups), CI",,,,,,,,,,,,,34,,,32,Negative,,,-1.5,-3.2,0.2,,-0.429039161,0.246246482,6.06E-02
Shi 2019,Functional performance  (functional status TAVR) ,1 month,"Raw difference (indep groups), CI",,,,,,,,,,,,,28,,,77,Negative,,,-5.2,-7.2,-3.2,,-1.129646395,0.232528701,5.41E-02
Shi 2019,Functional performance  (functional status TAVR) ,12 month,"Raw difference (indep groups), CI",,,,,,,,,,,,,20,,,63,Negative,,,-4.1,-6.4,-1.8,,-0.90186569,0.263732479,6.96E-02
Shi 2019,Functional performance  (functional status TAVR),3 month,"Raw difference (indep groups), CI",,,,,,,,,,,,,23,,,72,Negative,,,-5.1,-7.4,-2.9,,-1.069372734,0.249923702,0.062461857
Shi 2019,Functional performance  (functional status TAVR) ,6 month,"Raw difference (indep groups), CI",,,,,,,,,,,,,21,,,66,Negative,,,-3.7,-6,-1.5,,-0.81191712,0.255837947,6.55E-02
Shi 2019,Functional performance  (functional status TAVR) ,9 month,"Raw difference (indep groups), CI",,,,,,,,,,,,,19,,,63,Negative,,,-4.8,-7.2,-2.5,,-1.053893056,0.272019612,7.40E-02
Shi 2019,Functional performance  (lfunctional status SAVR) ,1 month,"Raw difference (indep groups), CI",,,,,,,,,,,,,34,,,35,Negative,,,-3,-4.9,-1,,-0.731126841,0.246091539,6.06E-02
Shi 2019,Functional performance  (lfunctional status SAVR) ,6 month,"Raw difference (indep groups), CI",,,,,,,,,,,,,35,,,30,Negative,,,-1.8,-3.5,-0.2,,-0.535917635,0.250286037,6.26E-02
Shi 2019,Functional performance  (lower functional status SAVR) ,3 month,"Raw difference (indep groups), CI",,,,,,,,,,,,,32,,,32,Negative,,,-2.1,-3.9,-0.3,,-0.575951982,0.252155843,6.36E-02
Sheng 2006,Functional performance  (ADL dependency) ,1 month,"Independent groups (means, SD's)",,,,,,,,,,,63.1,40.5,39,98.8,30.8,117,Negative,,,,,,,-1.06187122,0.19356992,0.037469314
Sheng 2006,Functional performance  (ADL dependency) ,12 month,"Independent groups (means, SD's)",,,,,,,,,,,70.9,41.8,39,102.7,28.2,117,Negative,,,,,,,-0.985946579,0.192278395,0.036970981
Sheng 2006,Functional performance  (ADL dependency) ,6 month,"Independent groups (means, SD's)",,,,,,,,,,,72.1,42,39,100.8,30.2,117,Negative,,,,,,,-0.852532035,0.1902231,3.62E-02
Rudolph 2010,Functional performance  (IADL),1 month,"Independent groups (means, SD's)",,,,,,,,,,,11,3.6,74,11.8,3,105,Negative,,,,,,,-0.244292889,0.151686952,2.30E-02
Rudolph 2010,Functional performance  (IADL) ,12 month,"Independent groups (means, SD's)",,,,,,,,,,,12.4,3.6,78,12.6,3.1,100,Negative,,,,,,,-5.98E-02,0.150453372,2.26E-02
Pasinska 2019,Functional performance  (Disability) ,12 month,"Independent groups (means, SD's)",,,,,,,,,,,3,2.23,164,1,1.48,518,Negative,,,,,,,-1.181861078,9.50E-02,9.03E-03
Pasinska 2019,Functional performance  (Disability) ,3 month,"Independent groups (means, SD's)",,,,,,,,,,,4,1.48,164,1,2.23,518,Negative,,,,,,,-1.444138732,9.77E-02,9.54E-03
Pasinska 2019,Functional performance  (IADL performance ) ,12 month,"Independent groups (means, SD's)",,,,,,,,,,,9,6.67,164,27,11.12,518,Negative,,,,,,,-1.757378989,0.101363534,1.03E-02
Pasinska 2019,Functional performance  (IADL performance ) ,3 month,"Independent groups (means, SD's)",,,,,,,,,,,10,7.4,164,27,8.89,518,Negative,,,,,,,-1.984598255,0.104393084,1.09E-02
Oldenbeuving 2011,Functional performance  (ADL decline),1 month,"Independent groups (means, SD's)",,,,,,,,,,,7.8832,4.3014,62,19.6159,3.3317,465,Negative,,,,,,,-3.387714149,0.170634043,2.91E-02
Neufeld 2015,Functional performance  (ADLs),18 month,"Independent groups (means, SD's)",,,,,,,,,,,5.6446,0.7721,36,5.6457,0.7658,45,Negative,,,,,,,-1.42E-03,0.221477237,4.91E-02
Neufeld 2015,Functional performance  (IADLs),18 month,"Independent groups (means, SD's)",,,,,,,,,,,7.2892,1.5442,36,7.6457,0.7658,45,Negative,,,,,,,-0.30024808,0.222729946,4.96E-02
Murray 1993,Functional performance  (Physical dysfunction: community) ,3 month,"Independent groups (means, SD's)",,,,,,,,,,,4.39,1.93,31,1.45,1.72,130,Negative,,,,,,,-1.661109306,0.219415098,4.81E-02
Murray 1993,Functional performance  (Physical dysfunction: community),6 month,"Independent groups (means, SD's)",,,,,,,,,,,4.42,2.16,34,1.5,1.93,38,Negative,,,,,,,-1.414830621,0.261603836,0.068436567
Murray 1993,Functional performance  (Physical dysfunction: nursing home) ,3 month,"Independent groups (means, SD's)",,,,,,,,,,,4.97,1.61,31,3.63,1.61,130,Negative,,,,,,,-0.828366019,0.204217545,4.17E-02
Murray 1993,Functional performance  (Physical dysfunction: nursing home) ,6 month,"Independent groups (means, SD's)",,,,,,,,,,,4.97,1.8,34,3.83,2.31,35,Negative,,,,,,,-0.543346531,0.24254244,5.88E-02
Monacelli 2018,Functional performance  (ADL),3 month,"Independent groups (means, SD's)",,,,,,,,,,,5.08,0.27,85,4.39,0.15,133,Positive,,,,,,,3.351164126,0.211913281,4.49E-02
Monacelli 2018,Functional performance  (Barthel index),3 month,"Independent groups (means, SD's)",,,,,,,,,,,84.17,3.64,85,75.85,2.04,133,Positive,,,,,,,2.988707879,0.199089843,3.96E-02
Monacelli 2018,Functional performance  (Hand-grip strength),3 month,"Independent groups (means, SD's)",,,,,,,,,,,12.29,1.63,85,14.62,0.91,133,Negative,,,,,,,-1.871466002,0.164871649,2.72E-02
Monacelli 2018,Functional performance  (IADL),3 month,"Independent groups (means, SD's)",,,,,,,,,,,4.5,0.5,85,3.72,0.27,133,Positive,,,,,,,2.064365939,0.170070559,2.89E-02
Miyamoto 2021,Functional performance  (Barthel Index score) ,12 month,"Independent groups (means, SD's)",,,,,,,,,,,83.1334,37.2469,22,98.2335,3.7995,59,Negative,,,,,,,-0.767865034,0.254676904,6.49E-02
Miyamoto 2021,Functional performance  (Barthel Index score) ,3 month,"Independent groups (means, SD's)",,,,,,,,,,,81.5405,33.2845,22,94.7004,11.3985,59,Negative,,,,,,,-0.660130484,0.252805594,6.39E-02
McCusker 2001,Functional performance  (Barthel index) ,12 month,"Raw difference (indep groups), CI",,,,,,,,,,,,,220,,,95,Negative,,,-13.89,-28.49,0.7,,-0.229333867,0.122813081,1.51E-02
McCusker 2001,Functional performance  (Barthel index) ,6 month,"Raw difference (indep groups), CI",,,,,,,,,,,,,220,,,95,Negative,,,-12.17,-25.3,0.95,,-0.223440201,0.122795835,1.51E-02
McCusker 2001,Functional performance  (IADL) ,12 month,"Raw difference (indep groups), CI",,,,,,,,,,,,,220,,,95,Negative,,,-0.42,-0.68,-0.14,,-0.374848324,0.123379918,1.52E-02
McCusker 2001,Functional performance  (IADL) delirium only vs neither,6 month,"Independent groups (Sample size, p)",,,,,,,,,,,,,220,,,95,Negative,,0.87,,,,2,-2.01E-02,0.122475341,1.50E-02
McCusker 2001,Functional performance  IADL (delirium & dementia vs dementia only),6 month,"Independent groups (Sample size, p)",,,,,,,,,,,,,220,,,95,Negative,,0.51,,,,2,-8.08E-02,0.122515014,1.50E-02
Liang 2014,Functional performance  (IADL) ,1 month,"Independent groups (means, SD's)",,,,,,,,,,,4.4,1.154469575,17,5.2,1.156070932,165,Negative,,,,,,,-0.689196527,0.25622009,6.56E-02
Liang 2014,Functional performance  (IADL),12 month,"Independent groups (means, SD's)",,,,,,,,,,,4,1.360624856,17,5.6,1.284523258,165,Negative,,,,,,,-1.233729582,0.261773517,6.85E-02
Liang 2014,Functional performance  (IADL) ,6 month,"Independent groups (means, SD's)",,,,,,,,,,,4.3,1.360624856,17,5.5,1.284523258,165,Negative,,,,,,,-0.925297186,0.258255572,6.67E-02
Liang 2014,Functional performance  (ADL) ,1 month,"Independent groups (means, SD's)",,,,,,,,,,,83,11.62715786,17,92.7,11.30380467,165,Negative,,,,,,,-0.852342244,0.257564858,6.63E-02
Liang 2014,Functional performance (ADL),12 month,"Independent groups (means, SD's)",,,,,,,,,,,86.4,13.11147589,17,95.2,12.84523258,165,Negative,,,,,,,-0.680954189,0.256159539,6.56E-02
Liang 2014,Functional performance (ADL),3 month,"Independent groups (means, SD's)",,,,,,,,,,,84.5,11.42100258,17,94.4,11.17535234,165,Negative,,,,,,,-0.880444319,0.257824423,6.65E-02
Liang 2014,Functional performance  (ADL),3 month,"Independent groups (means, SD's)",,,,,,,,,,,4.4,1.154469575,17,5.5,1.156070932,165,Negative,,,,,,,-0.947645224,0.258478106,0.066810931
Liang 2014,Functional performance (IADL),6 month,"Independent groups (means, SD's)",,,,,,,,,,,86.9,12.61670321,17,94.6,12.33142328,165,Negative,,,,,,,-0.620526191,0.255737461,6.54E-02
Jankowski 2011,Functional performance  (ADL),3 month,"Independent groups (means, SD's)",,,,,,,,,,,11.3,0.9,37,11.7,0.9,33,Negative,,,,,,,-0.439524395,0.239682398,5.74E-02
Jankowski 2011,Functional performance  (ADL),3 month,"Independent groups (means, SD's)",,,,,,,,,,,12.8,1.6,37,12.9,2.1,33,Negative,,,,,,,-5.34E-02,0.236829359,0.056088145
Humbert 2021,Functional performance  (IADL),3 month,"Independent groups (means, SD's)",,,,,,,,,,,5.4837,0.8624,15,5.8467,0.4301,62,Negative,,,,,,,-0.668134269,0.289898784,8.40E-02
Humbert 2021,Functional performance  (ADL),3 month,"Independent groups (means, SD's)",,,,,,,,,,,6.1396,2.0122,15,7.5401,1.2904,62,Negative,,,,,,,-0.954445109,0.295055829,0.087057942
Hshieh 2017,Functional performance  (IADL dependency) ,1 month,"Raw difference (indep groups), CI",,,,,,,,,,,,,135,,,431,Negative,,,-0.4,-0.8,,,-0.193466425,9.87E-02,9.73E-03
Hshieh 2017,Functional performance  (IADL dependency) ,18 month,"Raw difference (indep groups), CI",,,,,,,,,,,,,135,,,431,Negative,,,-0.2,,0.05,,-0.15477314,9.86E-02,9.72E-03
Hshieh 2017,Functional performance  (Physical function) ,1 month,"Raw difference (indep groups), CI",,,,,,,,,,,,,135,,,431,Negative,,,-1.5,-3.3,0.2,,-0.165828364,0.098620586,9.73E-03
Hshieh 2017,Functional performance  (Physical function) ,18 month,"Raw difference (indep groups), CI",,,,,,,,,,,,,135,,,431,Negative,,,-1.8,-3.2,-0.3,,-0.240165217,9.88E-02,9.75E-03
Hoogma 2023,Functional performance  (IADL),6 month,"Independent groups (means, SD's)",,,,,,,,,,,9,3.9,93,10.8,3.2,157,Negative,,,,,,,-0.516244757,0.13248254,1.76E-02
Giroux 2021,Functional performance ,2 month,"Independent groups (means, SD's)",,,,,,,,,,,22.1,3.8,69,24.4,2.3,310,Negative,,,,,,,-0.871305059,0.136563656,1.86E-02
Eide 2016,Functional performance  (ADL SAVR) ,1 month,"Independent groups (difference, p)",,,,,,,,,,,,,48,,,25,Auto,,,0,,,,0,0.244029541,5.96E-02
Eide 2016,Functional performance  (ADL SAVR) ,6 month,"Independent groups (difference, p)",,,,,,,,,,,,,48,,,25,Negative,,,-0.3,,,,-9.44E-02,0.244154598,5.96E-02
Eide 2016,Functional performance  (ADL TAVI),1 month,"Independent groups (difference, p)",,,,,,,,,,,,,28,,,35,Negative,,,-3.1,,,,-0.865761922,0.262024752,6.87E-02
Eide 2016,Functional performance  (ADL TAVI) ,6 month,"Independent groups (difference, p)",,,,,,,,,,,,,28,,,35,Negative,,,-1.6,,,,-0.418249808,0.253172999,6.41E-02
Eide 2016,Functional performance  (IADL SAVR),1 month,"Independent groups (difference, p)",,,,,,,,,,,,,48,,,25,Negative,,,-9.4,,,,-0.466419277,0.247063685,0.061040464
Eide 2016,Functional performance  (IADL SAVR) ,6 month,"Independent groups (difference, p)",,,,,,,,,,,,,48,,,25,Negative,,,-3,,,,-0.128545773,0.244261325,5.97E-02
Eide 2016,Functional performance  (IADL TAVI) ,1 month,"Independent groups (difference, p)",,,,,,,,,,,,,28,,,35,Negative,,,-10.5,,,,-0.729394248,0.258709412,0.06693056
Eide 2016,Functional performance  (IADL TAVI) ,6 month,"Independent groups (difference, p)",,,,,,,,,,,,,28,,,35,Negative,,,-2.3,,,,-0.169915564,0.250873171,6.29E-02
Eeles 2012,Functional performance (Frailty),60 month,"Independent groups (means, SD's)",,,,,,,,,,,0.33,0.14,102,0.18,0.11,171,Negative,,,,,,,-1.225641183,0.135338672,1.83E-02
Decrane 2012,Functional performance (Fall (hyperactive)),12 month,"Independent groups (Sample size, p)",,,,,,,,,,,,,14,,,250,Negative,,0.798,,,,2,-7.02E-02,0.273872705,0.075006258
Decrane 2012,Functional performance (Fall (hypoactive)),12 month,"Independent groups (Sample size, p)",,,,,,,,,,,,,33,,,250,Negative,,0.103,,,,2,-0.302159325,0.18515212,3.43E-02
Decrane 2012,Functional performance (Fall (mixed)),12 month,"Independent groups (Sample size, p)",,,,,,,,,,,,,23,,,250,Negative,,0.764,,,,2,-6.53E-02,0.217309453,4.72E-02
Cole 2008,Functional performance  (ADL),12 month,"Raw difference (indep groups), CI",,,,,,,,,,,,,83,,,87,Negative,,,-3.4,-13.1,6.2,,-0.106247623,0.152858118,2.34E-02
Cole 2008,Functional performance  (ADL),2 month,"Independent groups (means, SD's)",,,,,,,,,,,79.3,23.2,83,79.9,22.2,87,Negative,,,,,,,-2.63E-02,0.152756146,2.33E-02
Cole 2008,Functional performance  (ADL) ,6 month,"Raw difference (indep groups), CI",,,,,,,,,,,,,83,,,87,Negative,,,-3.1,-10.2,4.1,,-0.130744453,0.152913961,2.34E-02
Cole 2008,Functional performance  (IADL) ,2 month,"Independent groups (means, SD's)",,,,,,,,,,,8.3,3.6,83,8.1,3.5,87,Positive,,,,,,,5.61E-02,0.152779772,2.33E-02
Cole 2008,Functional performance  (IADL)  ,6 month,"Raw difference (indep groups), CI",,,,,,,,,,,,,83,,,87,Negative,,,0.02,-1.1,1.2,,-5.24E-03,0.152749741,2.33E-02
Cole 2008,Functional performance  (IADL) ,12 month,"Raw difference (indep groups), CI",,,,,,,,,,,,,83,,,87,Positive,,,0.3,-0.9,1.4,,0.078666719,0.152809044,0.023350604
Chan 2017,Functional performance  (functional status disability) ,1 month,"Independent groups (means, SD's)",,,,,,,,,,,63.1,40.5,39,98.8,30.8,117,Negative,,,,,,,-1.06187122,0.19356992,0.037469314
Chan 2017,Functional performance  (functional status disability) ,12 month,"Independent groups (means, SD's)",,,,,,,,,,,70.9,41.8,39,102.7,28.2,117,Negative,,,,,,,-0.985946579,0.192278395,0.036970981
Chan 2017,Functional performance  (functional status disability) ,6 month,"Independent groups (means, SD's)",,,,,,,,,,,72.1,42,39,100.8,30.2,117,Negative,,,,,,,-0.852532035,0.1902231,3.62E-02
Cartei 2022,Functional performance (Disability in ADLs ),12 month,"Hedges's g, SE",,,,,,,,,,0.458,,,193,,,194,Negative,,,,,,,-0.7498,0.458,0.209764
Vida 2006,Functional change (ADL dementia),12 month,"Independent groups (Sample size, p)",,,,,,,,,,,,,60,,,72,Negative,,0.809,,,,2,-4.21E-02,0.17381037,3.02E-02
Vida 2006,Functional change (ADL no dementia),12 month,"Independent groups (Sample size, p)",,,,,,,,,,,,,41,,,86,Negative,,0.259,,,,2,-0.21390577,0.189120356,3.58E-02
Vida 2006,Functional change (ADL dementia),18 month,"Independent groups (Sample size, p)",,,,,,,,,,,,,60,,,72,Negative,,0.808,,,,2,-4.23E-02,0.173810577,3.02E-02
Vida 2006,Functional change (ADL no dementia),18 month,"Independent groups (Sample size, p)",,,,,,,,,,,,,41,,,86,Negative,,0.902,,,,2,-2.33E-02,0.18864915,3.56E-02
Vida 2006,Functional change (ADL dementia),6 month,"Independent groups (Sample size, p)",,,,,,,,,,,,,60,,,72,Negative,,0.95,,,,2,-1.09E-02,0.173792361,3.02E-02
Vida 2006,Functional change (ADL no dementia),6 month,"Independent groups (Sample size, p)",,,,,,,,,,,,,41,,,86,Negative,,0.065,,,,2,-0.351189622,0.189926134,3.61E-02
Vida 2006,Functional change (BADL dementia),12 month,"Independent groups (Sample size, p)",,,,,,,,,,,,,60,,,72,Negative,,0.904,,,,2,-2.10E-02,0.173795868,3.02E-02
Vida 2006,Functional change (BADL no dementia),12 month,"Independent groups (Sample size, p)",,,,,,,,,,,,,41,,,86,Negative,,0.195,,,,2,-0.245785816,0.189272835,3.58E-02
Vida 2006,Functional change (BADL dementia),18 month,"Independent groups (Sample size, p)",,,,,,,,,,,,,60,,,72,Negative,,0.732,,,,2,-5.96E-02,0.173829827,3.02E-02
Vida 2006,Functional change (BADL no dementia),18 month,"Independent groups (Sample size, p)",,,,,,,,,,,,,41,,,86,Negative,,0.373,,,,2,-0.168661432,0.188940106,3.57E-02
Vida 2006,Functional change (BADL  dementia),6 month,"Independent groups (Sample size, p)",,,,,,,,,,,,,60,,,72,Negative,,0.727,,,,2,-6.08E-02,0.173831349,3.02E-02
Vida 2006,Functional change (BADL no dementia),6 month,"Independent groups (Sample size, p)",,,,,,,,,,,,,41,,,86,Negative,,0.207,,,,2,-0.239281941,0.189240021,3.58E-02
Vida 2006,Functional change (IADL  dementia),12 month,"Independent groups (Sample size, p)",,,,,,,,,,,,,60,,,72,Negative,,0.667,,,,2,-7.49E-02,0.173852265,3.02E-02
Vida 2006,Functional change (IADL no dementia),12 month,"Independent groups (Sample size, p)",,,,,,,,,,,,,41,,,86,Negative,,0.419,,,,2,-0.152959263,0.188887483,3.57E-02
Vida 2006,Functional change (IADL dementia),18 month,"Independent groups (Sample size, p)",,,,,,,,,,,,,60,,,72,Negative,,0.716,,,,2,-6.34E-02,0.173834812,3.02E-02
Vida 2006,Functional change (IADL no dementia),18 month,"Independent groups (Sample size, p)",,,,,,,,,,,,,41,,,86,Negative,,0.649,,,,2,-8.61E-02,0.188720782,3.56E-02
Vida 2006,Functional change (IADL  dementia),6 month,"Independent groups (Sample size, p)",,,,,,,,,,,,,60,,,72,Negative,,0.881,,,,2,-2.61E-02,0.173798467,3.02E-02
Vida 2006,Functional change (IADL no dementia),6 month,"Independent groups (Sample size, p)",,,,,,,,,,,,,41,,,86,Negative,,0.069,,,,2,-0.346013161,0.189888724,3.61E-02
Bulic 2020,PTSD ,12 month,"Independent groups (means, SD's)",,,,,,,,,,,30.3572,32.0901,27,13.4859,19.2605,33,Negative,,,,,,,-0.645116758,0.2628126,0.069070463
Bulic 2020,PTSD ,6 month,"Independent groups (means, SD's)",,,,,,,,,,,21.7144,21.9152,27,18.5795,23.1126,38,Negative,,,,,,,-0.13689628,0.248981174,6.20E-02
Chan 2017,Anxiety,1 month,"Independent groups (means, SD's)",,,,,,,,,,,4,2.23,17,5,5.18,82,Negative,,,,,,,0.205885811,0.26483191,7.01E-02
Chan 2017,Anxiety,12 month,"Independent groups (means, SD's)",,,,,,,,,,,6,3.7,11,6,4.26,74,Negative,,,,,,,0,0.320216061,0.102538325
Chan 2017,Anxiety ,6 month,"Independent groups (means, SD's)",,,,,,,,,,,5.5,6.48,16,4,5.18,73,Negative,,,,,,,-0.274036361,0.274424229,7.53E-02
Chan 2017,Depression ,1 month,"Independent groups (means, SD's)",,,,,,,,,,,5,2.97,17,6,4.26,82,Negative,,,,,,,-0.243470432,0.264992901,7.02E-02
Chan 2017,Depression ,12 month,"Independent groups (means, SD's)",,,,,,,,,,,5,2.23,11,6,3.7,74,Negative,,,,,,,-0.278725472,0.320928829,0.102995313
Chan 2017,Depression ,6 month,"Independent groups (means, SD's)",,,,,,,,,,,4,4.814814815,16,5,5.18,73,Positive,,,,,,,0.193665676,0.274039195,7.51E-02
Janssen 2021,Depression ,12 month,"Independent groups (means, SD's)",,,,,,,,,,,25.4873,10.9018,12,25.5085,9.7158,179,Negative,,,,,,,-2.16E-03,0.297009584,8.82E-02
Janssen 2021,Depression ,6 month,"Independent groups (means, SD's)",,,,,,,,,,,23.0442,10.0588,9,22.9305,8.5893,194,Negative,,,,,,,-0.01309153,0.339704371,0.11539906
Kat 2008,Depression ,30 month,"Independent groups (means, SD's)",,,,,,,,,,,2.2,2.7,20,1.2,1.6,21,Negative,,,,,,,-0.444630327,0.310302664,9.63E-02
Kat 2008,Neuropsychiatric symptoms,30 month,"Independent groups (means, SD's)",,,,,,,,,,,5.9,7.3,26,4.6,6.5,20,Negative,,,,,,,-0.183426107,0.292950979,8.58E-02
Miyamoto 2021,Anxiety ,12 month,"Independent groups (means, SD's)",,,,,,,,,,,6.905,4.1528,13,4.7115,3.0957,34,Negative,,,,,,,-0.632513422,0.327194914,0.107056512
Miyamoto 2021,Anxiety,3 month,"Independent groups (means, SD's)",,,,,,,,,,,7.6411,2.3775,22,5.3533,5.3193,59,Negative,,,,,,,-0.480112227,0.250287043,6.26E-02
Miyamoto 2021,Depression ,12 month,"Independent groups (means, SD's)",,,,,,,,,,,8,6.6444,13,5.3557,3.8697,34,Negative,,,,,,,-0.545054404,0.325516336,0.105960885
Miyamoto 2021,Depression ,3 month,"Independent groups (means, SD's)",,,,,,,,,,,8,4.7549,22,6,4.5594,59,Negative,,,,,,,-0.429504843,0.249718736,6.24E-02
Miyamoto 2021,PTSD,3 month,"Independent groups (means, SD's)",,,,,,,,,,,13.8709,19.0197,22,10.4132,12.1584,59,Negative,,,,,,,-0.239376106,0.248141947,6.16E-02
Nerdal 2022,Anxiety ,18 month,"Raw difference (indep groups), CI",,,,,,,,,,,,,7,,,93,Negative,,,-2.6,-5,-0.1,,-0.819060002,0.393212393,0.154615986
Nerdal 2022,Anxiety ,3 month,"Raw difference (indep groups), CI",,,,,,,,,,,,,8,,,100,Negative,,,-0.9,-3.4,1.4,,-0.271232406,0.365284115,0.133432485
Nerdal 2022,Anxiety ,36 month,"Raw difference (indep groups), CI",,,,,,,,,,,,,5,,,75,Negative,,,-2.8,-5.5,-0.3,,-0.980713764,0.463949001,0.215248675
Nerdal 2022,Depression ,18 month,"Raw difference (indep groups), CI",,,,,,,,,,,,,7,,,93,Negative,,,-2.44,-5.2,0.3,,-0.684802894,0.391926606,0.153606465
Nerdal 2022,Depression ,3 month,"Raw difference (indep groups), CI",,,,,,,,,,,,,8,,,100,Positive,,,0.04,-2.6,2.7,,1.09E-02,0.364818378,0.133092449
Nerdal 2022,Depression ,36 month,"Raw difference (indep groups), CI",,,,,,,,,,,,,5,,,75,Negative,,,-2.3,-5.1,0.64,,-0.729799441,0.461049047,0.212566224
Nerdal 2022,Neuropsychiatry symptoms ,18 month,"Raw difference (indep groups), CI",,,,,,,,,,,,,9,,,100,Positive,,,0.44,-0.8,1.7,,0.241135019,0.345950891,0.119682019
Nerdal 2022,Neuropsychiatry symptoms ,3 month,"Raw difference (indep groups), CI",,,,,,,,,,,,,10,,,117,Negative,,,-1.6,-2.7,-0.47,,-0.930054086,0.332642859,0.110651272
Nerdal 2022,Neuropsychiatry symptoms ,36 month,"Raw difference (indep groups), CI",,,,,,,,,,,,,5,,,84,Negative,,,-1,-2.5,0.5,,-0.604698463,0.458596568,0.210310812
Olofsson 2018,Depression ,12 month,"Independent groups (means, SD's)",,,,,,,,,,,5.4,3.7,62,3.6,2.5,50,Negative,,,,,,,-0.554987623,0.192384976,3.70E-02
Olofsson 2018,Depression ,36 month,"Independent groups (means, SD's)",,,,,,,,,,,4.1,2.9,39,3.2,2.3,36,Negative,,,,,,,-0.338745768,0.230408449,5.31E-02
Olofsson 2018,Depression,4 month,"Independent groups (means, SD's)",,,,,,,,,,,5.1,3.3,67,2.9,2.2,55,Negative,,,,,,,-0.764979062,0.187328903,0.035092118
Slor 2013,Anxiety,3 month,"Independent groups (means, SD's)",,,,,,,,,,,11.7,3.9,23,10.5,3,30,Negative,,,,,,,-0.345951849,0.275112992,7.57E-02
Slor 2013,Depression ,3 month,"Independent groups (means, SD's)",,,,,,,,,,,4.9,3.4,23,3,2.7,30,Negative,,,,,,,-0.619448977,0.279603377,7.82E-02
Slor 2013,PTSD,3 month,"Independent groups (means, SD's)",,,,,,,,,,,19,5.3,23,17.8,5.3,30,Negative,,,,,,,-0.223069058,0.273911498,7.50E-02
Svenningsen 2015,Anxiety ,2 month,"Independent groups (means, SD's)",,,,,,,,,,,14.1074,7.4814,157,13.4057,5.9935,138,Negative,,,,,,,-0.102532035,0.116464356,1.36E-02
Svenningsen 2015,Anxiety ,6 month,"Independent groups (means, SD's)",,,,,,,,,,,12.7575,5.2477,130,12.7583,5.2537,118,Negative,,,,,,,-1.52E-04,0.126761018,0.016068356
Svenningsen 2015,Depression ,2 month,"Independent groups (means, SD's)",,,,,,,,,,,9.8098,14.9627,158,9.1627,14.2345,138,Negative,,,,,,,-4.41E-02,0.116230574,1.35E-02
Svenningsen 2015,Depression,6 month,"Independent groups (means, SD's)",,,,,,,,,,,7.515,13.4941,130,8.2198,15.0106,118,Positive,,,,,,,0.049358851,0.126780391,1.61E-02
Svenningsen 2015,PTSD,2 month,"Independent groups (means, SD's)",,,,,,,,,,,1.3542,0.6658,158,1.3657,0.6593,138,Positive,,,,,,,1.73E-02,0.116218602,1.35E-02
Svenningsen 2015,PTSD,6 month,"Independent groups (means, SD's)",,,,,,,,,,,1.3025,0.6072,128,1.2393,0.4728,118,Negative,,,,,,,-0.11520666,0.127334124,1.62E-02
Whittamore 2014,Behavioural and psychological symptoms,6 month,"Independent groups (means, SD's)",,,,,,,,,,,16.5182,16.5327,107,11.9598,13.4833,140,Negative,,,,,,,-0.305414958,0.128750048,1.66E-02
Witlox 2013,Depression,3 month,"Independent groups (means, SD's)",,,,,,,,,,,5.1,3.5,22,2.5,2.1,26,Negative,,,,,,,-0.904784199,0.299524174,8.97E-02
Bagienski 2017,Quality of life,12 month,"Independent groups (means, SD's)",,,,,,,,,,,63.2164,11.6961,29,71.7587,11.2654,112,Negative,,,,,,,-0.748328261,0.211964821,4.49E-02
Duppils 2004,Quality of life: Physical functioning,6 month,"Independent groups (means, p)",,,,,,,,,,,21,,15,,34,56,Negative,,0.05,,,,,-0.573662893,0.291560014,8.50E-02
Duppils 2004,Quality of life: Vitality,6 month,"Independent groups (means, p)",,,,,,,,,,,39,,15,,54,56,Negative,,0.03,,,,,-0.637198157,0.292487639,8.55E-02
Eide 2016,Quality of life: Mental SAVR ,1 month,"Independent groups (difference, p)",,,,,,,,,,,,,48,,,25,Negative,,0.06,-6.3,,,2,-0.466419277,0.247063685,0.061040464
Eide 2016,Quality of life: Mental SAVR ,6 month,"Independent groups (difference, p)",,,,,,,,,,,,,48,,,25,Positive,,0.2,4.3,,,2,0.315673995,0.245424024,6.02E-02
Eide 2016,Quality of life: Mental TAVI ,1 month,"Independent groups (difference, p)",,,,,,,,,,,,,28,,,35,Negative,,0.2,-3.6,,,2,-0.324435204,0.252078546,6.35E-02
Eide 2016,Quality of life: Mental TAVI ,6 month,"Independent groups (difference, p)",,,,,,,,,,,,,28,,,35,Positive,,0.3,3,,,2,0.26176482,0.251499556,6.33E-02
Eide 2016,Quality of life: Physical SAVR,1 month,"Independent groups (difference, p)",,,,,,,,,,,,,48,,,25,Negative,,0.1,-4,,,2,-0.406699549,0.246339856,6.07E-02
Eide 2016,Quality of life: Physical SAVR ,6 month,"Independent groups (difference, p)",,,,,,,,,,,,,48,,,25,Negative,,0.05,-4.9,,,2,-0.486581085,0.247329878,6.12E-02
Eide 2016,Quality of life: Physical TAVI ,1 month,"Independent groups (difference, p)",,,,,,,,,,,,,28,,,35,Negative,,0.8,-0.6,,,2,-6.37E-02,0.250480408,6.27E-02
Eide 2016,Quality of life: Physical TAVI,6 month,"Independent groups (difference, p)",,,,,,,,,,,,,28,,,35,Positive,,0.7,1.1,,,2,0.096946074,0.250564967,6.28E-02
Hofhuis 2022,Quality of life: Health related (mental),12 month,"Independent groups (Sample size, p)",,,,,,,,,,,,,182,,,300,Negative,,0.029,,,,2,-0.205449307,9.40E-02,8.84E-03
Hofhuis 2022,Quality of life: Health related (physical),12 month,"Independent groups (Sample size, p)",,,,,,,,,,,,,182,,,300,Negative,,0.035,,,,2,-0.198346932,0.094026963,8.84E-03
Hoogma 2023,Quality of life,6 month,"Independent groups (means, SD's)",,,,,,,,,,,69,18,93,72,15,157,Negative,,,,,,,-0.184876313,0.130717117,1.71E-02
Jackson 2014,Quality of life: Mental ,12 month,"Independent groups (difference, p)",,,,,,,,,,,,,352,,,115,Negative,,0.18,-5.79,,,2,-0.143992522,0.107338509,1.15E-02
Jackson 2014,Quality of life: Mental ,3 month,"Independent groups (difference, p)",,,,,,,,,,,,,352,,,115,Negative,,0.1,-4.53,,,2,-0.176738072,0.107390876,1.15E-02
Jackson 2014,Quality of life: Physical ,12 month,"Independent groups (difference, p)",,,,,,,,,,,,,352,,,115,Negative,,0.09,-3.72,,,2,-0.182185557,0.107400622,1.15E-02
Jackson 2014,Quality of life: Physical ,3 month,"Independent groups (difference, p)",,,,,,,,,,,,,352,,,115,Positive,,0.77,0.79,,,2,3.14E-02,0.107239966,1.15E-02
Janssen 2021,Quality of life: Environment ,12 month,"Independent groups (means, SD's)",,,,,,,,,,,14,1.8,10,16.3,2.2,130,Negative,,,,,,,-1.051155331,0.332368736,0.110468977
Janssen 2021,Quality of life: Environment ,6 month,"Independent groups (means, SD's)",,,,,,,,,,,16.3,2.8,9,16.2,2.3,147,Positive,,,,,,,4.27E-02,0.341719347,0.116772112
Janssen 2021,Quality of life: Physical health ,12 month,"Independent groups (means, SD's)",,,,,,,,,,,13.9,2.5,10,15.4,2.8,130,Negative,,,,,,,-0.536356373,0.327948516,0.107550229
Janssen 2021,Quality of life: Physical health ,6 month,"Independent groups (means, SD's)",,,,,,,,,,,14.9,3,9,15.2,2.7,146,Negative,,,,,,,-0.109893689,0.341824311,0.116843859
Janssen 2021,Quality of life: Psychological health ,12 month,"Independent groups (means, SD's)",,,,,,,,,,,12.7,2,10,15.3,2.3,129,Negative,,,,,,,-1.133349602,0.333457183,0.111193693
Janssen 2021,Quality of life: Psychological health ,6 month,"Independent groups (means, SD's)",,,,,,,,,,,14.2,2.7,9,15.1,2.4,147,Negative,,,,,,,-0.370622438,0.342354376,0.117206519
Janssen 2021,Quality of life: Social relationships ,12 month,"Independent groups (means, SD's)",,,,,,,,,,,12.7,3.6,10,15.5,2.9,130,Negative,,,,,,,-0.943754911,0.331215615,0.109703783
Janssen 2021,Quality of life: Social relationships ,6 month,"Independent groups (means, SD's)",,,,,,,,,,,14.8,3.7,9,15.5,2.7,146,Negative,,,,,,,-0.252261354,0.342067507,0.117010179
Kainz 2022,Quality of life: Bodily pain,3 month,"Independent groups (means, SD's)",,,,,,,,,,,90.8296,19.6689,72,90.8662,19.4623,150,Negative,,,,,,,-1.87E-03,0.142882791,2.04E-02
Kainz 2022,Quality of life: Change in health state,3 month,"Independent groups (means, SD's)",,,,,,,,,,,2.6473,0.7565,72,3.3513,0.7485,150,Negative,,,,,,,-0.934104054,0.149601763,2.24E-02
Kainz 2022,Quality of life: General health,3 month,"Independent groups (means, SD's)",,,,,,,,,,,68.7635,18.9124,72,72,14.971,150,Negative,,,,,,,-0.197309449,0.143189268,0.020503167
Kainz 2022,Quality of life: Mental health,3 month,"Independent groups (means, SD's)",,,,,,,,,,,80,12.104,72,82.5948,14.971,150,Negative,,,,,,,-0.183276129,0.143147258,2.05E-02
Kainz 2022,Quality of life: Physical functioning,3 month,"Independent groups (means, SD's)",,,,,,,,,,,82.9458,22.6949,72,90,7.4855,150,Negative,,,,,,,-0.491998759,0.144778004,2.10E-02
Kainz 2022,Quality of life: Role emotional,3 month,"Independent groups (means, SD's)",,,,,,,,,,,100,0.0000001,72,100,0.0000001,150,Auto,,,,,,,0,0.142882763,2.04E-02
Kainz 2022,Quality of life: Role physical,3 month,"Independent groups (means, SD's)",,,,,,,,,,,66.1823,56.7373,72,82.435,37.4274,150,Negative,,,,,,,-0.363306451,0.143919291,2.07E-02
Kainz 2022,Quality of life: Social functioning,3 month,"Independent groups (means, SD's)",,,,,,,,,,,87.6473,18.9124,72,91.2175,18.7137,150,Negative,,,,,,,-0.189477285,0.143165441,2.05E-02
Kainz 2022,Quality of life: Vitality,3 month,"Independent groups (means, SD's)",,,,,,,,,,,65,15.13,72,70,14.971,150,Negative,,,,,,,-0.331698184,0.143747296,2.07E-02
Koster 2012,Quality of life: Bodily pain,6 month,"Independent groups (means, SD's)",,,,,,,,,,,78.355,33.0952,39,85.4387,24.6221,225,Negative,,,,,,,-0.27143296,0.173357564,3.01E-02
Koster 2012,Quality of life: General health perceptions,6 month,"Independent groups (means, SD's)",,,,,,,,,,,56,21,39,66,21,225,Negative,,,,,,,-0.474826034,0.174184714,0.030340315
Koster 2012,Quality of life: Mental health,6 month,"Independent groups (means, SD's)",,,,,,,,,,,74.32,18.4717,39,82.5965,14.9225,225,Negative,,,,,,,-0.532857856,0.174502344,3.05E-02
Koster 2012,Quality of life: Physical functioning,6 month,"Independent groups (means, SD's)",,,,,,,,,,,59.675,34.36345,39,83.2457,26.1143,225,Negative,,,,,,,-0.855756082,0.176918835,3.13E-02
Koster 2012,Quality of life: Role limitations (Emotional problems),6 month,"Independent groups (means, SD's)",,,,,,,,,,,76.215,51.5669,39,88.4214,24.6221,225,Negative,,,,,,,-0.404816394,0.173849588,3.02E-02
Koster 2012,Quality of life: Role limitations (Physical health),6 month,"Independent groups (means, SD's)",,,,,,,,,,,50,76.9655,39,66.2283,55.9593,225,Negative,,,,,,,-0.272110059,0.173359575,3.01E-02
Koster 2012,Quality of life: Social functioning,6 month,"Independent groups (means, SD's)",,,,,,,,,,,70.74,29.2469,39,87.6491,18.6531,225,Negative,,,,,,,-0.821214465,0.176608514,3.12E-02
Koster 2012,Quality of life: Vitality,6 month,"Independent groups (means, SD's)",,,,,,,,,,,58,23,39,67,19,225,Negative,,,,,,,-0.457150708,0.174095134,3.03E-02
Labaste 2020,Quality of life,36 month,"Independent groups (means, SD's)",,,,,,,,,,,60,18.6,61,75,22.23,112,Negative,,,,,,,-0.710208114,0.162965779,2.66E-02
Luz 2020,Quality of life: Environment,1 month,"Independent groups (means, SD's)",,,,,,,,,,,56.4,13.5,74,62.1,16.2,31,Negative,,,,,,,-0.39461626,0.214119947,4.58E-02
Luz 2020,Quality of life: Physical,1 month,"Independent groups (means, SD's)",,,,,,,,,,,46.8,23.6,74,50.8,23.7,31,Negative,,,,,,,-0.168046653,0.212697657,4.52E-02
Luz 2020,Quality of life: Psychological,1 month,"Independent groups (means, SD's)",,,,,,,,,,,53.4,24.1,74,62.7,20,31,Negative,,,,,,,-0.401720436,0.214182846,4.59E-02
Luz 2020,Quality of life: Social relationships,1 month,"Independent groups (means, SD's)",,,,,,,,,,,48.9,15.8,74,56.4,18.8,31,Negative,,,,,,,-0.44504005,0.214590224,4.60E-02
Minden 2005,Quality of life: Energy,6 month,"Independent groups (means, SD's)",,,,,,,,,,,34.2,7.1,8,52.3,2.6,27,Negative,,,,,,,-4.418738652,0.658507885,0.433632634
Minden 2005,Quality of life: Health perception,6 month,"Independent groups (means, SD's)",,,,,,,,,,,57.7,8,8,70.8,2.7,27,Negative,,,,,,,-2.91214651,0.525216015,0.275851863
Minden 2005,Quality of life: Mental health,6 month,"Independent groups (means, SD's)",,,,,,,,,,,81.6,8.5,8,78.7,3.1,27,Positive,,,,,,,0.592167807,0.399637261,0.15970994
Minden 2005,Quality of life: Pain,6 month,"Independent groups (means, SD's)",,,,,,,,,,,73.6,13.2,8,71,4.6,27,Positive,,,,,,,0.346898154,0.395499168,0.156419592
Minden 2005,Quality of life: Physical function,6 month,"Independent groups (means, SD's)",,,,,,,,,,,50.9,7.4,8,70,2.9,27,Negative,,,,,,,-4.369562744,0.653803287,0.427458738
Minden 2005,"Quality of life: Role, emotional",6 month,"Independent groups (means, SD's)",,,,,,,,,,,80.7,24.6,8,74.4,7.3,27,Positive,,,,,,,0.471632697,0.397338835,0.15787815
Minden 2005,"Quality of life: Role, physical",6 month,"Independent groups (means, SD's)",,,,,,,,,,,22.8,17.7,8,42.9,6.8,27,Negative,,,,,,,-1.936219293,0.456351654,0.208256832
Minden 2005,Quality of life: Social function,6 month,"Independent groups (means, SD's)",,,,,,,,,,,39.7,10.2,8,70,3.7,27,Negative,,,,,,,-5.165109885,0.731997202,0.535819903
Naidech 2013,Quality of life: Applied cognition executive function,12 month,"Independent groups (Sample size, p)",,,,,,,,,,,,,29,,,56,Negative,,0.045,,,,2,-0.461439229,0.229451407,0.052647948
Naidech 2013,Quality of life: Fatigue,12 month,"Independent groups (Sample size, p)",,,,,,,,,,,,,29,,,56,Negative,,0.01,,,,2,-0.597679633,0.231293625,5.35E-02
Naidech 2013,Quality of life: Fine motor,12 month,"Independent groups (Sample size, p)",,,,,,,,,,,,,29,,,56,Negative,,0.7,,,,2,-8.77E-02,0.226805291,5.14E-02
Naidech 2013,Quality of life: Mobility,12 month,"Independent groups (Sample size, p)",,,,,,,,,,,,,29,,,56,Negative,,0.7,,,,2,-8.77E-02,0.226805291,5.14E-02
Rosenthal 2017,Quality of life: Health related (delirium with agitation vs without delirium with agitation) ,1 month,"Independent groups (means, SD's)",,,,,,,,,,,20.9,7.3,11,36.6,17.5,5,Negative,,,,,,,-1.324668598,0.561137157,0.314874909
Rosenthal 2017,Quality of life: Health related (delirium with agitation vs without delirium with agitation) ,12 month,"Independent groups (means, SD's)",,,,,,,,,,,20.5,11.1,11,44,12.2,5,Negative,,,,,,,-1.944682,0.614995891,0.378219946
Rosenthal 2017,Quality of life: Health related (delirium with agitation vs without delirium with agitation) ,3 month,"Independent groups (difference, p)",,,,,,,,,,,,,11,,,5,Negative,,0.3,-24.4,,,2,-0.548838627,0.519087963,0.269452313
Rosenthal 2017,Quality of life: Health related (delirium without agitation vs neither delirious nor agitated) ,1 month,"Independent groups (means, SD's)",,,,,,,,,,,30.4,16.5,18,40.4,15.9,47,Negative,,,,,,,-0.61506529,0.279135349,7.79E-02
Rosenthal 2017,Quality of life: Health related (delirium without agitation vs neither delirious nor agitated),12 month,"Independent groups (means, SD's)",,,,,,,,,,,34.2,12.9,18,36.7,14.6,47,Negative,,,,,,,-0.174426367,0.274300086,7.52E-02
Rosenthal 2017,Quality of life: Health related (delirium without agitation vs neither delirious nor agitated) ,3 month,"Independent groups (means, SD's)",,,,,,,,,,,40.4,19,18,37.9,14,47,Positive,,,,,,,0.159271816,0.274229168,7.52E-02
Svenningsen 2014,Quality of life: Bodily pain ,2 month,"Independent groups (means, SD's)",,,,,,,,,,,73.82,30.41,148,71.62,31.74,131,Positive,,,,,,,7.07E-02,0.119672081,1.43E-02
Svenningsen 2014,Quality of life: Bodily pain ,6 month,"Independent groups (means, SD's)",,,,,,,,,,,71.73,31.78,126,68.77,32.44,114,Positive,,,,,,,0.091935116,0.128921668,0.016620796
Svenningsen 2014,Quality of life: General health perceptions ,2 month,"Independent groups (means, SD's)",,,,,,,,,,,59.85,22.98,148,59.3,26.08,131,Positive,,,,,,,2.24E-02,0.119638427,0.014313353
Svenningsen 2014,Quality of life: General health perceptions ,6 month,"Independent groups (means, SD's)",,,,,,,,,,,63.94,24.36,126,60.91,27.42,114,Positive,,,,,,,0.11680858,0.128963613,1.66E-02
Svenningsen 2014,Quality of life: Mental health ,2 month,"Independent groups (means, SD's)",,,,,,,,,,,82.51,18.71,148,82.66,16.99,131,Negative,,,,,,,-8.35E-03,0.11963519,1.43E-02
Svenningsen 2014,Quality of life: Mental health ,6 month,"Independent groups (means, SD's)",,,,,,,,,,,85.14,15.3,126,82.09,19.59,114,Positive,,,,,,,0.174047164,0.129098014,1.67E-02
Svenningsen 2014,Quality of life: Physical function ,2 month,"Independent groups (means, SD's)",,,,,,,,,,,58.07,30.9,148,62.48,31.14,131,Negative,,,,,,,-0.141813681,0.119785204,1.43E-02
Svenningsen 2014,Quality of life: Physical function ,6 month,"Independent groups (means, SD's)",,,,,,,,,,,64.6,30.44,126,69.25,30.88,114,Negative,,,,,,,-0.151235802,0.129038128,1.67E-02
Svenningsen 2014,Quality of life: Role emotional ,2 month,"Independent groups (means, SD's)",,,,,,,,,,,84.01,31.22,148,88.8,27.31,131,Negative,,,,,,,-0.162209431,0.119831581,1.44E-02
Svenningsen 2014,Quality of life: Role emotional ,6 month,"Independent groups (means, SD's)",,,,,,,,,,,89.15,27.27,126,89.77,28.09,114,Negative,,,,,,,-0.022342425,0.128857394,1.66E-02
Svenningsen 2014,Quality of life: Role physical ,2 month,"Independent groups (means, SD's)",,,,,,,,,,,35.81,37.25,148,37.02,37.39,131,Negative,,,,,,,-3.23E-02,0.1196425,1.43E-02
Svenningsen 2014,Quality of life: Role physical ,6 month,"Independent groups (means, SD's)",,,,,,,,,,,53.18,39.24,126,55.04,39.1,114,Negative,,,,,,,-4.73E-02,0.128871468,1.66E-02
Svenningsen 2014,Quality of life: Social function ,2 month,"Independent groups (means, SD's)",,,,,,,,,,,76.41,27.72,148,79.96,27.02,131,Negative,,,,,,,-0.129240607,0.119759708,1.43E-02
Svenningsen 2014,Quality of life: Social function ,6 month,"Independent groups (means, SD's)",,,,,,,,,,,83.93,26.26,126,85.09,23.22,114,Negative,,,,,,,-4.65E-02,0.128870844,1.66E-02
Svenningsen 2014,Quality of life: Vitality ,2 month,"Independent groups (means, SD's)",,,,,,,,,,,60.41,22.47,148,58.78,25.01,131,Positive,,,,,,,6.86E-02,0.119669912,1.43E-02
Svenningsen 2014,Quality of life: Vitality ,6 month,"Independent groups (means, SD's)",,,,,,,,,,,64.68,22.71,126,62.65,26.33,114,Positive,,,,,,,8.26E-02,0.128908517,1.66E-02
VandenBoogaard 2012,Quality of life :Role-emotional,18 month,"Independent groups (means, SD's)",,,,,,,,,,,72.6111,58.317,171,76.5324,49.7646,744,Negative,,,,,,,-7.61E-02,8.48E-02,7.18E-03
VandenBoogaard 2012,quality of life :Social functioning,18 month,"Independent groups (means, SD's)",,,,,,,,,,,70.7863,28.4109,171,83.446,27.482,744,Negative,,,,,,,-0.457357966,8.54E-02,7.29E-03
VandenBoogaard 2012,Quality of life: Bodily pain,18 month,"Independent groups (means, SD's)",,,,,,,,,,,77.6489,33.6489,171,78.3503,31.9385,744,Negative,,,,,,,-2.17E-02,8.47E-02,7.18E-03
VandenBoogaard 2012,Quality of life: General health,18 month,"Independent groups (means, SD's)",,,,,,,,,,,53.2443,26.1679,171,58.2487,25.9964,744,Negative,,,,,,,-0.192108785,8.49E-02,7.20E-03
VandenBoogaard 2012,Quality of life: Mental,18 month,"Independent groups (means, SD's)",,,,,,,,,,,50,14.08,171,53,11.12,744,Negative,,,,,,,-0.255590321,8.49E-02,7.22E-03
VandenBoogaard 2012,Quality of life: Physical functioning,18 month,"Independent groups (means, SD's)",,,,,,,,,,,53.2443,41.121,171,71.4974,29.7102,744,Negative,,,,,,,-0.567400301,8.58E-02,7.36E-03
VandenBoogaard 2012,Quality of life: Role-physical,18 month,"Independent groups (means, SD's)",,,,,,,,,,,33.7785,56.0741,171,50,74.2756,744,Negative,,,,,,,-0.227515973,8.49E-02,7.21E-03
VandenBoogaard 2012,Quality of life: Vitality,18 month,"Independent groups (means, SD's)",,,,,,,,,,,56.7557,26.1679,171,60,22.2827,744,Negative,,,,,,,-0.14059964,8.48E-02,7.19E-03
VanderHeijden 2023,Quality of life: Non-Persistent delirium)),12 month,"Independent groups (means, SD's)",,,,,,,,,,,0.776,0.1784,529,0.864,0.1929,1871,Negative,,,,,,,-0.463494902,4.97E-02,2.47E-03
VanderHeijden 2023,Quality of life: Persistent delirium)),12 month,"Independent groups (means, SD's)",,,,,,,,,,,0.72,0.1933,529,0.864,0.1929,1871,Negative,,,,,,,-0.74592643,5.04E-02,2.54E-03
VanRompaey 2009,Quality of life Health perception,3 month,"Independent groups (means, p)",,,,,,,,,,,47.5,,20,55.7,,85,Negative,,0.4,,,,2,-0.208501613,0.247130201,0.061073336
VanRompaey 2009,Quality of life: Heath perception  ,6 month,"Independent groups (means, p)",,,,,,,,,,,57.5,,20,68.9,,85,Negative,,0.42,,,,2,-0.199752964,0.247095787,6.11E-02
VanRompaey 2009,Quality of life: Mental health ,6 month,"Independent groups (means, p)",,,,,,,,,,,68,,20,74.9,,85,Negative,,0.21,,,,2,-0.311210987,0.247643945,6.13E-02
VanRompaey 2009,Quality of life: Pain ,3 month,"Independent groups (means, p)",,,,,,,,,,,17.5,,20,36.4,,85,Negative,,0.14,,,,2,-0.366924464,0.248006924,6.15E-02
VanRompaey 2009,Quality of life: Pain ,6 month,"Independent groups (means, p)",,,,,,,,,,,32.5,,20,20.8,,85,Positive,,0.3,,,,2,0.256993369,0.247347579,6.12E-02
VanRompaey 2009,Quality of life: Physical function ,3 month,"Independent groups (means, p)",,,,,,,,,,,41.7,,20,59.1,,85,Negative,,0.13,,,,2,-0.376555135,0.248075655,6.15E-02
VanRompaey 2009,Quality of life: Physical function ,6 month,"Independent groups (means, p)",,,,,,,,,,,66.7,,20,73.8,,85,Negative,,0.56,,,,2,-0.144262261,0.246911776,6.10E-02
VanRompaey 2009,Quality of life: Role function ,3 month,"Independent groups (means, p)",,,,,,,,,,,30,,20,62.5,,85,Negative,,0.05,,,,2,-0.489293099,0.249010761,6.20E-02
VanRompaey 2009,Quality of life: Role function ,6 month,"Independent groups (means, p)",,,,,,,,,,,40,,20,78.8,,85,Negative,,0.01,,,,2,-0.64747004,0.250724143,0.062862596
VanRompaey 2009,Quality of life: Social function ,3 month,"Independent groups (means, p)",,,,,,,,,,,52,,20,75.3,,85,Negative,,0.2,,,,2,-0.318213999,0.24768632,6.13E-02
VanRompaey 2009,Quality of life: Social funtion,6 month,"Independent groups (means, p)",,,,,,,,,,,62,,20,81.5,,85,Negative,,0.24,,,,2,-0.291567047,0.247530075,6.13E-02
VanRompaey 2009,Qulaity of life: Mental health,3 month,"Independent groups (means, p)",,,,,,,,,,,70,,20,71.6,,85,Negative,,0.48,,,,2,-0.174888643,0.247006012,6.10E-02
Wolters 2014,Quality of life,12 month,"Independent groups (means, SD's)",,,,,,,,,,,0.8167,0.2317,182,0.857,0.2084,364,Negative,,,,,,,-0.185945682,9.08E-02,8.25E-03
Zipprich 2020,Quality of life,6 month,"Independent groups (means, SD's)",,,,,,,,,,,0.5,0.36,64,0.64,0.33,527,Negative,,,,,,,-0.419459342,0.132765857,1.76E-02
Sánchez-Lozano 2023,Quality of life,3 month,"Independent groups (means, SD's)",,,,,,,,,,,61,20,43,69,18,38,Negative,,,,,,,-0.415089575,0.222924774,4.97E-02
Chen 2017,Quality of life,9.82 month,"Independent groups (means, SD's)",,,,,,,,,,,61.97,2.8,44,68.36,2.4,92,Negative,,,,,,,-2.506333889,0.23730914,5.63E-02
